Research Experience for Undergraduates Program, 2004 by University of Arkansas, Fayetteville. Dept. of Chemistry and Biochemistry
University of Arkansas, Fayetteville 
ScholarWorks@UARK 
Research Experience for Undergraduates Chemistry and Biochemistry 
2004 
Research Experience for Undergraduates Program, 2004 
University of Arkansas, Fayetteville. Dept. of Chemistry and Biochemistry 
Follow this and additional works at: https://scholarworks.uark.edu/chbc-research-experience 
Citation 
University of Arkansas, Fayetteville. Dept. of Chemistry and Biochemistry. (2004). Research Experience for 
Undergraduates Program, 2004. Research Experience for Undergraduates. Retrieved from 
https://scholarworks.uark.edu/chbc-research-experience/1 
This Periodical is brought to you for free and open access by the Chemistry and Biochemistry at 
ScholarWorks@UARK. It has been accepted for inclusion in Research Experience for Undergraduates by an 
authorized administrator of ScholarWorks@UARK. For more information, please contact ccmiddle@uark.edu. 
University of Arkansas 
Department of Chemistry and Biochemistry 
NSF – REU – Summer 2004 
Poster Session 
 
Michelle Childress University of Arkansas, Fayetteville, AR 
“Towards an In-Vivo Calibrated Oxygen Electrode” David Paul 
 
Courtney Conrad Clarion University, Clarion, PA 
“Synthesis of Tosyl Hydrazones and Tosyll Hydrazines” Josh Sakon 
 
Amber Evans North Carolina A&T State University, Greensboro, NC 
“Synthesis of [n.1.1](2,6)-Pyridinophanes for Transition Metal-Mediated Catalysis” David Vicic 
 
Yolanda Harrison Xavier University of Louisiana, New Orleans, LA 
“Synthesis and Chemistry of Potential Organometallic Anticancer Drugs” Neil Allison 
 
Jason Kelly Concordia College, Moorhead, MN 
“Investigation of Mass Spectral Variation of Bacteria MALDI-TOF Spectra Resulting from 
Changed Growth Conditions” Charles Wilkins 
 
Peter Milano Bard College, Annandale-on-Hudson, NY 
“Synthesis of Enantioenriched N-methyl-2-(n-butyl/phenyl)azepane Using trans-2-
Cumylcyclohexanol as a Chiral Auxiliary” Robert Gawley 
 
Micah Niphakis Houghton College, Houghton, NY 
“Isolation and Purification of Thrombomodulin from Human Urine” Wesley Stites 
 
Justin Stanovich Ohio Northern University, Ada, OH 
“Preliminary Studies in the Synthesis of Eunicellane Diterpenes” Matthias McIntosh 
 
Vanja Stojkovic Northland College, Ashland, WI 
“Synthesis of O-TBS Protected First Generation Dendrimers” Robert Gawley 
 
Andjela Subotic Saint Mary’s College, Notre Dame, IN 
“Synthesis and Characterization of Bovine Lactoferricin Peptides” Denise Greathouse 
 
Eugenia Tsamis University of Northern Iowa, Cedar Falls, IA 
“Synthesis and Characterization of Peptides Anchored by Trp and Arg” Roger Koeppe 
 
Lena Yurs Lakeland College, Sheboygan, WI 
“Enzyme-Linked Immuno and DNA Hybridization Assays with Electrochemical Detection for 
the Malaria Parasite Plasmodium falciparum” Ingrid Fritsch 
 
1 
Table of Contents 
 
2004 REU Participants ..................................................................................................................2 
Faculty Project List........................................................................................................................3 
Schedule of Events .........................................................................................................................5 
Table of Reports .............................................................................................................................8 
Project Reports 
Michelle Childress .....................................................................................................................10 
Courtney Conrad ........................................................................................................................17 
Amber Evans ..............................................................................................................................29 
Yolanda Harrison .......................................................................................................................34 
Jason Kelly .................................................................................................................................41 
Peter Milano ...............................................................................................................................52 
Micah Niphakis ..........................................................................................................................63 
Justin Stanovich .........................................................................................................................76 
Vanja Stojkovic ..........................................................................................................................87 
Andjela Subotic ........................................................................................................................101 
Eugenia Tsamis ........................................................................................................................124 
Lena Yurs .................................................................................................................................148 
 
2 
2004 CHEMISTRY AND BIOCHEMISTRY REU 
 
The department of chemistry and biochemistry hosted one of four Research Experience 
for Undergraduates (REU) programs at the University of Arkansas, during the summer of 2004.  
These 10-week summer programs, funded by the National Science Foundation (NSF), 
gave students an opportunity to gain hands-on research experience in a chosen research area 
while introducing them to careers in scientific research. 
All UA REU students met weekly to hear presentations from campus experts on topics 
ranging from how to get into graduate school and test taking skills, to ethics, to how to make a 
poster presentation. A number of social activities were planned. 
Students in all programs took field trips to industrial sites to gain a real-world sense of 
science in their area. 
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Schedule of Events 
 
Sunday, May 23 
9:00 a.m. – 5:00 p.m.  Arrival, Check-In & Registration 
Reid Hall, Northwest Arkansas Regional Airport 
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9:00 a.m. – 9:30 a.m.  Group Photo 
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Speaker:  Collis Geren, Vice Provost for Research   
Topic:  “Important Elements of a Graduate Research Presentation” 
 
Saturday, May 29 – 
Monday, May 31     Free for Memorial Day Weekend 
 
Wednesday, June 2 
4:30 p.m. – 6:00 p.m.  Dinner & Dialogue 
    Place:  Reynolds Center, Seminar Room A 
    Speaker:  Professor Navam Hettiarachchy, Moderator 





Friday, June 4   
1:00 p.m.   REU Meeting – Faculty Presentation 
    Place:  MAIN 523 
    Speaker:  Professor Bob Gawley 
 
6:00 p.m.   Friday Entertainment:  Trip to Devil’s Den State Park 
    Host:  Professor David Paul, Chemistry REU 
 
Wednesday, June 9 
4:30 p.m. – 6:00 p.m.  Dinner & Dialogue 
    Place:  Reynolds Center, Seminar Room A 
    Speaker:  Laura Soles 
    Topic:  “Standardized Test Taking Strategies & the Admissions Process” 
 
Friday, June 11 
1:00 p.m.   REU Meeting 
    Overview of graduate program at the University of Arkansas 
 
5:00 p.m. – 9:00 p.m.  Friday Entertainment:  BBQ & Volleyball at Wilson Park 
    Host:  Angela Wilson, Carver Project 
 
Wednesday, June 16 
4:30 p.m. – 6:00 p.m.  Dinner & Dialogue 
    Place:  Reynolds Center, Seminar Room A 
    Speaker:  Suzanne McCray, Associate Dean, Honors College 
Topic:  “Securing Funding for Graduate School” 
 
Friday, June 18   
1:00 p.m.   REU Meeting – Faculty Presentation 
Place:  Main 523 
Speaker:  Dr. Jack Lay, Director, Statewide Mass Spectrometry    
Facility 
 
Wednesday, June 23 
4:30 p.m. – 6:00 p.m.  Dinner & Dialogue 
    Place:  Reynolds Center, Seminar Room A 
    Speaker:  UA Faculty, David Paul Moderating 
    Topic:  “Hot Topics at the U of A”, Faculty Panel 
 
Thursday, June 24 
6:00 p.m. – 9:00 p.m.  “Concert in the Park”  
    Place:  Gulley Park 
    Host:  Lin Oliver, Chair, Physics REU 
 
Friday, June 25   
1:00 p.m.   REU Meeting 
    Place:  MAIN 523 
Half-way Progress Reports Due 
 
Monday, June 28   
Full Day   Canoe Trip on the Elk River, Noel, MO 
 
Friday, July 2  
1:00 p.m.   REU Meeting – Faculty Presentation 
Place:  MAIN 523 
    Speaker:  Donald R. Bobbitt, Dean; Scientific Ethics   
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Friday, July 9  
1:00 p.m.   REU Meeting – Faculty Presentation 
Place:  MAIN 523 
    Speaker:  Professor Xiaogang Peng; Nano Chemistry  
 
Evening   Friday Entertainment:  Food, Games & Fun at the Vickers’ 
    Host:  Professor Ken Vickers, Microelectronics-Photonics  
 
Monday, July 12   
Full Day   Road Trip, National Center for Toxicological Research,   
         Jefferson, AR    
 
Friday, July 16   
1:00 p.m.   REU Meeting 
Place:  Main 523 
Speaker:  Jennifer Sims, Editor, Chemistry and Biochemistry  
Topic:  How to make a poster 
 
Friday, July 23   
1:00 p.m.   REU Meeting – Faculty Presentation 
    Place:  MAIN 523 
    Speaker:  Professor Chin Yu, Protein NMR 
    
Evening   Friday Entertainment:  Outdoor Fun at Wilson Park 
    Host:  Hazel Sears, Space & Planetary Science REU 
 
Thursday, July 29 
10:00 a.m.       Meeting in Miniature, Lunch Served 
    Place:  Phoenix House Lobby 
    Topic:  Student Poster Presentation 
  
Friday,  July 30 
5:00 p.m.    End of Program 
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Towards an In-Vivo Calibrated Oxygen Electrode 





The implantation of amperometric oxygen sensors enables doctors and/or scientists 
to measure oxygen content in the blood and/or tissues in-vivo.  Currently, this type of 
sensor has to be taken out of the body to be re-calibrated due to changes in sensitivity with 
use.  A sensor providing a means of in-vivo calibration would be a significant advance in 
this area.  In this experiment, calibration curves for dissolved oxygen were constructed 
using gold and glassy carbon electrodes with and without either a polyethylene membrane 
or a liquid Nafion membrane.  The data indicates that gold produced the best linear fit for 




Thermodynamically, oxygen is expected to reduce easily at +1.727 V, but the reduction 
of oxygen is difficult due to the activation energy barrier (or the over-potential) related to the 
electron transfer step.  The reaction is kinetically driven such that steady state diffusion limited 
current is only achieved at extreme negative potentials (–0.6 V).  (1)  The traditional oxygen 
electrode first introduced by Clark in 1956 is still in use today.  Other than miniaturization, this 
oxygen sensor still holds to Clark’s original design.  A noble metal electrode poised at a negative 
potential serves as a site for diffusion limited oxygen reduction.  The limiting current is 
proportional to the amount of oxygen present in the solution.  Part of the cleverness was to cover 
the electrode with a polyethylene membrane, trapping a thin layer of solution between the 
membrane and the electrode.  Oxygen diffuse through the membrane causing a straight-line 
concentration gradient between the membrane and electrode at all times.  At the steady state, the 
diffusion-limited current (iL) is proportional to the concentration of oxygen in the solution. 
The membrane keeps the noble metal electrode from being fouled by large organic or 
biological molecules.  Oxygen passes unheeded.  The oxygen permeability of the membrane 
determines the sensitivity of the electrode.  These same contaminates adsorb onto the membrane, 
the electrode still functions as an oxygen sensor, but the permeability of the membrane is altered.  
The sensor must then be re-calibrated, once more relating oxygen concentration to current, the 
constant of proportionality (sensitivity) set by the altered permeability of the membrane.  
The re-calibrating procedures for in-vivo oxygen sensors are impractical, disruptive to the 
patient, and very expensive. Contamination of the membrane covering the sensor from body-
fluids causes a change in the sensor's sensitivity.  The sensor must be withdraw and recalibrated 
or replaced.  In this paper we describe fundamental studies focusing on the optimization of the 
oxygen detecting electrode and membrane.  Ultimately we hope to develop an in-vivo calibration 
scheme which if proven successful, will enable doctors and /or scientists the ability to measure 
oxygen content in the blood and/or tissue in-vivo reliably, and over long periods of time.  One 
specific example of the long-term goal of this project is measuring oxygen using an implanted 
catheter for blood or fetal oxygen.  (3) 





Chemicals and Materials: 
 Compressed nitrogen and breathing air was obtained from Airgas, Inc. (Radnor, PA), 
reagent grade potassium chloride was purchased from Mallinckrodt Baker (Phillipsburg, NJ), 
and liquid Nafion (Dupont) perfluorinated ion-exchange resin (5wt % in a mixture of lower 
aliphatic alcohol and water) was obtained from Aldrich (Milwaukee, WI).  All solutions were 
made using purified water (>18 milli-ohms-cm milli-Q purification system, Millipore (Bedford, 
MA).  A 2mm gold electrode, (CH instruments, Austin, TX), or a 3mm glassy carbon electrode 
were used as a detecting electrodes, along with a platinum auxiliary electrode, and a calomel 
reference electrode.  Polyethylene membrane was obtained from YSI, Inc. (Yellow Springs, 
OH).  
    
 Instrumentation: 
 An YSI Model 55 handheld dissolved oxygen and temperature system, YSI, Inc. (Yellow 
Springs, OH) was used to monitor the dissolved oxygen concentration.  For data collection and 
analysis, a Gateway 2000 computer was interfaced to a CH Instruments Electrochemical 
Detector, Model 830 Potentiostat, CH Instruments, and (Austin, TX).  
 
Electrochemical Cell Construction: 
 The detecting electrodes were polished per manufacturers supplied instruction using a 
BAS (Bioanalytical Systems, West Lafayette, IN) polishing kit.  Ten micro-liters of Nafion was 
placed on the tip of the glassy carbon or gold detecting electrodes respectively and allowed to air 
dry for 2 hours.  A 500 mL beaker of 0.1 M potassium chloride containing a stir bar was placed 
on a magnetic stirrer.  Tygon tubing connected two disposable pipettes one to compressed 
nitrogen, the other to breathing quality air was placed in the solution.  An YSI Model 55 
dissolved oxygen probe was calibrated according to manufacturer’s instructions and added to the 
solution.  A platinum flag auxiliary, Calomel reference, and the detecting and generating 
electrode construction were placed within the beaker.  The electrodes were attached via copper 
leads to a CH Instruments Model 830 Potentiostat interfaced to a computer for collection and 
analysis of the electrochemical data.   
 
Calibration Procedure: 
 The magnetic stirrer was turned on to a setting of “4”.  Nitrogen was bubbled into the 
solution until a minimum oxygen level was reached.  The nitrogen was then turned off, but 
stirring continued for 30 seconds.  I then recorded the dissolved oxygen (D.O) reading, ceased 
stirring, and waited 30 seconds.  An amperometric i-t experiment was performed to reduce all the 
oxygen that may have been trapped in the Nafion membrane.  The parameters I used were:  
Initial E (V):  -0.8, Sample interval (s): 0.1, Running time (s): 300, Quiet time (s): 0, Scales 
during run: 1, Sensitivity (A/V): 1 x 10-5.  I then immediately performed a cyclic voltametric 
experiment using the following parameters:  Initial E (V): 0, High E (V): 0, Low E (V): -1, Initial 
scan polarity: negative, Scan rate (V/s): 0.1, Sweep segments: 2, Sample interval (V): 1 x 10-3, 
Quiet time (s): 2, Sensitivity (A/V): 1 x 10-5.  I then began stirring and bubbling breathing air 
into the solution until the concentration of oxygen had risen to 1.00 mg/L.   I then turned off the 
air, but I continued to allow the solution to stir for exactly one minute to allow the oxygen to 
equilibrate across the membrane.  I recorded the D.O. reading, ceased stirring, and waited 30 
12  
seconds.  I then performed a cyclic voltammeter on the glassy carbon electrode with the same 
parameters as before.  This procedure was repeated at 2, 3, 4, 5, 6, 7, 7.5 mg/L oxygen.  The CV 
current at –0.6 V was plotted against the oxygen concentration using an Excel spread sheet.  The 
electrodes were cleaned and polished to begin a new calibration procedure using polyethylene as 
the membrane.  The calibration procedure was repeated as stated above.  The electrodes were 
once again cleaned and polished, but were inserted into the solution without a membrane.  This 
calibration procedure was repeated as stated above.   
 After analysis of the data collected for the glassy carbon-detecting electrode, the process 
was repeated using each membrane with gold as the detecting electrode.  
 
Results and Discussion 
 
Figure 1 shows CV scans at various concentrations of dissolved oxygen at a glassy 
carbon electrode.  Figure 2 shows the same CV experiment using a gold electrode.  The 
voltammograms for oxygen between the two electrode materials are starkly different.  Both 
electrodes show irreversible reduction waves, far negative of the expected thermodynamic 
potential.  This indicates that the kinetics of the electron transfer between the electrode and the 
oxygen controls the reduction.   
Figure 3 shows calibration curves for oxygen at a gold electrode, derived from measuring 
the CV current at –0.6 V and plotting the values as a function of dissolved oxygen concentration.  
Figure 4 shows the same calibration curves for oxygen using glassy carbon as the electrode.  
Comparisons of the oxygen calibration curves between the two electrodes show that gold 
provides a more linear calibration curve than glassy carbon regardless of the type of membrane 
present.  Because oxygen diffusion is identical in both cases, we assume that this difference is 
caused by differences in electron transfer kinetics between the two electrode materials.  In 
addition, the sensitivity is higher on gold than glassy carbon even though the glassy carbon has a 
larger area.   
The Nafion coated electrode shows about the same sensitivity toward oxygen as the bare 
gold or glassy carbon electrodes.  For the glassy carbon, but especially the gold electrode, 
switching to the polyethylene membrane causes a non-linear calibration curve.  The exact cause 
of this is unknown but may be due to a lack of electrolyte between the membrane and the 
electrode.  Such a thin film of solution is provided for in the construction of the commercial 
oxygen electrode.  Future designs using polyethylene membranes should try to incorporate this 




The re-calibrating procedures for in-vivo oxygen sensors are impractical, disruptive to the 
patient, and very expensive. Contamination of the membrane covering the sensors from body-
fluids causes a change in the sensor's sensitivity.  In this paper we describe fundamental studies 
which focus on the optimization of the oxygen detecting electrode and membrane. Now that 
these aspects of the detecting electrode have been determined, the project can proceed with gold 
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Figure 4 (a) Peak current for a cyclic voltammetry of O2 at a glassy carbon electrode with 
no membrane.  (b) Peak current for a cyclic voltammetry of O2 at a glassy carbon electrode with 
a polyethylene membrane.  (c) Peak current for a cyclic voltammetry of O2 at a glassy carbon 







Figure 1 Cyclic voltammetry of O2 at a gold detecting electrode.   
 
Figure 2 Cyclic voltammetry of O2 at a glassy carbon electrode.   

































Figure 3 (a) Peak current for a cyclic voltammetry of O2 at a gold detecting electrode with 
no membrane.  (b) Peak current for a cyclic voltammetry of O2 at a gold detecting electrode with 
a polyethylene membrane.  (c) Peak current for a cyclic voltammetry of O2 at a gold detecting 










Synthesis of Tosyl Hydrazones and Tosyl Hydrazines 





The hydroisobenzofuran core is common to many of the 2, 11-cyclized cembranoids, 
which are a class of biologically active natural products with antimitotic activity. The 
broad aim of this project is to build libraries of compounds by functionalizing each 
compound while maintaining the hydroisobenzofuran core common to all. The McIntosh 
lab has established a synthetic pathway in order to produce compounds possessing the 
isobenzofuran backbone using recently developed cycloaldol reactions. A 2-Bromophenyl 
based scaffold for diversification to build libraries of compound has been synthesized by 
utilization of sulfonylhydrazones, which are potentially versatile linkers for solution and 
solid phase synthesis to build libraries of isobenzofuran derivatives. Aldehydes and ketones 
readily undergo condensation with sulfonyl hydrazide, including sterically hindered 
ketones. Model studies on various α−β unsaturated ketones to synthesize sulfonyl 
hydrazones and hydrazines have been investigated in this paper. Upon successful synthesis 
of tosyl hydrazines, data will be evaluated and applied to further studies for the elimination 




A class of marine natural products called the 2, 11-cyclized cembranoids is of special 
interest to researchers due to the possession of an isobenzofuran core (Figure I).1   By modifying 
the stereochemistry and degree of oxidation of the isobenzofuran core backbone, various 
compounds can be synthesized in order to create a library of substances with potential antimitotic 
capabilities. The synthesizing of compounds containing an isobenzofuran backbone, which was 
based on the work of Chai1, has shown to be beneficial in the development of anti-cancer agents 
that interrupt mitosis.  For instance, eunicellin diterpenes, a family of biologically active natural 
products, possess a modified isobenzofuran core backbone.2  Eleutherobin (Figure 2), which 
belongs to the family of eunicellin diterpenes, exhibits anti-cancer characteristics. By stabilizing 
microtubules, eleutherobin suppresses cell division in various tumor cell lines.3-4  In addition, 
Sclerophytin-A (Figure 3), which also belongs to the eunicellin diterpenes, has shown promising 










































Due to the medical importance of antimitotic compounds, we are performing research in 
order to optimize the production of various compounds containing the isobenzofuran core 
backbone. By synthesizing a library of these compounds, both in solution and solid phase, we 
may analyze the compound’s ability to adhere to specific enzymes in order to inhibit cell 
division by preventing microtubule degradation.  
We have been performing extensive research on sulfonylhydrazones, which are 
potentially versatile linkers for solution and solid phase synthesis. The use of sulfonylhydrazone 
as a linker is of particular interest during the synthesis of isobenzofuran derivatives due to four 
important advantages: (i) aldehydes and ketones readily undergo condensation with 
sulfonylhydrazides;6 (ii) literature reveals that the sulfonylhydrazone functional group is tolerant 
of various reaction types;7 (iii) the sulfonylhydrazone functional group can act as a nucleophile;8 
and (iv) solid supported sulfonyl hydrazide is readily accessible from commercially available 
polymer supported sulfonyl chloride.9   
In corroboration with Paul Hanson, we have devised a system to develop a collection of 
isobenzofuran derivatives (Scheme 1).  The proposed procedure calls for the utilization of ring 
opening metathesis polymerization (ROMP) for phase trafficking, a procedure that was 
formulated by Hanson.10 Currently, we are performing model studies by using (R)-carvone 
derived esters to test the viability of this approach, as seen in Scheme I.  The initial step in the 
proposed system is to synthesize compounds with an isobenzofuran core. Reacting sodium 
vinylsulfonate (1.1) with thionyl chloride (1.2) produces vinyl sulfonyl chloride (1.3). Upon 
preparation of vinyl sulfonyl chloride (1.3), cyclopentadiene (1.4) is added to generate a 
norborenyl sulfonyl chloride (1.5) by utilization of a Diels Alder reaction. The chlorine is then 
displaced by a hydrazine to yield hydrazide (1.6), which can further react with the aldehyde, (R)-
carvone (1.7), to produce the desired hydrazone (1.8). Ring opening metathesis polymerization 
(ROMP) of the hydrazone with Grubbs catalyst gives the desired oligomer (1.9). Upon synthesis 
of the oligomer (1.9), additional reactions may be done to the (R)-carvone substructure. After 
purification, the hydrazone linkage is cleaved to isolate limonene (1.12) by reducing the 
hydrazone oligomer to the desired hydrazide. Elimination of the sulfonate polymer and 




















































As stated previously, norborenyl sulfonylhydrazine is used in the proposed system; 
however, complications have arisen, and the synthesis is currently being revised. Because 
norborenyl sulfonylhydrazine (1.6) and tosyl hydrazine (2.2) are alike in structure, preliminary 
work is being performed by synthesizing various tosyl hydrazones. Theoretically, norborenyl 
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sulfonylhydrazine (1.6) and tosyl hydrazine (2.2) should react similarly with various α−β 
unsaturated ketones and aldehydes.  
Reacting various α−β unsaturated ketones and aldehydes with an excess of tosyl 
hydrazine (1.1 equiv.) (2.2), which is also known as p-Toluenesulfonic acid, will produce various 
tosyl hydrazones. As seen with α− ionone (2.1), ketones can easily be converted into hydrazones 
(Scheme 2). Upon synthesis of tosyl hydrazone (2.3), catecholborane (1.5 equiv.) (3.1) is used to 


































Synthesis of α−ionone Tosyl Hydrazone 
 Tosyl hydrazine (1.06g, 5.2 mmol) was dissolved in methanol (40mL) and added to a 
flame dried round bottom flask. α−ionone (1.00g, 5.2 mmol) was added via syringe, resulting in 
a white solid suspended in a pale yellow liquid. The solution was then allowed to reflux at 78° C 
over forty-eight hours, or until the depletion of α−ionone was verified by TLC. Upon 
completion, the solution was cooled to room temperature and concentrated in vacuo. A yellow 
solid was obtained and purified by recrystallization from hot ethanol to yield a pale yellow 
crystalline solid. The crystals were isolated by vacuum filtration. The filtrate was then 
concentrated in vacuo, and the recrystallization process was repeated. After all desired crystals 
were obtained from the mother lacquer, crystals were combined and purified further by 
recrystallization, resulting in a white, powdery solid (1.432, 75% yield).  
 
Synthesis of β−ionone Tosyl Hydrazone 
Tosyl hydrazine (1.06g, 5.2 mmol) was dissolved in methanol (40mL) and added to a 
flame dried round bottom flask. β−ionone (1.00g, 5.2 mmol) was added via syringe, resulting in 
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a white solid suspended in an orange liquid. The solution was then allowed to reflux at 78° C 
over forty-eight hours, or until the depletion of β−ionone was verified by TLC. Upon 
completion, the solution was cooled to room temperature and concentrated in vacuo. A dark 
yellow solid was obtained and purified by recrystallization from hot ethanol to yield a yellow 
crystalline solid. The crystals were isolated by vacuum filtration. The filtrate was then 
concentrated in vacuo, and the recrystallization process was repeated. After all desired crystals 
were obtained from the mother lacquer, crystals were combined, and purified further by 
recrystallization, resulting in a fine, white crystalline solid (1.7923g, 95% yield). 
 
Synthesis of Testosterone Propionate Tosyl Hydrazone 
 Tosyl hydrazine (.5946g, 3.9 mmol) was dissolved in methanol (40mL) and added to a 
flame dried round bottom flask. Testosterone propionate (1.00g, 2.9 mmol) was added, resulting 
in a pale yellow solution. The solution was then allowed to reflux at 78° C over forty-eight 
hours, or until the depletion of testosterone propionate was verified by TLC. Upon completion, 
the solution was cooled to room temperature and concentrated in vacuo. A dark brown oil was 
obtained, and recrystallization by hot ethanol was attempted; however, a crystalline solid was not 
recovered.  
 
Synthesis of 4-carbethoxy-3-methyl-2-hexen-1-one Tosyl Hydrazone 
 Tosyl hydrazine (1.1243g, 6.0 mmol) was dissolved in methanol (40mL) and added to a 
flame dried round bottom flask. 4-carbethoxy-3-methyl-2-hexen-1-one (1.00g, 5.5 mmol) was 
added, resulting in a pale yellow solution. The solution was then allowed to reflux at 78° C over 
forty-eight hours, or until the depletion of 4-carbethoxy-3-methyl-2-hexen-1-one was verified by 
TLC. Upon completion, the solution was cooled to room temperature and concentrated in vacuo. 
A brown oil was obtained, and recrystallization by hot ethanol was attempted; however, a 
crystalline solid was not recovered. 
 
Synthesis of 2-methoxy cinnamaldehyde Tosyl Hydrazone 
 Tosyl hydrazine (1.1482g, .68 mmol) was dissolved in methanol (40mL) and added to a 
flame dried round bottom flask. 2-methoxy cinnamaldehyde (1.00g, .62 mmol) was added, 
resulting in an orange liquid. The solution was then allowed to reflux at 78° C over forty-eight 
hours, or until the depletion of 2-methoxy cinnamaldehyde was verified by TLC. Upon 
completion, the solution was cooled to room temperature and concentrated in vacuo. A dark 
orange solid was obtained and purified by recrystallization from hot ethanol to yield a brown 
crystalline solid. The crystals were isolated by vacuum filtration. The filtrate was then 
concentrated in vacuo, and the recrystallization process was repeated. After all desired crystals 
were obtained from the mother lacquer, crystals were combined and purified further by 
recrystallization, resulting in a white solid (1.13783g, 56% yield). 
 
Synthesis of Perillaldehyde Tosyl Hydrazone 
 Tosyl hydrazine (1.3637g, 7.3 mmol) was dissolved in methanol (40mL) and added to a 
flame dried round bottom flask. Perillaldehyde (1.00g, 6.6 mmol) was added via syringe, 
resulting in a yellow liquid. The solution was then allowed to reflux at 78° C over forty-eight 
hours, or until the depletion of perillaldehyde was verified by TLC. Upon completion, the 
solution was cooled to room temperature and concentrated in vacuo. A pale yellow solid was 
obtained and purified by recrystallization from hot ethanol to yield a pale yellow solid. The 
 22 
crystals were isolated by vacuum filtration. The filtrate was then concentrated in vacuo, and the 
recrystallization process was repeated. After all desired crystals were obtained from the mother 
lacquer, crystals were combined and purified further by recrystallization, resulting in clear, 
needle-like crystals (1.7345g, 82% yield). 
 
Synthesis of α−ionone Tosyl Hydrazine 
α−ionone tosyl hydrazone (5g, 13.9 mmol) was dissolved in chloroform (~30mL) and, 
syringed into a flame dried round bottom flask. The reaction flask was cooled to 0° C, and 
catecholborane (2.45g, 20.8 mmol) was added dropwise, resulting in a yellow solution. Reaction 
was then stirred overnight. Upon completion, the solution was quenched by the addition of acetic 
acid (3 mL). After stirring for thirty minutes, the mixture was transferred to a separatory funnel 
with water and dichloromethane. The organic layers were washed twice with water (10 mL), and 
the combined water layers were then extracted three times with dichloromethane (10 mL). 
Combined organic layers were dried over magnesium sulfate and concentrated in vacuo, 
resulting in a brown oil. The oil was placed on high vacuum in order to obtain a solid. The 
residue solid was dissolved in dichloromethane and precipitated out with cold methanol. The 
crystals were isolated by vacuum filtration, and the product was stored in the freezer. 
 
Synthesis of β−ionone Tosyl Hydrazine 
β−ionone tosyl hydrazone (.7g, 2.8 mmol) was dissolved in chloroform (~30mL) and, 
syringed into a flame dried round bottom flask. The reaction flask was cooled to 0° C, and 
catecholborane (.37g, 3.1 mmol) was added dropwise, resulting in a yellow solution. Reaction 
was then stirred overnight. Upon completion, the solution was quenched by the addition of acetic 
acid (3 mL). After stirring for thirty minutes, the mixture was transferred to a separatory funnel 
with water and dichloromethane. The organic layers were washed twice with water (10 mL), and 
the combined water layers were then extracted three times with dichloromethane (10 mL). The 
combined organic layers were dried over magnesium sulfate and concentrated in vacuo, resulting 
in a light brown oil. The oil was placed on high vacuum in order to obtain a solid. The residue 
solid was dissolved in dichloromethane and precipitated out with cold methanol. Crystals were 
isolated by vacuum filtration, and the product was stored in the freezer. 
 
Synthesis of 2-methoxy cinnamaldehyde Tosyl Hydrazine 
2-methoxy cinnamaldehyde tosyl hydrazone (.7g, 3.0 mmol) was dissolved in chloroform 
(~30mL) and, syringed into a flame dried round bottom flask. The reaction flask was cooled to 
0° C, and catecholborane (.54g, 4.5 mmol) was added dropwise, resulting in a yellow solution. 
Reaction was then stirred overnight. Upon completion, the solution was quenched by the 
addition of acetic acid (3 mL). After stirring for thirty minutes, the mixture was transferred to a 
separatory funnel with water and dichloromethane. The organic layers were washed twice with 
water (10 mL), and the combined water layers were then extracted three times with 
dichloromethane (10 mL). The combined organic layers were dried over magnesium sulfate and 
concentrated in vacuo, resulting in an orange oil. The oil was placed on high vacuum in order to 
obtain a solid. The residue solid was dissolved in dichloromethane and precipitated out with cold 
methanol. Crystals were isolated by vacuum filtration, and the product was stored in the freezer. 
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Synthesis of Perillaldehyde Tosyl Hydrazine 
Perillaldehyde tosyl hydrazone (.7g, 3.1 mmol) was dissolved in chloroform (~30mL) 
and, syringed into a flame dried round bottom flask. The reaction flask was cooled to 0° C, and 
catecholborane (.57g, 4.7 mmol) was added dropwise, resulting in a yellow solution. Reaction 
was then stirred overnight. Upon completion, the solution was quenched by the addition of acetic 
acid (3 mL). After stirring for thirty minutes, the mixture was transferred to a separatory funnel 
with water and dichloromethane. The organic layers were washed twice with water (10 mL), and 
the combined water layers were then extracted three times with dichloromethane (10 mL). The 
combined organic layers were dried over magnesium sulfate and concentrated in vacuo, resulting 
in a dark yellow oil. The oil was placed on high vacuum in order to obtain a solid. The residue 
solid was dissolved in dichloromethane and precipitated out with cold methanol. Crystals were 
isolated by vacuum filtration, and the product was stored in the freezer. 
 
Results and Discussion 
 
The synthesis of various tosyl hydrazones (Scheme 2) and tosyl hydrazines (Scheme 3) 
was attempted by reacting α−β unsaturated ketones and aldehydes with tosyl hydrazide. This 
method proved to be successful in the synthesis of tosyl hydrazones and tosyl hydrazines. 
However, a slight modification was implemented in the production of tosyl hydrazones in order 
to gain optimal yields.  
 According to the procedure for synthesizing tosyl hydrazones, by the utilization of 
various α−β unsaturated ketones and aldehydes, the reaction is to be refluxed for twenty-four 
hours at 78° C. Upon performing TLC, starting material was shown to be present after this time 
period; however, after approximately forty-eight hours, the reaction came to completion.  
Initially, difficulties in the recrystallization of various tosyl hydrazones were observed, 
but after varying the amount of 95% ethanol added to dissolve crude tosyl hydrazone, 
purification was finally attained. In the recrystallization of α-ionone tosyl hydrazone, β-ionone 
tosyl hydrazone, 2-methoxy cinnamaldehyde tosyl hydrazone, and perillaldehyde tosyl 
hydrazone, the minimal amount of 95% ethanol yielded the best results.  Reactions were 
monitored by 1 H NMR. 
In the first trial of synthesizing hydrazones, the percent yields vary, as seen in Table 1. 
α-ionone tosyl hydrazone and β-ionone tosyl hydrazone show decent yields, whereas 2-methoxy 
cinnamaldehyde and perillaldehyde tosyl hydrazone do not. The fluctuation in yields is believed 
to have been an outcome of washing with methanol during the isolation of the desired hydrazone. 
While isolating desired crystals of the second with hexanaes, rather than methanol, yields 
increased significantly (Table 2). 
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Table 1 
























































































































































































 Purification of testosterone propionate and 4-carbethoxy-3-methyl-2-hexen-1-one was 
not achieved. After these compounds were concentrated in vacuo, an oil was formed. Because 
recrystallizations that do not begin from solids are difficult to perform, the main troubleshooting 
task aimed towards the solidification of the crude material. Various solvent systems were 
attempted in order to attain crystals; however, none gave purification of testosterone propionate 
tosyl hydrazone or 4-carbethoxy-3-methyl-2-hexen-1-one tosyl hydrazone. A column and prep 
plate were planned methods of purifying these tosyl hydrazones; however, were not due to time 
restraints.  
 The synthesis of tosyl hydrazines proved to be more difficult than the synthesis of tosyl 
hydrazones, most notably in the purification procedure. One-gram scales of α-ionone, β-ionone, 
2-methoxy cinnamaldehyde, and perillaldehyde tosyl hydrazones to tosyl hydrazines were 
attempted (Scheme 3). A five-gram scale of α-ionone tosyl hydrazone to tosyl hydrazine was 
also performed. Reactions were monitored by 1H NMR. 
 Small scales of various tosyl hydrazones to crude tosyl hydrazines were not difficult; 
however, the recrystallization process was very troublesome. Crude products were dissolved in 
dichloromethane, and desired products were precipitated out with cold methanol, resulting in 
fine, miniscule crystals. Due to the quality of crystals obtained, problems in the isolation of the 
desired tosyl hydrazine occurred. This complication resulted in poor yields as seen in Table 3. 
Although, the yield of 2-methoxy cinnamaldehyde tosyl hydrazone was calculated to be 141%; 
however, this finding indicates that the product is impure and needs further purification. 
Perillaldehyde tosyl hydrazine was not completed due to an accident in which the product was 
lost. 
The large, five-gram scale of α-ionone tosyl hydrazone to tosyl hydrazine proved to be 
more promising than the small-scale synthesis. Dichloromethane and cold methanol was used to 
purify crude α-ionone tosyl hydrazine. More robust crystals formed, therefore, making the 
isolation process somewhat easier.  
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Table 3  































































































Conclusion and Further Research 
 
 The preliminary study of synthesizing various tosyl hydrazones and crude tosyl 
hydrazines using the proposed system has been achieved; however, techniques in the purification 
of tosyl hydrazines need to be investigated further. Due to structural similarities between tosyl 
hydrazines and norborenyl sulfonyl hydrazines, a purification procedure that provides adequate 
tosyl hydrazine crystals would be tremendously useful in future studies concerning the synthesis 
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Synthesis of [2.1.1](2,6)-Pyridinophanes for Transition-Metal  
Mediated Catalysis 
Amber O. Evans, North Carolina Agricultural & Technical State University 




 Ligands of the [n.1.1.](2,6)-pyridinophane family are attractive because they have 
the ability to efficiently stabilize a metal center within a pyridine macrocycle, thus 
producing a stable catalyst.  The motivation of this work is to better catalyze reactions in 
which new carbon-carbon bond are formed.  Transition metal catalysts are of growing 
importance to industry because utilization of them produces more of the desired product 
and less waste, resulting in more efficient and environmentally-benign processes. The 
present work reports the synthesis of 1,2-bis(2-pyridyl)ethane, a precursor to the ligand, 




 The present work is a component of a larger project whose objective is to develop new 
transition metal-catalyzed methods for Calkyl-Calkyl bond forming reactions, also referred to as 
coupling reactions.  Ligands are of importance to this study because they can influence the 
behavior of a transition-metal catalyst by modifying the steric or electronic environment at the 
active site, the site at which the participative ligands combine.1 Therefore, when varied, they 
affect catalytic properties such as selectivity of the transition metal complex. 
 Transition-metal catalysts are used widely in nature, industry, and in the laboratory, and it 
is estimated that they contribute to one-sixth of the value of all manufactured goods in 
industrialized countries.2  Industrial processes that produce additives, plasticizers, drugs, and 
other high-value items are concerned with maximizing the ratio of product to waste, a principle 
known as the Q factor.3  In these reactions, the metal catalysts are present in minimal quantity 
and the selectivity of the reaction is enhanced.  With these parameters intact, energy is 
conserved, pure products are produced in higher yield, and cleaner industrial processes are 
achieved.   
   The current study focuses on the synthesis of ligands 
of the [n.1.1]-(2,6)-pyridinophane family (Figure 1).  These 
ligands are facially tridentate, and comprised of pyridines 
linked into a macrocycle.  Pyridinophanes are of interest to 
studies of transition-metal mediated catalysis because they 
contain ethylene bridges that contribute flexibility to the 
macrocyle and pyridines that contribute rigidity, which 
affects the ability of the ligand to act as a preorganized metal 
coordination unit.  The metal of interest to this work is nickel because its catalytic effects have 
proven to be comparable to those of palladium (II), which is commonly used to catalyze coupling 















General Procedures and Instrumentation 
  All manipulations were carried out under purified argon using standard Schlenk 
techniques.  All solvents were dried and distilled over sodium and stored in a nitrogen-filled 
glovebox.  Reagents were obtained from Aldrich Chemical Co.  1H NMR analysis was conducted 
on a JEOL Eclipse-270 MHz NMR spectrometer in CDCl3.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               
 
Synthesis of 1,2-bis(2-pyridyl) ethane, C12H12N2 
 A 250 mL Schlenk flask filled with argon was charged with 150 mL dry THF and 10 mL 
of picoline (0.10 mol, distilled over calcium hydride).  The stirring solution was placed in an ice 
bath and 12 mL of 9 M n-butyllithium (0.11 mol) in hexanes was syringed slowly.  After the 
addition, the cranberry-colored flask was removed from the bath and allowed to stir at room 
temperature for an hour.  Prior to the addition of 4.5 mL of 1,2-dibromoethane (0.05 mol)  in 10 
mL of THF, the flask was placed in an acetone/dry ice bath to maintain a temperature of -60°C.  
Proceeding the addition on 1,2-dibromoethane, the flask was removed from the bath and allowed 
to warm to room temperature.  A saturated aqueous solution of potassium hydroxide (20 g in 50 
mL) was added to the reaction mixture, and lithium hydroxide and potassium bromide were 
separated from the liquid, which was then dried over solid potassium hydroxide overnight.   The 
solvent was removed and the remains were distilled first under argon then vacuum.  The flask 
was placed under vacuum overnight, and 8.75 g (94%) of yellow orange solid was obtained. 
 
Synthesis of [2.1.1] (2,6)-Pyridinophane, C19H17N3 
  An argon-filled 1000 mL Schlenk flask was charged with 11 mL of 2,6-lutidine (0.10 
mol) dried over calcium hydride and 35 mL of diethyl ether.  The flask was placed in an ice bath 
and 12 mL of 10 M n-butylliuthium in hexanes (0.11 mol) was carefully added.  After the 
addition, the flask was allowed to stir for 1 h at ambient temperature, then the ether was removed 
in a vacuum, yielding a yellowish-red solid.  A solution of 4.25 g 1,2-bis(2-pyridyl) ethane 
(0.023 mol) in 50 mL toluene was cannulated into the flask.  The contents of the flask were 
refluxed at 170˚C for 24 hours, and then the resulting black solution was cooled.  Methanol (≈20 
mL) was added to decompose lithium hydride, followed by an equal amount of water to 
precipitate lithium hydroxide.  The mixture was filtered, dried over solid potassium hydroxide, 
and the resulting layers were separated using a 500 mL separatory funnel.  The organic layer 
afforded a brown oil after distillation under argon and vacuum.  Recrystallization from heptane 
produced 1 g (29 %) of brown oil. 
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 The synthesis of [2.1.1]-(2,6)-pyridinophane (2) was  significantly more challenging than 
expected.  First, the precursor, 1,2-bis(2-pyridyl) ethane (1), was produced by the lithiation of 
two mol 2-picoline followed by the addition of a 1,2-dibromoethane.4  No purification was 
necessary, as proven by the 1H NMR spectrum (Figure 2). Next, four mol of lithiated 2,6-
lutidine (LiLut) was treated with the precursor in a double condensation reaction.  According to 
the literature, a two equivalent sample is necessary by stoichiometry to produce two mol of 2 and 
two mol of lithium hydride; however the two acidic methylene bridges consume an extra two 
mol of LiLut. 5 
 The major setback in the synthesis of 2 was the inability to obtain a pure product.  
Although, the literature reported that the best yields of 2 could be obtained with the use of 4.5-5 
mol LiLut, each time this synthesis was conducted, the 1H NMR spectrum of the product (Figure 
3) indicated the presence of unreacted 2,6-lutidine and 1.  As a solution to this problem, more 
than the calculated amount of 10 M n-butyllithium was used to ensure that all of the lutidine was 
lithiated, and in turn ready to react with the precursor.  This modification of procedure did not 
seem to help the yields, because the reactants were still present in the final spectra.  Column 
chromatography was employed with 50:50 ethyl acetate-dichloromethane to isolate the product, 
but each time either the product stuck to the column or the separation was inadequate.  A few 
drops of triethylamine per thousand milliliters of solvent were used to remove the product from 
the column, but this resulted in loss of product and no separation.  Effective methods of 









1) Et2O, 170 C, 24 h
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Figure 2 1H NMR of 1,2-bis(2-pyridyl) ethane  
1H:  3.23 (s, 4H), 7.07 (ddd, 2H), 7.09 (dd), 7.11 (, 7.54(dt, 2H), 8.55 (m, 2H) 
 
 
Figure 3 1H NMR of [2.1.1](2,6)-Pyridinophane 
1H:  3.23 (s, 4H), 4.02 (s, 4H), 6.86 (d, 2H), 6.92 (d, 2H), 6.94 (d, 2H), 6.97 (d, 2H), 7.40 (t, 2H),             
7.43 (t, 2H) 
*The unlabeled peaks downfield of chloroform (7.24 ppm) are peaks that are characteristic of the 




 [2.1.1](2,6)-Pyridinophane was synthesized; however, the crude product will have to be 
purified to isolate the actual ligand from the reactants. Future work in this area entails the 
formation of a nickel complex, as illustrated by Scheme 3, characterization by 1H and 13C 
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spectroscopy, and X-ray crystallography. Finally, its ability to catalyze C(sp3)—C(sp3) bond-
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Synthesis and Chemistry of Potential Organometallic Anticancer Drugs 
Yolanda Harrison, Xavier University of Louisiana 




 Compounds that incorporate the o-quinone methide moiety have been used in the 
treatment of certain types of cancer and tumors. The Allison group is currently studying 
the synthesis and preparation of transition metal complexed 5-membered ring analogs of o-
quinone methide.  The immediate research is to prepare a selected benzannulated vinyl 
allene that is unsubstituted at the terminal carbon of the allene moiety.  It is believed that 
this compound can be converted to a transition metal complexed quinione methide analog 
whose reactivity will thus increase over the ones that have been prepared currently in the 
group having more substituents. Thus this synthesis aims to make an unsubstituted version 
of this 5-membered ring quinone methide from a propargyl alcohol reacted with lithium 





The significance of my research comes from preparing transition metal complexed 
analogs of an important compound o-quinone-methide.  Ortho quinione methide is thought to be 
the reactive moiety in some antibiotic and antitumor drugs.  By preparing selected analogs of this 
compound, it is hoped that we can control the reactivity thus controlling the effectiveness of 
newly designed drugs.  My purpose in lab is the attempt to make an σ complex aryl-allene that 
will rearrange to a 5-membered ring o-quinone methide analog.  This rearrangement, shown 
below for the dimethyl substituted analog, has been studied in the Allison group for the 













  This model study is important because if successful, it will generate the first o-quinone 



















 About 0.63 mL (5.4 mmol) of 2-bromo-benzyldehyde was added to a clean, oven-dried 
schlenk flask which already contained a stir bar. Approximately 30 mL of dry tetra-hydrofuran 
(THF) was added while the flask was under a nitrogen atmosphere. Next 16.2 mL (8.1 mmol) 
ethnyl magnesium bromide was added dropwise with a syringe. This solution was allowed to stir 
for 3 hours. 
 The resulting mixture was placed in a separatory funnel and washed with diethyl ether 
and deionized water. The aqueous layer (bottom) was removed and the organic layer was washed 
a second time with the ether and water. The aqueous layer was once again removed and the 
remaining organic layer was washed twice with hydrochloric acid. This final organic layer was 
put into a Erlenmeyer flask and dried with magnesium sulfate. This was then filtered and then 
place on the rotovap. An NMR was taken to help determine the structure of the compound. 
 










 0.21g (1.0 mmol) propargyl alcohol was slowly added to a stirred suspension of lithium 
aluminum hydride (.076g ; 2 mmol) and aluminum trichloride (0.40 mL ; .2mmol) in THF at 
0oC. The mixture was stirred at 65oC for 5-10 hours and monitored by TLC until no alcohol 
could be detected. Afterwards, the reaction was quenched with deionized water. The phases were 
separated and the aqueous layer was extracted with diethyl ether. The combined organic phase 
was dried, filtered, and concentrated. 
 Column chromatography using pentane should yield the purified allene. Yields of 
recovery were 28-65% due to the volatility of the allene formation of the by product (allyl 
alcohol) reported in the past. 
 











 Approximately 0.52 g (2 mmol) of triphenyl phosphine [P(Ph)3] was weighed out and put 
into a schlenk flask. The flask was then placed under a N2 atmosphere and 20mL of THF was 
added to dissolve the P(Ph)3. The flask was then placed into an ice bath at 0oC. Next .31mL (2 
mmol) of diethyl azodicarboxylate (DEAD) was added dropwise to the solution and allowed to 
stir for 20 minutes. 
 After 20 minutes, .21 g (1 mmol) of the propargyl alcohol was added dropwise to the 
solution. THF was the used to rinse any remaining alcohol from the flask. This was allowed to 
stir for 20 minutes. 
 Next .076 g (2 mmol) of LiAlH4 dissolved in approximately 3 mL of THF was added 
dropwise to the flask. This stirred for 20 minutes. After this time, The flask was removed from 
the ice bath and allow to warm to room temperature. This solution stirred overnight. 
 The resulting solution was washed with ether and deionized water twice. The aqueous 
layer was removed and washed one more time. The combined organic layer was washed twice 
with HCl. The final organic layer was dried over MgSO4, filtered, put onto the rotovap. This 
resulting solution was placed on silica gel column and flushed through with a 1% EtOAc in 
hexanes mixture. 
 
Results and Discussion (Data Analysis) 
 
 During the synthesis of the propargyl alcohol, a few problems were encountered. Within 
my first two weeks of synthesis, the Grignard reagent seemed to have gone bad. It was very hard 
to extract from the bottle and the solute would not dissolve in the remaining solvent, which was 
THF. A new bottle was ordered and the experiment continued. The biggest problem encountered 
was a simple miscalculation. The reaction was supposed to be ran on a 1:1.5  (benzyldehyde to 
Grignard) ratio. When the amounts for this ration were calculated the molarity of the Grignard 
were not taken into account. As a result of this mistake, the experiment was only successful on a 
1:3.5 ration of the reaction. A benzaldehyde peak around 10.4 can be seen when the experiment 
was unsuccessful (See appendix A). However, once the molarity was included into the 
calculation, the numbers for the 1:1.5 ratio turned out to be the numbers used in the 1:3.5 ratio. 
The 1H NMR of compound 4 shows aromatic peaks around the 7-8 range. There is also an OH 
peak around 6.1 (See appendix B).   
 The second step in my synthesis proved to be a very difficult reaction. Two different 
synthesis of the allene reaction were tried. The first of these experiments involved reacting the 
propargyl alcohol with LiAlH4 and AlCl3. The mechanism for the reaction is the AlCl3 was 
going to provide a good leaving group (Cl-) and the hydride could attack more easily, leaving a 
positive charge on the alpha carbon. The electrons in the triple bond shift to form a pi bond with 
the neighboring carbon. A proton from the hydride comes and adds a hydrogen to the terminal 
carbon. The reactions that were carried out during my synthesis showed a very high level of an 
alcohol. This alcohol could be my beginning propargyl alcohol or allyl alcohol, a side product 
that was seen in earlier reactions. Traces of the desired allene appeared to be present in the nmr 
spectra (see appendix C) around 5.3 and 6.0. This multiple splitting comes from the allene. 
 The second synthesis still used LiAlH4, but also incorporated triphenyl phosphine 
[P(Ph)3] and diethyl azodicarboxylate (DEAD). The new reaction is a variation of the Mitsunobu 
reaction which is a reaction between DEAD and [P(Ph)3] which makes a compound that is basic 
enough to pull a proton off of an alcohol1. The hydride would then supply the hydrogen that 
comes to attack the terminal carbon, causing a shift in the electron and from the triple-single 
37 
bond to two double bonds. In my synthesis, the resulting compound from the [P(Ph)3] and 
DEAD was not basic enough to pull the hydrogen from the alcohol. The hydride attacked the 





The final unsubstituted quinone analog was not synthesized. The main problem with this 
synthesis lies in the synthesis of compound 6. The two different synthesis that were carried out 
yielded a negligible amount of compound 6 and a large amount of compound 8. Changes to the 
amounts of the reactants in reaction 2 may lead to a more acceptable yield of compound 6. After 
a good yield has been reached, the experiment should be continued to make the quinone analog. 
N-butyllithium, and cyclopentadienyl iron dicarvbonyl iodide or triphenyl phosphine and DEAD 
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Investigation of Mass Spectral Variation of Bacteria MALDI-TOF Spectra 
Resulting From Changed Growth Conditions 





Matrix-assisted laser desorption/ionization MALDI) allows for the analysis of 
bacterial cellular components from intact cells. This makes MALDI an attractive tool in the 
attempt to find biomarkers. Use of MALDI-Time-of-Flight (TOF) whole cell analysis has 
not seen as much success as anticipated, for completely reproducible spectra are hard to 
obtain. Spectra obtained in different labs often have peaks that vary in both mass/charge 
and intensity. This investigation uses MALDI-TOF mass spectrometry to gain a deeper 
understanding of these changes. By growing Escherichia coli MV1190 in varying 
environments, we have shown that along with the expected variance in data, there is also 




 The introduction of matrix-assisted laser desorption/ionization (MALDI) was a key step 
in the field of bioanalysis.1 The process involves the mixing of the sample to be analyzed with an 
organic matrix.1 The MALDI event is a complex phenomenon and is not well understood.1 
However, desorbing the matrix with a laser results in ion formation. Time-of-flight and Fourier 
transform mass spectrometry are two popular analysis methods that utilize the MALDI process. 
The relatively fast pace in which MALDI analyses can be performed have made it a very 
popular tool.  In addition, MALDI gives the ability to not only characterize purified cellular 
components, but allows for the analysis of whole cell bacteria with little preparatory work as 
well.2 The combination of speed and whole cell analysis capabilities has made MALDI a very 
popular tool in bacterial taxonomy.2 Specifically, research is being done to identify biomarkers; 
ions that are unique to an individual species or strain.2,3 It is intended to include these ions, 
which are proteins as well as other compounds, in a database that will allow for quick, accurate 
identification of unknown samples. 
 The attempt to make a bacterial library based on biomarkers has hurdles to overcome. 
Reproducibility of spectra has been difficult to obtain both between labs and even at different 
times in the bacteria’s life cycle.4,5 Minor changes in procedure can result in the expression of a 
protein that makes it difficult to detect a protein that had been used in the identification of the 
bacteria.6 Although completely reproducible spectra are hard to obtain, Arnold and coworkers 
did observe proteins that remain constant in their experiments.5 Although their only variable was 
time, the work does provide hope that a complete bacterial database will someday be created 
based on these conserved proteins.   
 The research herein focuses on the 4000 – 10000 Dalton mass range of Escherichia coli 
MV1190. This region has been studied by many research groups using both MALDI-TOF and 
MALDI-FTMS and has been found to be very rich in proteins.5,6,7,8 In light of the 
aforementioned findings of variability in spectra obtained with minor variations in growth 
conditions, we set out to gain more understanding about these changes. Various different 
environments were prepared for Escherichia coli MV1190 to be inoculated in. MALDI-TOF 
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mass spectrometry of these bacteria grown under different conditions provides a scientific 
approach to this “striking” 9 problem of spectra variance.  
 
Materials and Methods 
 
 Escherichia coli MV1190 were obtained from the University of Arkansas Microbiology 
Department. Stock solutions were prepared in both 5.0ml of tryptic soy broth (TSB) (Sigma, St. 
Louis, MO) and 5.0ml of Luria broth Miller (LB) (EM Science, Gibbstown, NJ) and incubated at 
37˚C for 20 h. The stock solutions were then stored at 25˚C until needed for inoculations. 
 Luria and tryptic soy broths were made that varied in alcohol concentration and salt 
concentration. Isopropyl alcohol (Sigma, St. Louis, MO) was used to bring the broths to 
concentrations of 1.5, 2.0, and 2.5 M IsOH. A 4 M solution of KCl (Sigma, St. Louis, MO) was 
made and used to make 0.5, 0.75, 1.0, 1.25, and  1.5 M KCl broths. All broths were autoclaved 
prior to inoculation. 
 Inoculations were made from the stock solutions and the tubes were placed in a roller 
drum (New Brunswick Scientific Co. Inc., Edison, NJ) and incubated at 37˚C for 20 h. After 
removal from the incubator, the broths were poured into 50-ml centrifuge tubes and spun at ~31 
k relative centrifugation force (RCF) for 30 min. The supernatant was poured off and 5.0 ml of 
TRIZMA buffer solution (Sigma, St. Louis, MO) was added. The solution was vortexed to 
resuspend the cells and was then spun down at ~31 k RCF for 25 min. The supernatant was 
poured off and 1.0 ml of TRIZMA buffer solution was added. After being vortexed, solutions 
were transferred to 1.5 ml centrifuge tubes and spun at ~25 k RCF. The supernatant was removed 
and 25µl of both MeOH and TRIZMA were added to the pellet. The solution was vortexed and 
transferred to 0.5ml tubes for storage at 4˚C. 
 A saturated solution of 2,5-dihydroxybenzoic acid (DHB) (Fluka, Milwaukee, WI) in 
90/10 MeOH/H2O was used as the matrix. Samples were prepared by making a 2:1 DHB:sample 
mixture and then spotting 1µl of this solution on one of the ten spots of the stainless steel disk. A 
solution of ubiquitin and insulin was used as a calibrant. The individual disks were placed on a 
multiprobe adaptor plate to be analyzed by MALDI-TOF. 
 MALDI-TOF experiments were performed using a Bruker Reflex III mass spectrometer 
(Bruker Daltonics, Billerica, MA) equipped with a nitrogen laser operating at λ = 337 nm (Laser 
Science, Franklin, MA) in reflectron mode. A delayed extraction pulse was used in the source, 
with 20kV acceleration voltage and 23 kV reflecting potential. Measurements were taken using a 
dual-multichannel plate detector with a 1.55 kV detection voltage. The pressure in the vacuum 
chamber was maintained at ~1.5 x 10-7 torr by turbomolecular pumps. 
 Samples were analyzed using at least 150 laser shots. Individual analyses of like samples 
were combined to give sum values for each sample. Analysis of MALDI-TOF data was done 
using the XTOF program provided by Bruker. An Excel spreadsheet was created that included 
the mass and intensity of every peak detected. Graphs were made using the average relative 
intensity versus the Mass/Charge (m/z). Degree of conservation was determined by dividing the 
standard deviation by the relative intensity. Values of 0.15 and less were considered conserved, 





Results and Discussion 
 
 Bacteria were successfully harvested after growth in all of the conditions except certain 
KCL concentrations. We were unable to harvest any amount of bacteria, for Luria Miller or 
tryptic soy broth, at concentrations of greater than 1.0M KCL. It was encouraging to see that the 
different broths did have an effect on the amount of bacteria harvested and the appearance of the 



























Figure 1: Average relative intensities of all TOF spectra, including Luria Miller broth, tryptic soy broth, varying 
[KCl] and varying [IsOH]. White markers show peaks that were conserved (less than 15% standard deviation 
divided by relative intensity) while black markers show peaks that were varying (greater than 40% SD/RI) 
 
 Figure 1 is a good example of the variation that is seen in MALDI-TOF analysis. 
Eighteen of the peaks varied (by the criteria described above), while only four were conserved. 
The higher end of the mass range in which our research focused showed the greatest variation. 
Eight of the twelve ions detected above 8000 m/z were labeled as varying. Another observation 
from Figure 1 is the variance in ions that were observed on a regular basis. Ions that were found 
in nearly every spectrum obtained (data not shown), including ions with m/z of approximately 
4335, 5097, 7275, 7334, and 7872 were all found to vary by greater than 40%. In fact, only one 
of the peaks that were found in nearly every spectrum ended up being labeled as conserved, that 
with m/z 6256.  






























Figure 2: Average relative intensities of all tryptic soy broth samples. All spectra use the same conservation/varying 






























Figure 3: Average relative intensities of all the Luria Miller broth samples 
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Figures 2 and 3 show what changes are observed when you look at the tryptic soy broth 
and Luria Miler broth samples individually. This split results in much more conservation being 
observed in the tryptic soy broth samples (10), but this does not hold true for the Luria Miller 
broth samples (2). This breakdown also allows for the observation that the ion with m/z 5733 is 
only found in Luria Miller broth. Although the ion does have a standard deviation of greater than 
its relative intensity, with further investigation it could someday be used as an indicator of 
whether a sample was grown in Luria Miller or some similar type of broth. Another observation 
that can be made from Figures 2 and 3 has to do with the ion with m/z 7350. First, the peak is 
only found in unaltered TSB and LB (not present in Figures 4 or 5) and second, it is found with 
greater relative abundance in Luria Miller broth. Once again this is a peak that is not conserved 
in either broth, but it does raise questions about how it came to be. The fact that it is not observed 
in the KCl or IsOH broths gives more information. It is a conceivable hypothesis that whatever is 
necessary for the peak to be observed will be present in normal broths, but the addition of KCl or 
IsOH to the broths destroys or inhibits its function. A study that shows the changes in the 
makeup of both broths before and after KCl and IsOH addition could give insight into what is 



























Figure 4: Average relative intensities of the varying [KCl] samples. 
 
 The KCl samples, like the TSB samples (Figure 2), had a larger amount of conserved 
peaks than the other spectra. Figure 4 shows that 7 of the peaks were conserved. Figure 4 also 
shows that the KCl samples are the only ones in which there was no ion detected at m/z 6216. 
The previously mentioned lack of a peak at m/z 7350 in either the [KCl] (Figure 4) or [IsOH] 



























Figure 5: Average relative intensities of the varying [IsOH] samples. 
 
 The data shows a number of different trends. As reported in conjunction with Figure 1, 
the peaks that are normally found in every spectrum are not well conserved in any of the 
different breakdowns. Conserved peaks were only found in four of the 53 observed ions with a 
m/z greater than 8000, with three of them occurring in the tryptic soy broth data (Figure 2). It 
should also be noted that our criteria for determining whether or not a peak is conserved could be 
argued.  We decided that in order for a peak to be conserved it had to have a value of less than 
0.15 for standard deviation/relative intensity and a value greater than 0.40 to be considered 
varying. Change of only a couple of hundredths will result in a change in the number of 
conserved and varying ions. Use of these thresholds was arbitrary and some other choice would 
obviously produce different results. 
    
Conclusion 
  
 This research shows that the “striking” problem of spectra variance actually opens the 
door to possibly thousands of different questions and the data could be broken down in many 
different ways than the five I have reported. The research gives a better understanding of the 
spectra variability issue as well.  It confirmed that many ions detected in the 4000 – 10000 m/z 
region using MALDI-TOF whole cell analysis vary. It shows that although ions may be detected 
in every spectrum, one must take into the account the abundances of each of these ions in order 
to confirm that they are in fact conserved from sample to sample. Although many of the ions 
were not conserved, there are ions that are well conserved in the 4000 – 10000 m/z region. Thus 
the search for biomarkers should not be abandoned.  
This research only focuses on six of the millions of possible growth conditions.  Further 
work needs to be done looking at other environments, combinations of environments, and at 
m/z’s outside of the 4000 to 10000 window we focused on to make progress in biomarker 
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research. In addition to MALDI-TOF, the accurate mass capabilities of MALDI-FTMS will be 
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  The attached appendix contains selected MALDI-TOF spectra. All data were imported 
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Synthesis of enantioenriched N-methyl-2-(n-butyl/phenyl)azepane using 
trans-2-Cumylcyclohexanol as a Chiral Auxiliary. 
Peter Milano, Bard College 




N-acylazepinium with trans-2-cumylcyclohexanol as a chiral auxiliary is 
synthesized and diastereoselective addition products are studied through the 
reaction with two Grignard reagents: n-butyl and phenyl.  The diastereomer ratios 
demonstrate that the incorporation of (-)-TCC is an effective method for producing 
a large excesses of one diastereomer for the reaction with phenyl Grignard, which 
upon purification thru recrystallization provides a single diastereomer.  The (-)-
TCC was less effective for the reaction with butyl Grignard and the product 






Biological activity of a chemical is dependent on chirality, resulting in chemical 
manufacturers seeking methods of enantioselective synthesis.  The most common 
strategies use a chiral substrate, reagent or catalyst, typically naturally occurring.  
Another method that exists is the use of a chiral auxiliary—creating a chiral environment 
through attaching a chiral molecule to the substrate.  A chiral auxiliary, although 
requiring stiochiometric amounts, can be recovered and reused.   
N-acyliminium ions are extremely versatile.  The polarized carbonyl bond 
electronically enhances the reactivity of the iminium, allowing for a greater range of 
nucleophiles to be reactive.  Methods have been established using sparteine to synthesize 




All reactions were carried out in oven dried glassware.  THF and Et2O were 
distilled over Na benzophenone ketyl.  1H- and 13C-NMR spectra were recorded on a 
Bruker 300 MHz instrument.  Elemental analysis was carried out by Atlantic Microlab, 
Norcross, GA.  LC/MS and high resolution MS was carried out by the University of 
Arkansas Mass Spectrometry Facility.  Flash column chromatography was performed 


















In an oven-dried flask equipped with a stirbar, (335.7mg, 2.97mmol) ε-caprolactam was 
dissolved in 8.8mL distilled THF under nitrogen.  The solution was cooled to -78o with a 
CO2(s)/IPA bath.  (1.85mL, 4.63mmol) of a 2.5M n-butyl lithium solution in THF was 
added dropwise through a syringe.  The CO2(s)/IPA bath was replaced with an icebath, 
warming the reaction to 0o over 10 min.  After stirring for 15 additional minutes, the 
reaction was again cooled to -78o and (1.00g, 3.56mmol) of the chloroformate in 35.5mL 
distilled THF was added.  The now yellow reaction was allowed to warm to rt and was 
monitored for completion through TLC (30% EtOAc:hexanes), quenching with 18.5mL 
5% NaHCO3(aq) after 1 h.  The reaction mixture was transferred to a separatory funnel, 
washing the flask with an additional 5mL THF.  The aqueous layer was separated and 
extracted with 3x15mL Et2O.  The pooled organics were washed with sat NaCl(aq), dried 
with anhydrous MgSO4.  Evaporation of the solvent afforded a yellow oil.  Crude yield 
was greater than quantitative due to the weight of unreacted reagents.  The crude oil was 
purified through flash chromatography (1/5 ethyl acetate:hexanes) to provide 911.5mg 
product (75%).  1H-NMR δ 0.86-1.08 (m, 2H), 1.14 (s, 3H), 1.25 (s,3H), 1.41-1.62(m, 















In an oven-dried flask equipped with a stirbar 1.08g, 3.027mmol) of the above lactam 
was dissolved in 30mL distilled THF over nitrogen.  The solution was brought to -78o 
with a CO2(s)/IPA bath and (1.077mL;859mg, 6.05mmol) diisobutylaluminum hydride 
was added dropwise.  The reaction was kept at this temperature for 1 h, monitoring the 
elimination of starting material through TLC (30% EtOAc:hexanes).  After allowing the 
reaction to warm to rt, 10mL sat NaOAc(aq) was added, vigorously quenching the 
unreacted hydride.  The reaction fluid was then diluted with 60mL CH2:Cl2:H2O(3:1).  
The precipitate aluminum salts were filtered off through Celite.  The cake was washed 
with CH2Cl2 and the organic layer was washed with sat NaCl(aq) and dried with 
anhydrous MgSO4.  The solvent was removed and the oil further dried under reduced 
pressure to provide 901.1mg (82.9% crude yield).  1H-NMR δ 074-0.91 (m, 6H), 1.01-
54 
1.66 (m, 30H), 1.71-2.11 (m, 4H), 2.74-2.98 (m, 2H), 3.32-3.51 (m, 2H), 4.49 (m, 1H), 






To a stirred solution of (484mg, 1.348mmol) of the above alcohol in 27mL distilled 
toluene was added ~20 4A molecular sieves, (241mg, 2.022mmol) benzotriazole 
dissolved in 2mL toluene and a few crystals of p-toluenesulfonic acid on the end of a 
spatula.  The mixture was refluxed for 4.5 hrs and then stirred at rt overnight.  In the 
morning the brown mixture was washed with 2M NaOH(aq) and dried with sat NaCl(aq) 
followed by anhydrous MgSO4.  The toluene was stripped off to provide 505mg of 
colorless oil which crystallized upon standing (81.5% crude yield).  The crude oil was 
purified through flash chromatography (1/10 ethyl acetate:hexanes) to produce 371mg of 
pure product (60% yield).  1H-NMR δ 0.83-1.47 (m, 30H), 1.49-2.16 (m, 10H), 2.27-2.64 
(m, 2H), 2.74-3.18 (m, 2H), 3.37-3.73 (m, 3H), 3.92 (m, 1H), 4.81 (m, 3H), 5.40 (m, 1H), 
















To a well stirred solution of the above substrate (145mg, .315mmol) was added (1.26mL, 
1.260mmol) of a 1.0M phenyl magnesiumbromide solution in THF dropwise under 
nitrogen atmosphere.  The reaction mixture was stirred overnight while allowing it to 
attain r.t..  In the morning 1mL sat NH4Cl(aq) was added.  The aqueous layer was 
washed with 3x10mL Et2O.  The organic fractions were pooled and dried with sat 
NaCl(aq) and anhydrous MgSO4.  The solvent was evaporated and the oil further dried 
under reduced pressure to provide an oil which was purified by flash chromatography 
(ethyl acetate:hexanes, 1:25) to provide 84.5mg (64% yield) of an oil which crystallized 
upon standing.   SFC Column: Chiracel OD-H, Modifier: 10% ethanol, Flow rate: 3.0 
mL/min., Temp: 30o, Diastereomeric ratio (dr):  26 : 74, Retention time: 11.47 : 16.22 













with H2O, the major diastereomer was obtained (mp 104-106o n.c.).  1H-NMR δ 0.62-
2.00 (m, 25H), 2.26-2.37 (m, 2H), 2.79-2.98 (m, 2H), 3.80-4.11 (m, 1H), 4.72-4.80 (m, 
1H), 5.00-5.08 (p, 1H), 6.98-7.28 (m, 10H).  13C-NMR δ  24.56, 24.67, 25.72, 25.81, 
26.04, 27.56, 28.99, 29.49, 29.56, 29.62, 29.99, 30.72, 34.17, 34.39, 35.71, 37.01, 30.58, 
40.66, 43.36, 44.00, 51.06, 51.10, 59.56, 60.02,125.09, 125.12, 125.54, 125.59, 125.74, 
126.50, 126.54, 127.75, 127.96, 128.33, 128.44, 143.81, 144.31, 150.64, 151.34, 156.10, 
156.37. IR 2927, 2252, 1674, 1450, 908 cm-1; m/z 442.2721 (M+ Na)+; [α]D = + 51.3 
(c=.00265, CH2Cl2); Anal. Calcd. For C28H37NO2: C, 80.15; H, 8.89; N, 3.34. Found: C, 














To a well stirred solution of the above substrate (94mg, .204mmol) was added (.41mL, 
.815mmol) of a 2.0M n-butylmagnesium chloride in THF dropwise under nitrogen 
atmosphere.  The reaction mixture was stirred overnight while allowing it to attain r.t..  In 
the morning 1mL sat NH4Cl(aq) was added.  The aqueous layer was washed with 
3x10mL Et2O.  The organic fractions were pooled and dried with sat NaCl(aq) and 
anhydrous MgSO4.  The solvent was evaporated and the oil further dried under reduced 
pressure to provide an oil which was purified by flash chromatography (ethyl 
acetate:hexanes, 1:10) to provide 56mg (68% yield) of an oil.  SFC Column: Chiracel 
OD-H, Modifier: 10% ethanol, Flow rate: 3.0 mL/min., Temp: 30o, Diastereomeric ratio 
(dr):  46 : 54, Retention time: 13.71 : 11.72 min. respectively. HPLC Column: C8, 
Mobile Phase: 30% MeCN / H20, Flow rate: 2.0mL/min., Retention time: 31.39 : 46.32.  
1H-NMR δ 0.76-1.80 (m, 70H), 1.80-2.12 (m, 7H), 2.28-2.33 (m, 1H), 2.47-2.73 (m, 1H), 
3.37-3.79 (m, 2H), 3.83-4.00 (m, 2H), 4.67 (m, 1H), 4.79 (m, 1H), 7.03-7.15 (m, 10H).  
13C-NMR δ 13.12, 13.19, 21.80, 21.84, 23.65, 23.79, 23.81, 25.16, 27.42, 27.50, 27.99, 
28.91, 32.95, 33.78, 38.75, 39.59, 50.04, 50.34, 53.56, 73.83, 74.66, 75.58, 76.00, 76.43, 
123.68, 123.91, 124.02, 124.20, 124.29, 124.42, 124.69, 124.74, 124.80, 126.80, 126.90, 
126.97, 149.85, 150.40, 151.64, 154.63, 154.76, 155.21.  IR 2931, 2251, 1671, 909 cm-1; 












To a well stirred solution of the carbamate (14.4mg, .033mmol) in 2 mL dry THF under 
nitrogen was added dropwise DIBAL-H (.035mL, .200mmol).  After a night of refluxing 
the reaction was quenched with .5mL MeOH, .5mL 15% NaOH, and .5mL water 
successively.  The aqueous layer was washed with 3x5mL CH2Cl2 and the combined 
organic layers were dried with brine and MgSO4.  After removal of solvent the crude 
product was purified by radial chromatography (ethanol/ethyl acetate/hexane; .5:1:5). 
[Yield pending on drying of product] 
 
Results and Discussion 
 
The synthesis begins with the commercially available (1R, 2S)-trans-2-
cumylcyclohexanol ((-)-TCC).  This alcohol is reacted with phosgene to form a 
chloroformate which is attacked through nucleophilic substitution by ε-caprolactam 
deprotonated with n-butyl lithium.  The carbonyl of the lactam is reduced with diisobutyl 
lithium hydride at the temperature of -78o to avoid reduction of the carbamate carbonyl.  
The resulting alcohol is treated with and replaced by benzotriazole in a mixture of 
constitutional and stereoisomers through acid catalysis as developed by Katritzky, et al.2,3  
This addition functions as a resonance-stabilized leaving group to form an N-
acyliminium ion without acidic conditions, which can be attacked by carbanions such as 
Grignards.  Phenyl and n-butyl Grignards were used to test generic efficacy.  The 
absolute configurations of the 6 and 7 membered products were inferred by analogy to 
the 5, the 5 being known by comparison of 
it’s optical rotation to that of the literature 
values.  Through this inference the 
Grignards were found to attack 
predominantly the Si face of the s-cis 
conformer, opposite the steric bulk of the 
cumyl phenyl ring.  
It was found that p-toluenesulfonic 
acid was a helpful addition to the reaction 
of the alcohol with benzotriazole, the acid 
protonating the alcohol forming a better 
leaving group.  Reactions without the 
catalyst resulted in a yield of 38% which 
was raised to 60% with the acid.  How the 
reaction works at all can be explained by 
the molecular sieves acting as a Lewis 
Acid. 
The separation of the diastereomer 
mixtures formed in the additions of the Grignards to the azepinium ions failed through 
attempts with silica gel including radial, flash column and gravity column 
chromatography.  Samples of analytical scale were successfully separated through 
reverse phase high-pressure liquid chromatography, while those of preparative scale 
failed.  A cause for this difficulty not experienced with the analogous pyrrolidine and 
piperidine rings is that the added methylene in the ring reduced the polarity of the 
molecule enough that it did not have a high enough affinity to the highly polar silica.  The 
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failure of separation using reverse phase HPLC when a nitrile functionality is added to 
the C8 column further supports this trend.   Purification of the more rigid phenyl 
compound was however achieved through recrystallization whereas the more flexible 
butyl compound did not. 
The results for the reaction of n-butyl magnesiumbromide with the azepinium 
indicate that the described method is not useful for this substrate.  It is possible that the 
phenyl Grignard experiences more stereoselectivity because of its greater steric bulk and 
interference with the phenyl ring of the auxiliary.  This trend is seen to a lesser extent in 
the pyrrolidine and piperidine systems.  To further support this possibility one could carry 
out experiments using t-butyl Grignard, expecting for a larger selectivity than the straight 
chain. 
There are no trends across the increase of ring sizes used.  One confounding 
variable which might account for this is the substrate concentration prior to addition of 
the Grignard.  The azepane system is less polar than the others and was found to be less 
soluble in diethyl ether.  Even after prolonged stirring and sonication, concentrations of 
that described by Madan6 could not be achieved.  It could be that this more dilute solution 
prevented larger Grignard aggregates from forming, the smaller aggregates being less 
influenced by the auxiliary.  To test this possibility one could carry out the smaller ring 




(-)-TCC has proven effective as a chiral auxiliary in the enantioselective addition 
of phenyl Grignard to the azepinium ion and less effective in the addition of butyl 
Grignard.  The major diastereomer obtained for the phenyl compound can be easily 
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Isolation and Purification of Thrombomodulin from Human Urine 
Micah Niphakis, Houghton College 




  The development of methods to efficiently, accurately and quantitatively measure 
oxidized and non-oxidized Met 388 in thrombomodulin from urine is essential for clinical 
trials comparing the oxidative stress on smokers and non-smokers.  Previous methods to 
isolate thrombomodulin from human urine have been too inefficient to use in clinical trials.  
Most importantly, previous methods have not taken measures to assure that Met388 is not 
oxidized.  The method outlined in the following paper attempts to remove all of the 
contaminating proteins from urine while concentrating micrograms of thrombomodulin in 
a few milliliters, all with minimal oxidation to Met388.  The procedure, thus far, consists of 
three ethanol precipitations and chromatography using both Sepharose FF Q and 
Sepharose FF SP, all which can be performed in approximately two hours.  This work in 
progress has found conditions for both ion exchanges with minimal loss of 
thrombomodulin and significant impurity removal.  The ethanol precipitations still show 




Thrombomodulin is an endothelial cell membrane protein that is vital in the regulation of 
blood coagulation.  This protein, when complexed with thrombin, activates protein C that in turn 
degrades factors Va and VIIIa, which are responsible for blood coagulation1 and fibronolysis2.  A 
lack of protein C in the body has been shown to increase the risk of thrombosis3. It has also been 
shown that fibronolysis has been directly linked to the thrombin-thrombomodulin complex 
through a key factor called thrombin-activatable fibrinolysis inhibitor (TAFI)4 or 
procarboxypeptidase B (PCB).  TAFI has been known to have a strong inhibitory action on 
fibrinolysis4, as the name suggests.  Based on these facts, one can see the importance of 
thrombomodulin in blood coagulation lies in the fact that it controls the rate of clot formation 
and degradation. 
Recent studies have shown that the oxidation of Met388 is responsible for the 
deactivation of thrombomodulin5.  This oxidation causes the thrombin-thrombomodulin 
interaction to alter so that protein C is not as readily activated6.  On the other hand, it has been 
shown that this same oxidation does not change the activity of the thrombin-thrombomodulin 
complex in its interaction with TAFI.  Together, these studies have shown that the oxidation of 
Met388 decreases the rate of blood clot degradation while the rate of clot formation remains 
constant.  With this in mind, one would expect that blood clots are more readily formed in areas 
where a considerable amount of Met388 has been oxidized. 
 A noteworthy suspect for the oxidation of Met388 in humans is tobacco smoke.  
Tobacco smoke is known to contain numerous oxidizing agents such as organic radicals and 
hydrogen peroxide.  Moreover, tobacco smoke stimulates the release of leukocytes and 
neutrophils in the lungs, both of which discharge oxidative species.  It is easy to see that 
oxidative stress in the body due to smoking or even certain diseases can increase the chance of 
thrombotic arterial occlusive diseases.  Since cardiovascular disease is the leading cause for 
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death in smokers7, the relationship between smokers and degree of oxidized Met 388 in 
thrombomodulin is an important detail.  If this oxidation is the main cause for cardiovascular 
diseases then efforts may be put towards its prevention.  The scope of this research project is to 
show, qualitatively and quantitatively, that Met 388 in thrombomodulin is oxidized to a greater 
degree in smokers.  This involves the development of methods to efficiently, accurately and 
quantitatively measure oxidized and non-oxidized Met 388 in thrombomodulin.  Specifically, 
this paper outlines a method for the isolation and purification of thrombomodulin from human 





Thrombomodulin Purification Procedure 
ethanol (100%), imidizole, glacial acetic acid, imidizole acetate pH 4.5 – 6.5 
0.025M – 2M in acetate, 1M ammonium bicarbonate pH 9.0 
  Ion Exchanges: 
Sepharose FF Q, Sepharose FF SP (purchased from Amersham Biosciences) 
  
  SDS-PAGE: 
I. Separating Gel 
40% acrylamide, 1% Bis, TEMED, 10% APS, 1.5M Tris HCl pH 8.8,      20% 
SDS, doubly deionized H2O 
  II. Stacking Gel 
40% acrylamide, 1% Bis, TEMED, 10% APS, 0.5 Tris HCl pH 6.8,                   
20% SDS, doubly deionized H2O 
  
 ELISA: 
IMUBIND® Thrombomodulin ELISA Product No. 837 (purchased from  
American Diagnostica Inc.)   
 
Instrumentation: 
 IMUBIND® Thrombomodulin ELISA wells were spectrophotometrically analyzed at 
450nm using a TECAN Sapphire Microplate Reader.   
 A280 was measured using an HP Diode Array Spectrophotometer.  25mM Imidizole 
Acetate was used as a blank.  
   
Thrombomodulin Purification Procedure: 
Ethanol Precipitations:  
A fresh sample of urine was collected in a clean container and stored at 4o C until further 
use.  Note: Urine should not be stored for longer than 6 hours.  The urine was transferred to a 1L 
beaker containing 0.5 volumes of cold 100% EtOH.  The contents of the beaker were equally 
divided into 2 or 3 centrifuge bottles at let sit for 10 minutes at 4o C.  The samples were 
centrifuged at 5K (2600RCF) for 10 minutes at 4o C.  The supernatants were pooled in another 
1L beaker.  2M imidizole acetate was added to the sample to reach an imidizole acetate 
concentration of 200mM.  2.4 volumes of cold 100% EtOH was added to the same beaker and let 
sit for ten 10 minutes at 4o C.  The sample was divided equally into six centrifuge bottles and 
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centrifuged at 5K (2600RCF) for 10 minutes at 4o C.  The supernatants were discarded and each 
pellet was briefly dried by inverting the centrifuge bottles for 1-2 minutes.  A minimum volume 
(25-50mL) of 25mM imidizole acetate pH 5.0 was used to resuspend all of the pellets.  Note: The 
pellet should completely dissolve. If it does not, spin out the solid material.   
 
First Ion Exchange: 
 A column was prepared containing a 4mL bed volume of Sepharose Q.  The column was 
washed with 8mL (2 bed volumes) of 25mM imidizole acetate pH 5.0.  The resuspended pellet 
solution from the previous step was loaded onto the column.  The flow through was discarded.  
The column was washed with 8mL (2 bed volumes) of 25mM imidizole acetate pH 5.0. The 
column was eluted with 8mL of 25mM imidizole acetate / 2.5M NaCl pH 4.6.  1.5 volumes of 
cold 100% EtOH was added to the eluent and mixed.  The sample was let sit for 10 minutes at 4o 
C and centrifuged at 13K (18000RCF) for 10 minutes at 4o C.  The supernatant was discarded 
and the pellet briefly dried and completely dissolved in a minimum volume (1-4mL) of 25mM 
imidizole acetate pH 5.5.  
 
Second Ion Exchange: 
 A column was prepared containing a 2mL bed volume of Sepharose SP.  The column was 
washed with 4mL (2 bed volumes) of 25mM imidizole acetate pH 5.5.  The resuspended pellet 
solution from the previous step was loaded onto the column.  The flow through was collected.  
The column was washed with 2mL of 25mM imidizole acetate pH 5.5 and collected with the 
flow through.  The pH of the flow through and wash was adjusted to ~7 by adding 40μL of 1M 
ammonium bicarbonate pH 9.  The sample was stored at -20oC.    
 
Tests for Optimization of Protocal: 
 Ethanol Precipitations: 
 For the first ethanol precipitation, volumes ranging from 0.3 to 1.1 of 100% EtOH were 
analyzed. 
 For the second ethanol precipitation, volumes ranging from 2.0 to 2.5 of 100% EtOH 
were analyzed.    
 For the third ethanol precipitation, volumes ranging from 1.3 to 3.0 of 100% EtOH were 
analyzed. 
 The resuspended pellet was analyzed in each case for thrombomodulin concentration and 
protein impurities. 
 
First Ion Exchange: 
 Variations were made to the bed volume of Sepharose FF Q and to the pH of the 
resuspended pellet.  Testing for the optimal bed volume involved loading the resuspended pellet 
onto a column with a small bed volume and loading the flow through onto another column with a 
small bed volume, etc.  The flow through and eluents were analyzed after each step for 
thrombomodulin concentration and protein impurities.    
 Test for an optimal pH to carry out the first ion exchange involved splitting the sample 
into several equal portions, adjusting the pHs of the resuspended pellet and loading each sample 
onto a separate columns with equal bed volumes.  The flow throughs and eluents were analyzed 




 Thrombomodulin concentration was determined through the use of ELISA tests.  The 
relative amount of protein impurities was determined using spectophotometric analysis at 280nm 
and through the use of 18% SDS-PAGE.    
 
Results and Discussion 
 
Note: In all of the following data tables and graphs, the volumes of urine within a given batch are equal.  For 
example, 0.6 volumes of ethanol were added to the same volume of urine as was 0.7 volumes in TMU-3 batch 32. 
 
TMU-3 batch 32 TMU-5 batch 4 TMU-5 batch 5 TMU-5 batch 6
EtOH added (volumes) TM Conc (ng/mL) TM Conc (ng/mL) TM Conc (ng/mL) TM Conc (ng/mL)
0.6 83.58 40.57 38.864 45.431
0.7 48.592 23.124 15.016 22.565
0.8 30.406 16.795 16.29
0.9 24.938 10.836 15.57 30.651
1 9.332 8.6864 11.871 21.004































TMU 5 batch 5
TMU-5 batch 6
 
Figure 1  
 
The first ethanol precipitation is primarily to eliminate excess proteins and salt in the 
urine.  In figure 1, it is apparent that 0.5 volumes of ethanol retains the most thrombomodulin in 
solution as would be expected.  Anything below this point, although giving a better yield of 










TMU-5 batch 1 TMU-5 batch 2 TMU-5 batch 3 TMU-5 batch 7
EtOH added (volumes) TM Conc (ng/mL) TM Conc (ng/mL) TM Conc (ng/mL) TM Conc (ng/mL)
2 55.845 14.45 10.286 24.076
2.1 70.039 26.961 35.062
2.2 59.634 16.994 10.351 28.333
2.3 53.275 15.624 23.399 29.851
2.4 41.161 20.672 14.049 21.722


































The second ethanol precipitation serves to isolate thrombomodulin from some of the soluble 
impurities and allows the volume of sample to be drastically reduced and easier to work with.  
Figure 2 shows that 2.1 volumes of ethanol precipitates the most thrombomodulin when the first 

















TMU-5 batch 18 TMU-6 batch 7 TMU-6 batch 9 TMU-5 batch 21
Imidizole Acetate pH
Flow Through TM 
Conc. (ng/mL) 
Flow Through TM 
Conc. (ng/mL) 
Flow Through TM 
Conc. (ng/mL) 
Flow Through TM Conc. 
(ng/mL) 
4.6 13.337 1.2123 0.031809
4.8 13.825 1.3074 0.72762




1st Ion Exchange - Sepharose FF Q
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TMU-5 batch 18 TMU-6 batch 7 TMU-6 batch 9 TMU-5 batch 21
Imidizole Acetate pH
Eluent TM Conc. 
(ng/mL) 
Eluent TM Conc. 
(ng/mL) 
Eluent TM Conc. 
(ng/mL) Eluent TM Conc. (ng/mL) 
4.6 3.9 3.6478 5.307
4.8 6.9156 4.6403 6.7564
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Eluent Abs. at 
280nm
4.6 0.39026 0.1073 0.59917 0.19124
4.8 x 0.24762 0.25751
5 0.39618 0.099197 0.13628 0.43501
5.5 0.27759 0.16022 x x
6 0.164 0.20317 x x
6.5 x x x
1st Ion Exchange
TMU-5 batch 20 TMU-5 batch 21
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The biggest change to the protocol was made to improve the substantial loss of 
thrombomodulin in the first ion exchange.  At first, the pH of 25mM imidizole acetate used to 
dissolve the pellet from the second ethanol precipitation was varied.  In figures 3 and 4, it is 
shown that when the pellets are resuspeded in 25mM imidizole acetate at a pH close to 5 and 
passed through the Sepharose FF Q column, the eluent contains more thrombomodulin while still 
separating some of the protein impurities.  
 Upon the discovery of this ideal pH to carry out the first ion exchange a new step was 
added to the protocol.  This step was to add 2M imidizole acetate pH 5.0 to the supernatant of the 
first ethanol precipitation so that the sample had a final imidizole acetate concentration of 
200mM.  This was done to assure that the imidizole acetate had the buffering capacity to keep 
70 
the pH of the sample close to 5.0.  The change was also made to encourage more 
thrombomodulin to precipitate out in the second ethanol precipitation by bringing the pH of the 
solution closer to the isoelectric point of thrombomodulin which is close to 4.   
 
TMU-5 batch 9 TMU-5 batch 11 TMU-5 batch 24 TMU-6 batch 10
EtOH added (volumes) TM Conc (ng/mL) TM Conc (ng/mL) TM Conc (ng/mL) TM Conc (ng/mL)
1.3 7.9259 6.0106


































Variations in the third ethanol precipitation were also examined.  Figure 6 shows that 
small ethanol volumes of 1.3 – 1.9 shows little difference in the amount of thrombomodulin 
being precipitated.  After observing that most of the thrombomodulin was being lost at this stage 
the amount of ethanol used was increased to 3.0 volumes.  Figure 6 shows that 3.0 volumes of 
ethanol precipitates a significant amount more than 1.5 volumes. 
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1st PPT 2nd PPT




















Since 0.8 volumes of ethanol precipitated too much thrombomodulin in the first ethanol 
precipitation and follow up experiment was conducted where the first and second ethanol 
precipitations varied, but the final amount of ethanol stayed at 2.9 volumes.  This experiment 
showed that the first and second ethanol precipitations should be at 0.45 and 2.45 respectively to 
recover a reasonable amount of thrombomodulin and still rid the samples of some of the protein 
impurities.  To make calculations easier these volumes were rounded to 0.5 and 2.4 for the first 

















TMU-5 batch 23 TMU-5 batch 22
Sepharose FF Q Bed 
Volume (mL)
Flow Through TM 
Conc. (ng/mL) 









1st Ion Exchange Bed Volume
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TMU-5 batch 23 TMU-5 batch 22
Sepharose FF Q Bed 
Volume (mL)
Eluent TM Conc. 
(ng/mL) 









1st Ion Exchange Bed Volume
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In fear that protein impurities were competing for sites in the ion exchange column, the 
bed volume of Sepharose FF Q was varied.  Figure 8 shows that the vast majority of 










Eluent Abs. at 
280nm
4 0.59019 0.6357 0.8519 0.52837
8 0.45383 0.35895 0.63602 0.26347
10 0.39046 0.22339 0.7106 0.25247
12 x x 0.57635 0.22925
14 x x 0.52347 x
16 x x 0.42569 0.2002
18 x x 0.38081 0.16719
1st Ion Exchange Bed Volume
TMU-5 batch 22 TMU-5 batch 23
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Figure 9 shows that increasing the bed volume slowly decreases the amount of protein 
impurities in the eluent.  However, it doesn’t decrease the impurities enough to make a bed 






TM Concentration (ng/mL) 2.0506 7.7993 0.98487 1.5496 45.859 49.227 24.344 5.2897
Total Volume (mL) 410.0 50.0 42.5 6.5 7.5 3.0 4.5 4.0
Total TM (ng) 820.24 389.97 39.39 10.07 343.94 147.681 109.548 21.1588
% TM 100.0% 47.5% 4.8% 1.2% 41.9% 18.0% 13.4% 2.6%
Anionic Exchange Cationic Exchange 
Urine
2nd EtOH PPT 
Resuspended 
Pellet






Figure 10 shows the final process and where thrombomodulin is being lost.  It can be 
seen that in the two first ethanol precipitations about 50% of the thrombomodulin is lost.  It is 
also apparent that in the third ethanol precipitation another half of the remaining 
thrombomodulin is lost.  Minimal losses can be observed in the ion exchange steps but this little 
can be done to prevent this.  The final yield of thrombomodulin is only 13.4%, but with the 
correct adjustments to the precipitation steps this value will greatly increase.       
              
Conclusion 
 
 In the attempt to purify thrombomodilin, the chief obstacle was recovering this protein 
after the ethanol precipitations.  At the optimal volumes suggested in this paper approximately 
50% of the thrombomodulin is lost in the first two precipitations.  Another 50% of the remaining 
thrombomodulin is lost during the third ethanol precipitation.     Changes made to the first ion 
exchange, on the other hand, have been quite beneficial in recovering most of the 
thrombomodulin.  The second ion exchange also showed little loss of thrombomodulin and was 
not changed.  Although the total recovery of thrombomodulin has been improved, the protocol is 
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Preliminary Studies in the Synthesis of Eunicellane Diterpenes 





 A group of eunicellane diterpenes contains a stereochemically and functionally rich 
cis-hydroisobenzofuran core, which can be synthesized in 6 steps from commercially 
available starting material.  The cis-hydroisobenzofuran core can be substituted in two 
positions to create a large library of compounds that can be tested by fluorescence-based 
assay for tubulin polymerization and by 60-cell line screening for anticancer activity.  The 
large library can easily be purified by attachment of an oligomer that limits the solubility 
of the substrate.  The final step in accessing the cis-hydroisobenzofuran core is a novel 
diazene rearrangement.  The preliminary studies for the diazene rearrangement were 
performed on an inexpensive starting material ,which is similar to the natural product’s 




 A class of marine naturals products given the name eunicellane diterpenes has shown to 
have biological activity, in particular, cytotoxicity against cancer cell lines.  To inhibit the 
development of cancer, a drug or natural product needs to inhibit cell growth.  A mechanism to 
inhibit cell growth is to disturb mitosis in a cell.  Most known antimitotic agents induce mitotic 
arrest by two ways: (i) inhibiting the polymerization of tubulin into microtubules or (ii) 
stabilizing microtubules against depolymerization.2 A particular member of the 2,11-cyclized 
cembranoids, eleutherobin (1), has shown to stabilize α and β microtubules during cell division, 
thus preventing the multiplification of cells.1  This mechanism of cancer retardation is similar to 
the mechanism used by other mitotic agents: (i) paclitaxel (Taxol), a current drug used to treat 
cancer, and two other classes of compounds, (ii) epothilones and (iii) discodermolides.    Since 
paclitaxel is used clinically, synthesizing other natural products or analogs of natural products 
with similar properties is of interest.               
 Eunicellane diterpenes (Scheme 1) consists of an [8.4.0]tetradecane carbon skeleton with 
an oxygen bridge between C(2) and C(9) or C(4) and C(7).    The individual members of the 
2,11-cyclized cembranoids differ in the oxidation and substitution of the hydrocarbon rings.  
Members of the class of compounds such as lytophynin-E (2) and astrogorgin (3) have hemolytic 





























































































 The natural products are very complicated chemical structures and the total synthesis of 
only a few of the large number of isolated 2,11-cyclized cembranoids have been attempted by 
Nicolaou, Danishefsky, Overman, Paquette, and others.  With this being said, there exists a large 
amount of potential biologically active natural products and natural product analogs that have not 
been synthesized or been tested beyond the initial biological assay.  The McIntosh research 
group has developed a scheme in which the cis- hydroisobenzofuran core (Figure 1) of the 2,11-
cyclized cembranoids will be substituted in two positions to create a library of compounds.  The 
process will begin with the solution phase synthesis (Scheme 2) of a 
parent compound similar to the substituted isobenzofuran hydrazone 
(10).  The optimal conditions used to synthesize (10) will be used to 
develop a large library of compounds via solution phase parallel 
synthesis.   Once the methods of developing solution phase parallel 
synthesis libraries are developed, solid phase supported synthesis will 
be explored.   
 The substituted isobenzofuran hydrazone (10) can be prepared 
by nucleophilic attack of  the carbonyl of the α,β-unsaturated enone 
(4) by tosylhydrazide (5) to form tosylhydrazone (6).  Then DCC 
coupling of (6) with N-methylpiperazine (7)  will afford amide (8).  Pd catalyzed cross coupling 
of aryl bromide (8) with propargyl carbamate (9) will afford aryl alkyne (10). 



































































Scheme 2 - Parent Compound
 
 
 The parent library of compounds can then be easily converted to multiple daughter 
libraries via hydrogenation and/or cycloisomerization.  An example of one of a parent compound 










































































Scheme 3 - Parent Compounds to Daughter Compounds via Reduction or Cycloisomerization
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 When creating a large library of compounds via solution phase parallel synthesis, facile 
separation of the desired product is always desired.  Once the solution phase chemistry using 
tosylhydrazide (5) is optimized, a method first developed by Hanson and coworkers using 
ROMP (ring opening metathesis polymerization) along with phase trafficking will be used to 
prepare solution phase libraries with little or no chromatography.  The method involves 
preparing a similar hydrazide to 5, norbornenylsulfonylhydrazide (14), which will react similarly 
with 4 to form the corresponding norbornenylhydrazone.  Norbornenylsulfonylhydrazide (14) is 
formed from readily available 2-chloro-1-ethane sulfonyl chloride (11).  11 is with deprotonated 
with 2,6 lutidine and the chlorine is beta-eliminated to form ethylene sulfonyl chloride (12).  12 
undergoes a Diels-Alder reaction with freshly cracked cyclopentadiene to form 
norbornenylsulfonylchloride (13).  Hydrazide monohydrate nucleophilcally attacks 



































 At this point we have a similar hydrazide (14) to the tosylhydrazide (5) above.  Thus 14 is 
then used in the same fashion as tosylhydrazine (5) and reacted with the carbonyl of α,β-
unsaturated enone (4) to form norbornenylsulfonylhydrazone (15).  ROMP will then afford 
sulfonylhydrazone oligomer (16) that makes the oligomer soluble in particular solvents.  The 
sulfonylhydrazone oligomer (16), as before, can undergo DCC coupling to form 17 and Pd 
catalyzed cross coupling to form 18.  At this point the sulfonylhydrazone oligomer (18) can 
undergo various degrees of hydrogenations and/or cycloisomerizations to afford a library of 
daughter compounds with little or no chromatography and facile purification, or protiodeboration 
to afford sulfonylhydrazine (19).  19 will undergo an allylic diazene rearrangement when treated 
with pyridine and catalytic pyrollidino pyridine, which will result in the crashing out of the 
























































































































 The development of the libraries via solution phase parallel synthesis and solid phase 
supported synthesis is dependent on a α,β-unsaturated sulfonylhydrazone functional group and 
acleave via an allylic diazene rearrangement.  The reasons for using a sulfonyl hydrazone 
functional group are: (i) ketones and aldehydes easily and readily form sulfonylhydrazones5, (ii) 
sulfonyl hydrazones are tolerant to many to many reaction types including reduction6, acid 
catalysis, protection, and deprotection, (iii) commercial availability of starting materials is 




Results and Discussion 
 
Diazene Rearrangement 
 Preliminary studies were done on a relative inexpensive, readily available substrate 
similar to the cis-hydroisobenzofuran core.  The preliminary studies consisted of taking R-
Carvone (22) and converting it to the corresponding hydrazone (23) with 4-toluene sulfonyl 
hydrazide.  The reaction takes place with good yield (>70%).  23 is then reduced with a hydride 































 The hydrogen on the nitrogen alpha to the ring of 24 is then deprotonated with base to 
form the rearranged olefin.  The conditions for the diazene rearrangement are being investigated 
due to the unusual reactivity of the tosyl hydrazine (24).  Table 1 and Table 2 are a summary of 
a portion of the various bases, solvents, and reaction conditions used to optimize the formation of 
the corresponding olefin (26).  The various reactions were run on the benchtop and in the 
microwave.  The microwave was used to alleviate the long reaction times on the benchtop 
(>24h).  Due to large amount of reactions run, the success of the production of limonene (26) 
was rated on whether or not any product formed, not on yield.  The yield can be determined after 









1. Base, solvent, temperatue





Table 1 - Microwave Reactions    
Base Equ. Catalyst Solvent Conditions Product 
Pyridine d5 5 none none Microwave 1hr 140˚C limonene 
Pyridine d5 3 none dichloromethane Microwave 1hr 80˚C starting material 
Pyridine d5 3 10mol% DMAP dichloromethane Microwave 1hr 80˚C limonene 
Pyridine 5 none none Microwave 2hr 130˚C mostly S.M. and limonene 
Pyridine 5 none dichloromethane Microwave 2hr 130˚C starting material 
Pyridine 3 10mol% TEA dichloromethane Microwave 2hr 80˚C starting material 
Pyridine 3 10mol% DMAP dichloromethane Microwave 2hr 80˚C limonene 
Pyridine 5 10mol% 4-PP dcm Microwave 30 min 120˚C limonene 
polyvinylpyridine 3 10mol% pyridine dichloromethane Microwave 2hr 80˚C starting material 
polyvinylpyridine 3 10mol% DMAP dichloromethane Microwave 2hr 80˚C starting material 
polyvinylpyridine 3 pyridine pyridine Microwave 1hr 140˚C starting material 
Tetramethylguanidine 3 none none Microwave 1hr 190˚C Multiple products 
Tetramethylguanidine 5 none dcm Microwave 1hr 190˚C Multiple products 
N-methylimidazole 3 none none Microwave 1hr 140˚C starting material 
N-methylimidazole 3 none dcm Microwave 1hr 140˚C starting material 
N-methylmorpholine 5 none none Microwave 30 min 120˚C Multiple products 
N-methylmorpholine 5 none dcm Microwave 30 min 120˚C Multiple products 
2,6-lutidine 5 none none Microwave 1hr 150˚C starting material 
P.S. DMAP 3 none dichloromethane Microwave 1hr 80˚C starting material 
P.S. DMAP 3 pyridine dichloromethane Microwave 1hr 80˚C starting material 
P.S. DMAP 3 pyridine d5 dichloromethane Microwave 1hr 80˚C starting material 
P.S. DMAP 3 DMAP dichloromethane Microwave 1hr 80˚C starting material 




Table 2 - Bench Top Reactions    
Base Equ. Catalyst Solvent Conditions Product 
Pyridine d5 5 none none reflux 24hrs limonene 
Pyridine d5 3 none dichloromethane reflux 24hrs starting material 
Pyridine d5 3 10mol% DMAP dichloromethane reflux 24hrs starting material 
Pyridine d5 3 none acetonitrile reflux 24hrs starting material 
Pyridine 5 10mol% DMAP chloroform reflux 48hrs starting material 
Pyridine 5 none none reflux 48hrs mostly S.M. and limonene 
Pyridine 5 none dichloromethane reflux 48hrs starting material 
Pyridine 5 10mol% DMAP xylenes reflux 48hrs starting material 
Pyridine 5 none acetonitrile reflux 48hrs starting material 
Pyridine 5 10mol% TMG dcm reflux 24hrs 65˚C starting material 
Pyridine 5 10mol% DMAP DMF reflux 24hrs 140˚C starting material 
Pyridine 3 10mol% DMAP dcm reflux 24hrs 65˚C starting material 
Pyridine 3 10mol% DMAP dcm reflux 24hrs 108˚C starting material 
Pyridine 3 10mol% DMAP dichloromethane reflux 48hrs press. Tube trace limonene 
polyvinylpyridine 5 pyridine pyridine reflux 24hrs 121˚C starting material 
polyvinylpyridine 5 pyridine dcm reflux 24hrs 113˚C starting material 
polyvinylpyridine 5 pyridine acetonitrile reflux 24hrs 118˚C starting material 
polyvinylpyridine 5 10mol% TMG dcm reflux 24hrs 65˚C starting material 
polyvinylpyridine 3 10 %pyridine acetonitrile reflux 24hrs starting material 
Tetramethylguanidine 3 none none reflux 6hrs Multiple products 
Tetramethylguanidine 5 none acetonitrile reflux 24hrs 90-100˚C Multiple products 
Tetramethylguanidine 5 none dcm reflux 24hrs 90-100˚C Multiple products 
N-methylimidazole 5 none DMF reflux 24hrs 140˚C starting material 
2,6-lutidine 5 none none Reflux press.tube starting material 
2,6-lutidine n/a none none reflux 24hrs 140˚C starting material 
2,6-lutidine 1.5 none THF reflux 72hrs 110˚C starting material 
DMAP 1.1 none dcm reflux 24hrs 121˚C possible limonene 
DMAP 1.1 none xylenes reflux 24hrs 140˚C Multiple products 
  
 To summarize the tables, it was found that the conditions and bases to form the 
rearranged olefin are d5-pyridine (neat, microwave 1h at 140ºC), d5-pyridine and catalytic 
DMAP (dcm, 1h, 80ºC), pyridine and catalytic 4-pyrollidino pyridine (dcm, 30 min, 120ºC), 
and pyridine and catalytic DMAP (microwave, 2h, 80ºC).   
 
Synthesis of Norbornenyl Sulfonyl Chloride 
 Hanson and coworkers developed a procedure to synthesize norbornenyl sulfonyl 
chloride (13) and published a paper reporting the progress.7  In the paper they left out the 
experimental for the development of the reagent.  We contacted the research group and they 
emailed a procedure to produce this reagent.  Throughout the summer I tried the procedure to no 
avail.  The byproducts of the reaction to produce ethylene sulfonyl chloride (12) were the major 
products and thus contaminated further reactions.  I determined that the procedure did not work 
as they had written and found a commercially available reagent (11) that is inexpensive and 



















Scheme 8 - Hanson's Procedure
 
 
 The synthesis of norbornenyl sulfonyl chloride (13) is complete and proceeds in high 
yield.  The next step to produce the norbornenyl hydrazine (14) proceeds in approximately 60% 
recrystallized yield.  The reaction to produce the 14 has been tried at -30ºC, -13ºC, 0ºC, rt, and 
47ºC.  As the temperature increased, the yield of the product increased.  The length of reaction 
has been varied also and the best experimental is listed in the experimental section.  14 is then 
refluxed with R-Carvone in methanol for 6-8 hours to produce the norbornylsulfonyl hydrazone 
(27).  The next step in the synthesis is to ROMP 27 to form the oligomer that makes the substrate 
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 4-toluene sulfonyl hydrazine (20.46g, 110 mmol) is dissolved in methanol (650 mL) in a 
flame dried 1 L rb flask equipped with a reflux condenser.  R-Carvone (15.6 mL, 99.8 mmol) is 
added to the stirred solution and the solution is refluxed at 79 ºC.  The TLC showed no 
significant change from 5-8h thus the rxn was cooled to rt.  Upon removal of the stir bar, instant 
crystallization occurred and the precipitate is filtered and washed with cold methanol and 
hexanes to yield R-carvone tosylhydrazone (>70% yield).  The filtrate is conc. in vacuo and 
recrstallized from ethanol. 1H-NMR: (CDCl3, 300 MHz)  7.85 (2H, d), 7.67 (1H, s), 7.28 (2H, 
d), 6.05 (1H, s), 4.74 (1H, s), 4.69 (1H, s), 2.7 (1H, dd), 2.4 (3H, s), 2.3-1.9 (4H, m), 1.75 (3H, 
s), 1.66 (3H, s) ppm.  13C-NMR (CDCL3, 300 MHz):  154, 147, 144, 135, 133, 132, 129, 128, 
1120, 40, 30, 29, 21, 20, 17 ppm.     
 
R-Carvone Tosylhydrazine 
 R-carvone tosylhydrazone (2.50g, 7.85 mmol) is dissolved in chloroform in a 100 mL 
flame dried rb flask and cooled to 0 ºC.  Catecholborane (1.25 mL, 11.78 mmol) is added 
dropwise to the solution over 10 min and the rxn is stirred at 0 ºC for 3h and then warmed to rt 
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over 2h.  Acetic acid (0.25 mL) is added to quench the rxn, the solution is stirred for 20 min., and 
then transferred to a separatory funnel with H2O and CHCl3.  The organic layer is washed with 
H2O (2x15mL).  The combined organic layers are dried over MgSO4, filtered, and conc. in 
vacuo.  The residual solid is dissolved in CH2Cl2 and precipitated with cold MeOH.  The final 
recrystallized yield of R-carvone tosylhydrazine is >70%.  1H-NMR: (CDCl3, 300 MHz) 7.82 
(2H, d), 7.3 (2H, d), 5.8 (1H, s), 5.54 (1H, s), 4.65 (1H, s), 4.54 (1H, s), 3.27 (1H, s), 2.41 (3H, 
s), 2.1 (2H, m), 1.95 (1H, m), 1.82 (1H, m), 1.61 (6H, s), 1.1 (1H, m) ppm.  13C-NMR (CDCL3, 
300 MHz):  148, 143, 135, 132, 129, 128, 126, 109, 60, 40, 33, 30, 21, 20, 19 ppm.   NOESY, 
COSY, and DEPT data available. 
 
R-Carvone Norbornenyl Hydrazone   
 Norbornyl sulfonyl chloride (200 mg, 1.06 mmol) is dissolved in MeOH (4 mL) in a 10 
mL rb flask equipped with a reflux condenser.  R-carvone (0.11 mL, 0.70 mmol) is added to the 
reaction mixture and the resulting solution is refluxed at 79ºC.  After 4h TLC (10% 
EtOAc/Hexanes) showed  disappearance of all starting material., but the reaction is allowed to 
react overnight.  The rxn is cooled to rt and conc. in vacuo.  The residual solid is recrystallized 
from ethanol, filtered, and washed with hexanes and cold MeOH.  After one crystallization, 83 
mg (63%) of R-carvone norbornyl hydrazone is dried under high vac.   
 
Ethlylene Sulfonyl Chloride 
 2-chloro-1-ethane sulfonyl chloride (2.0 mL, 20 mmol) is dissolved in ether (11 mL) in a 
100 mL rb flask and cooled to -40ºC in a acetonitrile/dry ice bath.  2,6-lutidine (2.67 mL, 23 
mmol) is dissolved in ether (4 mL) and added to the ethane/ether mixture dropwise over 20 min.  
The reaction is warmed to room temperature over 3h in which the liquid turns to a white solid.  
The reaction is cooled to 0ºC and cold 1% H2SO4 (15 mL) is added to dissolve the white solid.  
The soln is transferred to a separatory funnel and the ether layer is washed with cold 1%H2SO4, 
H2O, and brine.  The ether layer is dried over MgSO4, filtered, and conc. in vacuo.  The crude 
product is either a purple/red or a clear/yellowish color.  The desired product is a clear liquid.  
The crude product does not need to be purified and can be used in the next step.  Characteristic 
peaks of the desired product appear at 7.05 (1H, m), 6.55 (1H, d), 6.3 (1H, d).   
 
Norbornenyl Sulfonyl Chloride 
 Crude ethylene sulfonyl chloride (4.80g, 38 mmol) is dissolved in benzene in a 500 mL 
rb flask.  Freshly cracked cyclopentadiene (3.92 mL, 47 mmol) at 0ºC is added to the soln in 
0.20-0.60 mL aliquots until the theoretical volume is added.  The reaction is stirred until the 
elimination of starting material is observed by TLC (10% EtOAc/Hexanes).  The reaction is 
stirred for another 1 h and then conc. in vacuo.  The crude product is purified by column 
chromatography (10%EtOAc/Hexanes).  1H-NMR:  6.35 (1H, m), 6.0 (1H, m), 4.37 (1H, m), 
3.54 (1H, s), 3.10 (1H, s), 2.34 (1H, m), 1.63 (2H, m), 1.37 (1H, m) ppm.  13C-NMR:  138, 131, 
49, 47, 43, 31 ppm. 
 
Norbornenyl Sulfonylhydrazine 
 Norbornyl sulfonyl chloride (500 mg, 2.6 mmol) is dissolved in THF (3 mL) in a 10 mL 
rb flask equipped with a reflux condenser.  Hydrazine monohydrate (0.30 mL, 9.7 mmol) is 
added to the soln and the resulting soln is refluxed at 47 ºC.  The disappearance of starting 
material is observed after one hour by TLC (10% EtOAc/Hexanes).  The reaction is stirred for 
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6h, EtOAc is added, the rxn is stirred for 15 min, and then transferred to a separatory funnel.  
The organic layer is washed with cold 10% NaCl (4x10mL), dried over MgSO4, and conc. in 
vacuo.  The residual is recrystallized from EtOAc/Hexanes.  The recrystallized product (290 mg, 
58%) is dried under high vac.  1H-NMR:  6.26 (1H, m), 6.10 (1H, m), 5.71 (1H, s), 3.82 (3H, m), 
3.28 (1H, s), 2.98 (1H, s), 2.07 (1H, m), 1.53 (2H, m), 1.32 (1H, s) ppm.  13C-NMR:  137, 131, 
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Synthesis of O-Tbs Protected First Generation Dendrimer 
Vanja Stojkovic, Northland College 




 The search for inexpensive, easy to maintain, and rapid sensors for detection of the 
marine toxin-saxitoxin, which would replace the most commonly used mouse bioassay, has 
been going on for years. One possible solution could be nanoscale chemosensors, which 
would be attached to polystyrene beads. These chemosensors contain a coumaryl crown 
that detects saxitoxin based on the inhibition of PET, and  dendrimers, which try to mimic 
the solvent-excluded binding site of saxitoxin. Previous research concentrated on finding 
ways to maximize growth of dendrimers; whereas today the main focus is concentrated on 
synthesizing dendrimers with an alcohol group on its periphery; therefore they will be 
water-soluble. One of the most important “building blocks” in this synthesis is the first 
generation dendrimer protected with an O-Tbs protecting group. Synthesis of this 




When a large concentration of the microscopic algae Alexandrium tamarense pervades 
the ocean, the water becomes a reddish color; this is called a red tide.1 Red tides contain several 
biotoxins. For many years, marine biotoxins produced by algal blooms have represented a threat 
to people as well as aquatic life. The problem dates as far back as 1793 when a member of 
Captain George Vancouver’s crew died from bio-intoxication after eating shellfish.2 That was 
the first recorded case, in Northern America, of poisoning caused by marine biotoxins; however, 
the problem still continues today and not only in North America, but all around the world. 
    Saxitoxin is a strong neurotoxin produced by red tides that can cause paralytic shellfish 
poisoning (PSP). PSP is a respiratory paralysis that can be treated if the symptoms of the disease 
are noticed in first 24 hours.3 Usually the symptoms are dizziness, vomiting, thirst etc., and in 
severe cases it can result in complete respiratory paralysis; rarely it can be fatal.4 Saxitoxin is 
very toxic for it binds to and blocks Na+ channels inhibiting the action potentials completed by 
the cell. Resistance to intoxication of saxitoxin varies with age, weight, and health of the 
individual; however reported results (in adults) showed that 340 µg of consumed saxitoxin could 
cause mild symptoms, and that the intake of 1000 µg of saxitoxin resulted in death.4 
Nonetheless, LD50 in humans is unknown. 
   One of the problems is fast accumulation of the saxitoxin in some of the shellfish, for 
example mussels can become very toxic without apparent alert. In August 1980, scientists in 
Maine, observed that the level of saxitoxin in mussels increased significantly from “the detection 
level to 8000+µg/100g in 2 days”.4 Also, some research indicated that during the bloom of 
Alexandrium fundyense, the level of saxitoxin in mussels could exceed acceptable levels in less 
than one hour. Therefore, it is very important to find a way to monitor both the presence and the 
level of the saxitoxin in shellfish beds. Several tests are available at this time, such as the mouse 
bioassay, HPLC, autoanalyzer, radioimmunoassay, and competitive displacement assay. 
Problems with these methods of testing include high cost, inconvenience for the fast in field 
detection of toxins, and high rate of data processing.2 Also, most of these tests are limited in their 
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detection levels, for example, mouse bioassay, which is most commonly used, has a “minimum 
detection level of 37µg/100g meat, [that] is close to the maximum [allowance] level of 80 
µg/100g meat”.5 Moreover, it can underestimate the concentration of the toxin at low toxin 
levels. These problems inspired Dr. Gawley’s group to develop a chemosensor that would be 
inexpensive, easy to handle, and fast. The idea is to create nanoscale sensors that would be 
attached to polystyrene beads, in order to detect the toxin by using only “a hand-held UV lamp 
and magnifying glass.”9 
Chemosensors are also called PET chemosensors because they operate through the 
principle of photoinduced electron transfer. The initial chemosensor, aminomethylanthracenes 
fluorescents slightly as free base because the lone pair on the nitrogen suppresses the excited 
state by photoinduced electron transfer. If the sensor is protonated, hydrogen bonded to 
something(like solvent-water), the electron transfer will be suppressed and the 















                                                          Figure 1. Coumaryl crowns 
                                              
According to the previous research done by Dr. Gawley, coumaryl crown ether based 
chemosensors showed selective detection of saxitoxin in the presence of sodium and potassium 
ions. New coumaryl crowns 1 and 2 (Figure 1), which were synthesized in the Gawley lab, and 
anthracylmethly-crown, showed identical binding constants, indicating that aza-crown moiety is 
responsible for binding of saxitoxin.6 Also, detection of the fluorescence of coumarin crown was 
carried in the buffer EtOH environment. The fluorescent response was much better in the EtOH 
indicating that hydrogen bonding between coumarine crown and saxitoxin maybe responsible for 
the fluorescence.  
 To explain the bonding of saxitoxin to coumaryl crown, the Gawley group looked for the 
fluorescence response of adenine (because it is biomolecule and has a purine ring as STX), 
argenine and guanidinium( because it is known that guanidinium ions bind to crowns), and o-
bromophenol (because it has same pKa as saxitoxin). As a result none of the above molecules 
showed evidence of binding, which suggests that crown binds STX selectively, which indicates 
that simple hydrogen bonding between STX and the nitrogen on the crown is not the only thing 
that occurs when binding happens. Although it is still difficult to completely explain the bonding, 
the research showed that these chemosensors were able to fluoresce nicely when the level of the 


















 However, there is an idea that selectivity, and/ or sensitivity of chemosensors towards 
saxitoxin could be improved by incorporating dendrimers to encapsulate the sensor moiety. The 
first, reason for this is that dendrimers, as highly branched polymers, are able to create inner 
spaces that do not contain much of the solvent. Second, they are able to surround the crown ether 
and minimize the interaction between the crown ether and an aqueous solvent.   
 Structure and characteristics, explained previously, enable dendrimers to mimic receptors 
proteins of the saxitoxin’s binding site. There is a hypothesis that the binding site is solvent-
excluded, and dendrimers are exactly that solvent exclusive.7 
 Previous work done by Dr. Gawley’s group included synthesis of dendrimers which 
contained tert-butyl esters at the periphery. Tert-butyl group showed the best results in 
maximizing spreading in the second- and third- generation; however the problem is that those 
dendrimers were insoluble in water. To make dendrimer soluble in the water solution, some 
heptane sulfonate was added during the fluorescent titration. The hydrophobic heptane will be 
attracted to the inner “hydrophobic” part of the dendrimer. Sulfonate will be on the outside 
“holding” the negative charge, which makes the dendrimer charged and soluble. On the other 
hand, saxitoxin is also soluble in water and appears as a positive charged ion. There is a 
possibility that sulfonate ion will interact with saxitoxin, and this interaction could be the reason 
why the observed binding constant was higher.  
The current research is focused on synthesis of water-soluble dendrimers so that 















                                                                  
 
 
Figure 2. Third generation dendrimer containing OH at the peripheries  
 
The goal is to create third generation dendrimers, which would contain alcohol groups at 
the terminal end, so that it is water-soluble but not charged. In that case, we would be able to see 
if that dendrimer is a good mimic of binding receptor, and to see how big is its contribution to 
increase of binding constant.  
My part during this summer was to test already proposed synthesis of first generation 
dendrimer containing O-Tbs protecting group, which is one of the intermediates in making the 
















































































































































Results and Discussion 
 
As in previous research, synthesis of dendrimers was based on tris core 1 (Scheme 1). 
The difficulty of removing DMSO with an adequate pump was solved with the usage of a 
separatory funnel. However, it was very important to wash the water layer with a sufficient 
amount of dichloromethane in order to achieve an ultimate separation as well as a better yield. 
Due to the small possibility of impurities, this reaction was carried on both small (2g) and larger 
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 In order to find the optimal protection group for the amine of 3, my mentor dr. Shan did 
few experiments using both Cbz and Fmoc groups. The latter one was shown to be easier to 
remove, and the conditions under which reaction went were milder, which did not affect 
protecting silyl group. 
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A straight forward synthesis of 3 showed to be more efficient and less complicated, as seen with 
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 Fmoc triacid 6 was prepared as shown in Scheme 3. Presence of formic acid in the finial 
compound turned out to be a difficult. If in the following step O-tbs protected ethanol amine is 
not pure enough and contains traces of methanol then the excess of formic acid in the Fmoc 
triacid is a concern because a lot of undesired products will be created. To minimize this problem 
formic acid was removed under vacuum, and the compound was washed few times with acetone 




                                                
  +    
 
        7                                           8                                                                    9                                                                                            
 
 
 The starting material O-Tbs protected ethanol amine 9, that I used was already 
synthesized by reaction of ethanol amine 7 with tert-butyldimethylsilyl chloride 8 under 
Et3N/DMAP conditions (Scheme 4).  The reaction afforded 71% of desired material after 
purification on a silica gel column using dichloromethane and methanol. The removal of these 




















































 Treatment of Fmoc triacid with O-Tbs protected ethanol amine turned to be the most 
difficult step. Few trials of this reactions were run, using different coupling reagents. The best 
results were achieved under HATU conditions affording 10 in 30% yield (Scheme 5). No 11 was 
seen as evidence by the 1H NMR spectrum of the different fractions after the column 
chromatography.  Purity of 10 is crucial for future synthesis. 1H NMR that I was obtained had an 
impurity peak around 3ppm, which is believed to be a urea derivative. Because this compound is 
not very soluble in water, washing with water was not very successful in removing it. 
 Unless we are dealing with very pure compound, removal of the Fmoc group can be very 
difficult.  
 The Fmoc group can be removed in the presence of 20% piperidine/DMF solution at rt 































































































 The proposed Gawley’s method of synthesizing dendrimers has shown promising results 
for further investigations. Recent studies also indicate the possibility of a four-step synthesis, 
which would enable researchers to produce desired dendrimers more efficiently. Nonetheless, 
investigations pertaining to the purification process need to be furthered. Only in the presence of 




General Methods.  
All reagents were commercially available and used without further purification. THF was freshly 
distilled from sodium-benzophenone ketyl and CH2Cl2 from CaH2. Column chromatography 
was performed on silica gel 60 (60-200 mesh) while TLC was carried out using aluminum-
backed plates coated with 0.25 mm silica gel 60 and visualized under UV light. 1H NMR and 13C 
NMR spectra were recorded on a Bruker 300 MHz instrument. 
 
Synthesis of TRIS{[2-(tert-butoxycarbonyl)ethoxy]methyl}methylamine 
Procedure from J. Organic Chemistry , Vol. 67, N.4, 2002, p1413: 
The Tris (1.21g, 10.0mmol) in 2.0 ml of a newly opened bottle of DMSO was cooled to 15.0 °C 
under N2. Then , 0.2ml of 5.0M NaOH was injected while stirring, followed by the tert-butyl 
acrylate (5.0ml, 34mmol),which was injected dropwise. The reaction was allowed to reach room 
temperature and left stirring for 24 hours. At this point, the excess reagent and solvent were 
removed under vacuum at room temperature and the residue was purified by column 
chromatography (SiO2, 2:1 EtOAc/hexane +0.05%v/v NH4OH) to yield a colorless oil (2.70g, 
54%). 
  
A small modification of the procedure was made to make the removal of the DMSO easier. After 
24 hours the mixture was washed with 200 ml of dichloromethane and 200ml of distilled water 
in order to remove excess of reagent and solvent. Residue was purified by column 
chromatography (SiO2, 2:1 EtOAc/hexane +0.05%v/v NH4OH) to yield a colorless oil. (See 
NMR in supporting information) 
My yield was 30%. 
 










The Tris{[2-(tert-butoxycarbonyl)ethoxy]methyl}methylamine(6.45g,12.78mmole) was 













Fmoc (3.9678g,15.33mmole) was added dropwise and the reaction mixture was stirred for 24 
hours. The product was extracted with CH2Cl2 and dried over MgSO4 and concentrated in 
vacuo. The residue was purified by column chromatography (SiO2, 2:1 hexane/ EtOAc) to yield 
colorless oil (4.6g, 73%) ( See NMR in supporting information) 
 











Fmoc-triester (5.895g,559g/mol) was stirred in 30 ml of 95% HCOOH for 24 hours. Then the 
excess of formic acid was removed in vacuo, and the reaction mixture was washed with 50ml of 
acetone and 50 ml of dichloromethane, which were evaporated to yield a white solid(4.6325g, 















 Fmoc-triacid (1.1808g,2.11mmol), HATU(2.556g, 6.72mmol), and Et3N(0.68g, 6.721mmol) 
were dissolved in 10.0ml of dry THF under nitrogen atmosphere, and was allowed to stir at rt for 
10min. Then, O-Tbs protected ethanol amine (1.1763g, 6.721mmol) with 5.00ml of dry THF was 
added for 10 min, and the reaction was stirred for 24 hours. After removal of the solvent at 
reduced pressure, the residue was dissolved in 50 ml of dichloromethane and washed with water 
and brine. The organic layer was then dried over MgSO4, and concentrated in vacuo, and 
purified by column chromatography (CH2Cl2:MeOH, 95:5) to yield 0.6192 g( 30%) of product 













































Compound 10 (0.44g, 0.438mmol) was stirred in 15.0 ml of 20% piperdine /DMF solution for 36 
h. Then, the reaction mixture was diluted with 50.0 ml of dichloromethane and washed twice 
with water (100.00ml). The organic layer was dried over MgSO4, concentrated in vacuo, and 
purified by silica gel column chromatography (CH2Cl2:MeOH, 95:5) to yield 0.278g (81%) of 
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Synthesis, Deuteration and Analysis of Bovine Lactoferricin Peptides 
Andjela Subotic, Saint Mary’s College 




The increase in drug-resistant pathogens has triggered an interest in naturally-
occurring antimicrobial peptides as antibiotic candidates.  A hexapeptide fragment (6mer) 
believed to be the antimicrobial center of one such peptide, lactoferricin, has been 
determined; the 6mer is rich in Trp and Arg residues.  In order to understand the role of 
Trp and Arg in membrane interactions, three derivatives of the bovine lactoferricin 6mer 
were synthesized by Solid Phase Peptide Synthesis.  In this study, the quality of synthesis 
was analyzed by RP-HPLC, MS, and Sequence analysis, and peptide/lipid interactions 
were investigated by CD spectroscopy and NMR analysis.  HPLC data in each case shows 
more than one peak, but MS results confirm that the majority of product is the desired 
6mer, with a minor component containing the residual Pmc protecting group.  MS analyses 
of TFA-D deuterated peptides show that deuteration was more successful for 1MeTrp than 
Trp.  Sequence analyses of two peptides gave the correct sequences for both; however, 
extra peaks were observed around the Trp residue in both cases indicating possible 
modification of the Trp residue.    
  
Abbreviations:  LF, lactoferrin; Lf, lactoferricin; LfB, bovine lactoferricin; LfH, human 
lactoferricin; Trp, tryptophan; Arg, arginine; Phe, phenylalanine; Gln, glutamine; Asn, 
asparagines; Lys, lysine; 1MeTrp, 1-methyl tryptophan; 6mer, hexapeptide fragment 
corresponding to amino acids 4-9 of lactoferricin; Fmoc, 9-fluorenylmethyloxycarbonyl; Pmc, 
2,2,5,7,8-pentamethyl-chroman-6-sulphonyl; DMF, dimethylformamide; DCM, 
dichloromethane; NMP, N-methylpyrrolidone; HBTU, [2-(1-H-benzotriazol-1-yl)-1,1,2,3-




There is an increasing problem in the world with drug-resistant pathogens.  As 
evolutionary changes in pathogens are occurring, antibiotics are becoming less effective due to 
the ability of pathogens to resist antibiotics.  The development of new antimicrobial substances 
to inhibit pathogen growth and ultimately kill pathogens is necessary in order to save lives and 
treat infections.  Researchers are becoming interested in understanding naturally occurring 
antimicrobial peptides, which may take the place of antibiotics and prove more effective against 
pathogens.1     
Finding an inexpensive and enhanced method for antimicrobial peptide synthesis is 
increasingly important as peptides become antibiotic candidates.  The simplest method to reduce 
the cost of producing peptides is to reduce the size of the peptide.  In order to reduce the size of a 
peptide without reducing antimicrobial activity, peptide fragments are being tested.   
Lactoferrin (LF) is a naturally occurring antimicrobial protein 80 kDa in length. It is 
important in the innate immune response of all living organisms.1  LF is secreted in human breast 
milk, tears, and saliva as well as other exocrine fluids.  Lactoferricin (Lf) is a twenty-five amino 
acid long peptide (amino acids 17-41 of LF) derived from the gastric pepsin cleavage of LF, 
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which has antimicrobial activity. There is a growing interest in the membrane interaction of Lf, 
because the peptide can disrupt bacterial membranes to inhibit bacterial growth2 or possibly 
cause bacterial lysis.  Elucidating the mechanism by which Lf interacts with membranes and 
understanding the basic properties of Lf in various environments may lead to a new class of 
antimicrobial drugs to act against drug-resistant pathogens. 
  The amino acids tryptophan (Trp) and arginine (Arg) are believed to be crucial to 
understanding the interactions between the peptide and bacterial membranes3 as it has been 
discovered that a hexapeptide fragment (6mer) of Lf rich in Trp and Arg exhibits antimicrobial 
activity.  Amino acids 4-9 of the twenty-five residue long Lf (or 20-25 of LF) make up this 
fragment, which is considered to be the antimicrobial center of LfB. 
The amino acid sequence of bovine lactoferricin (LfB) and human lactoferricin (LfH) are 
very similar; however, LfB has greater antimicrobially activity than LfH.4  Table 1 shows the 
difference between the LfB 6mer and LfH 6mer.  The LfB 6mer has one more Trp and two more 
Arg residues than LfH, which probably contributes to LfB being more active.  Trp is a 
hydrophobic amino acid with an amphipathic, aromatic indole ring, which helps anchor Lf at the 
membrane/water interface.5  Arg is cationic, allowing it to electrostatically interact preferentially 
with negatively charged bacterial cell membranes.  This study will investigate the role of Trp and 
Arg in peptides derived from LfB.      
 
Table 1. Amino Acid Sequences of Lactoferricin Peptides  
 1* 2 3 4 5 6  
LfH Phe Gln Trp Gln Arg Asn NH2 
LfB Arg Arg Trp Gln Trp Arg NH2 
LfB Phe3 Arg Arg Phe Gln Trp Arg NH2 
LfB Phe5 Arg Arg Trp Gln Phe Arg NH2 
LfB Lys2 1MeTrp3 Arg Lys 1MeTrp Gln Trp Arg NH2 
* The numbers 1-6 correspond to amino acid numbers 4-9 of lactoferricin (20-25 of lactoferrin) 
 
To understand the function of Trp and Arg in the LfB 6mer, several derivatives of the 
LfB 6mer have been made.  This paper focuses on the synthesis and analysis of three LfB 
peptide derivatives shown in Table 1 (LfB Phe3,  LfB Phe5, and LfB Lys2 1MeTrp3).  LfB Phe3 
and LfB Phe5 differ from native LfB by replacement of one Trp with phenylalanine (Phe).  LfB 
Lys2 1MeTrp3 has lysine (Lys) in place of Arg and 1-methyl-Trp (1MeTrp3) in place of Trp3.  To 
maintain the integrity of the peptide, replacements were chosen based on specific classifications.  
Both Trp and Phe have aromatic rings, and Arg and Lys are cationic (Figure 1).  The addition of 
a methyl group to nitrogen on Trp inhibits hydrogen bonding at the amino group.  It has been 
reported that replacing Trp and Arg with Phe and Lys reduces antimicrobial activity3, but our 
goal is to understand the importance of Trp and Arg to the structure of lactoferricin peptides and 
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Figure 1.  Amino Acid Structures 
 
 In this study, peptides were synthesized by standard Fmoc solid phase protocols using a 
Rink Amide AM resin (Figure2).  Fmoc is base-labile and is used to protect the α-amino group 
of amino acids during synthesis.  Reactive amino acid side chains are protected with acid-labile 
groups.  Figure 3 shows Arg with Fmoc protecting the α-amino group and Pmc protecting the 




Figure 2.  Rink Amide AM resin   [4-(2',4'-Dimethoxyphenyl-Fmoc-aminomethyl)-




Figure 3.  Fmoc-Arg(Pmc)-OH   The structure shows Fmoc on the α-amino group and Pmc on 
the side-chain amino group. 
 
When resin beads are solvated by DMF, DCM, and NMP, they swell allowing reactions 
to take place in their interior.  The linker on the resin is highly acid-labile providing a reversible 
linkage between a peptide chain and the resin. The linker also protects the C-terminal α-carboxyl 
group of the first amino acid once it is covalently bonded.  The Fmoc group on the first amino 
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acid is removed with 20% piperidine allowing attachment of the next amino acid.  Before 
coupling occurs, the α-carboxyl group of the next amino acid is activated by HBTU forming an 




Materials and Abbreviations 
  
  [N(9-Fluorenylmethoxycarbonyloxy)]-succinamide, 96%, (Fmoc-ONSu), 1-Methyl-L-
Trp, Dimethoxyethane (DME), and Sodium Carbonate were all purchased from Sigma-Aldrich.  
Amino acids were purchased from NovaBiochem (EMD BioSciences, San Diego, CA), Bachem 
(King of Prussia, PA), and Advanced ChemTech (Louisville, KY).  The Rink Amide AM resin, 
substitution 0.63 mmol/gram, was from NovaBiochem.  Chemicals used on the synthesizer and 
acetonitrile were from Applied Biosystems (Foster City, CA).  Trifluoroacetic acid (TFA) was 
from Pierce Chemical (Rockford, IL). Deuterium oxide (D2O) and deuterated TFA (TFA-D1) 
were from Cambridge Isotope Laboratories (Andover, MA).  Triisoproplysilane (TIPS) was from 
Sigma-Aldrich (St. Louis, MO).  Methyl t-butyl ether (MtBE) and methanol were from Burdick 
& Jackson (VWR, Irving, TX).  Hexane and anhydrous magnesium sulfate were from EM 
Science (Gibbstown, NJ).  1,2-Dioleoyl-sn-Glycero-3-Phosphocholine (DOPC) and 1,2-
Dioleoyl-sn-Glycero-3-[Phospho-rac-(1-glycerol)] (Sodium salt) (DOPG) lipids were from 
Avanti Polar Lipids (Alabaster, AL).  The deuterium oxide for NMR analysis was from Norell, 
Inc. 
 RP-HPLC, reversed phase high-performance liquid chromatography; MALDI/TOF MS, 
Matrix Assisted Laser Desorption Ionisation Time-of-flight Mass Spectrometry; CD, circular 
dichroism spectroscopy; SDS-d25, perdeuterated sodium dodecyl sulfate; ESI Mass 
Spectrometry, Electrospray Ionization Mass Spectrometry. 
 
Fmoc Addition to 1-Methyl-Trp NH group 
  
Procedure 1 
Day 1:  A 10% sodium carbonate (Na2CO3) solution was prepared, and 30 mL of the 
solution was added to 4.6 mmol (1 g) 1-Methyl-L-Trp in a 100 mL beaker forming a chunky, 
cloudy mixture.  In a 250 mL round bottom flask (RBF), 7.4 mmol (2.5 g) Fmoc-ONSu was 
dissolved in 30 mL DME in an ice bath (4°C).  The 1-Methyl-L-Trp solution was added 
dropwise with a plastic pipette to the Fmoc solution while continuously stirring at 4°C.  The pH 
was tested to ensure a basic pH of 8-9.  15 mL DME was added.  After 1 hour, 15 mL acetone 
was added, and the mixture was left to stir at room temperature overnight.  The pH was checked 
several times, and when the pH fell below 8, enough 10% Na2CO3 was added to keep the pH 
between 8 and 9.  When the solution became thick, enough DME/acetone (50:50) was added so 
that the stir bar would easily stir. 
 Day 2:  The solution was filtered with a Buchner funnel discarding the precipitate.  The 
RBF was rinsed with a small amount of DME/acetone (50:50), and the filtrate was returned to 
the RBF. The pH of the filtrate was tested to ensure a pH of about 8.5.  The liquid was 
concentrate on a BŰCHI RE111 Rotavapor, then 60 mL 1.5 N HCl was added to the RBF.  The 
RBF was sonicated so that the solid material would form a large chunk in the bottom of the flask.  
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Filtration was done with a Buchner funnel and the solid material was washed with cold MtBE 
several times.  The white precipitate was dried overnight under high vacuum. 
 Day 3:  The solid was dissolved in ethyl acetate in a water bath at 60°C.  The solution 
was filtered to discard insoluble material.  The filtrate was returned to the RBF and 
approximately 5 mL of hexane was added dropwise.  The volume was reduced with N2 gas; the 
solution was transferred to a crystallization vial and left in the freezer to crystallize. 




 Day 1:  Same as above. 
 Day 2: The solution was filtered with a Buchner funnel discarding the precipitate.  The 
filtrate was neutralized to pH 7 with a few drops of concentrated HCl and filtered to remove the 
HCl.  The liquid was concentrated on the rotavapor, then MtBE was added until the precipitate 
stopped turning a yellow color.  The RBF was sonicated to remove material from the sides.  The 
mixture was filtered with a Buchner funnel and washed with cold MtBE.  The precipitate was 
transferred to a 250 mL beaker; 60 mL ethyl acetate and 60 mL 0.1 N HCl were added to 
dissolve the precipitate.  More ethyl acetate was added until the precipitate completely dissolved.  
The solution was transferred to a separatory funnel, and the aqueous (bottom) layer was 
discarded.  The extraction was repeated with another 60 mL 0.1 N HCl, and a third extraction 
was done using saturated NaCl.  The solution was dehydrated with anhydrous magnesium sulfate 
and filtered, and the filtrate was dried to a white solid on the rotavapor.  Then, the solid was 
dried further on high vacuum. 
 Day 3:  About 60 mL ethyl acetate was added to dissolve the product while stirring at 
50°C.  The mixture was filtered.  The filtrate was transferred to a crystallization jar, and the 
volume was reduced with N2 gas.  The jar was placed in the freezer.  Several days later, there 
were no crystals, so a small amount of hexane was added (about 1 mL), and the volume was 
reduced further with N2 gas.  The jar was seeded after another several days. 
 
 All crystallization jars formed a solid that floated and melted into aqueous drops at room 
temperature.  As this was not the desired product, the jars were placed in the freezer to solidify 
the unwanted material, which was then filtered and discarded.   
 
Solid Phase Peptide Synthesis 
  
 The peptides were synthesized using a 433A Peptide Synthesizer from PE Applied 
Biosystems according to standard Fmoc solid phase protocols.  Loading was done on the Rink 
Amide AM resin using double-coupling with 10-fold excess of Fmoc-Arg(Pmc)-OH and 6 hour 
coupling times.  The loading was tested by measuring the absorbance of the Fmoc group at 
301nm, and unreacted functional groups on resin were capped with acetic anhydride.  All other 
amino acids were added using approximately 5-fold excess of Fmoc amino acids and 90 minute 
coupling times. 
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TFA Cleavage for Peptides with Arg(Pmc) and Trp(Boc) 
 
To remove resin and protecting groups from peptides, TFA cleavages were performed for 
each peptide.  All three peptides were cleaved with a non-deuterated TFA cocktail (Reagent 1 in 
Table 2) and a deuterated TFA cocktail (Reagent 2 in Table 2 ).  For the non-deuterated TFA 
cleavage, 2mL of Reagent 1 was prepared and added to 100 mg of the peptide/resin in a 4 mL 
glass vial with a Teflon lined cap.  The mixture was flushed with N2, covered with foil, and 
mixed for 4 hours at room temperature in an orbital shaker.  After 4 hours, the mixture was 
transferred to a filter stuffed with glass wool using a plastic pipette and collected in a pre-
weighed 15 mL centrifuge tube.  The resin was rinsed with 1.5 mL neat TFA, filtered again, and 
dried under N2 for about 30 minutes to remove most of the TFA.  To precipitate the sample, 
approximately 12 mL ice cold MTBE/hexane (50/50) was added to the resin in the 15 mL 
centrifuge tube and incubated on ice for 30 minutes.  Then, the sample was centrifuged at 4°C 
for 10 minutes at 1700 rpm using a Heraeus Labofuge 400 R centrifuge.  The supernatant was 
decanted, and the precipitation procedure repeated three times.  After removing the 
MTBE/hexane the last time, the centrifuge tube was placed on the vacuum line for a few minutes 
to remove the residual solvent.  Upon drying, the sample was dissolved in 500 µL dH20, and 500 
µL acetonitrile was added.  The sample was frozen with liquid N2 and left on the vacuum line 
overnight to lyophilize.   
 For the deuterated TFA cleavages using Reagent 2, the same procedure outlined above 
was followed; however, only 50 mg peptide/resin was used, and the resin was rinsed with TFA-
D1.  Peptides LfB Phe3 and LfB Phe5 were treated with deuterated TFA again to obtain more 
deuterated product.  The same cleavage cocktail was prepared (Reagent 2) and added directly to 
the lyophilized peptide in the centrifuge tube.  The tube was mixed in an orbital shaker in the 
cold for 4 hours.  The volume was reduced with N2 gas.  MtBE precipitations and lyophilization 
were done as above.    
 To determine the most favorable time for a TFA cleavage and to determine if a cleavage 
using thiol scavengers would yield better results, miniature cleavages were performed using the 
peptide LfB Lys2 1MeTrp3.  Three cleavages using Reagent 1 and three cleavages using Reagent 
3 were done at 2-hr, 3-hr, and 4-hr shaking times using only 10 mg peptide/resin in a 1 mL glass 
vial with a Teflon lined cap and approximately 300 µL of the cleavage cocktail per vial.  Two 
additional large scale thiol cleavages of LfB Phe3 and LfB Phe5 were performed using 50 mg 
resin/peptide and 1 mL cleavage cocktail. 
 
Table 2.  Cleavage Cocktails 
Reagent 1 Reagent 2 Reagent 3 
88% TFA (1.75 mL) 88% TFA-D1 (1.0 mL) 82.5% TFA (825µL) 
5% dH20 (100µL) 5% dH20 (50µL) 5% dH20 (50µL) 
2% TIPS (40µL) 2% TIPS (20µL) 5% Thioanisole (50µL) 
5% Phenol (100mg) 5% Phenol (50mg) 2.5% EDT (25µL) 
  5% Phenol (50mg) 
 
RP-HPLC, MS, and Sequence analysis 
 
 The cleaved peptides were analyzed using a Hitachi L-7100 HPLC pump and Zorbax C8 
reversed phase column (SB80, 4.6×50 mm, 3.5 µm particle size) at an absorbance of 280 nm on a 
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Kratos Spectroflow 757 absorbance detector.  The gradient can be found in Table 3 below.  The 
peptides were also analyzed by MALDI/TOF MS (University of Arkansas, Statewide Mass 
Spectrometry Facility), and two peptides were sequenced on an ABI 473 Peptide Sequencer.   
 
 
Table 3.  RP-HPLC Gradient 
Time (min) dH20 + TFA (0.1%) MeOH + TFA (0.1%) 
0 90 10 
2 90 10 
10 40 60 
15 40 60 
15.1 90 10 




 CD samples were prepared in DOPC alone or DOPC:DOPG (3:1) at different peptide to 
lipid ratios: 1:10, 1:20, 1:50, and 1:100.  For all samples, the peptide concentration was 75µM.  
The total lipid concentrations were as follows: 1:10, 0.375 µmol lipid; 1:20, 0.75 µmol lipid; 
1:50, 1.88 µmol lipid; 1:100, 3.75 µmol lipid.  Lipids were added to 1.5 mL Eppendorf tubes 
from stock chloroform solutions (25 mg/mL), and were dried under a stream of N2 gas, and 
further dried under high vacuum for 48 hours to remove all traces of solvent.  Dried lipids were 
hydrated with 400 µL dH2O, vortexed to disperse the lipid, and sonicated at 40 °C for 30 
minutes or until clear.  The peptides were added from aqueous stock solutions (~1mg/mL) to the 
lipid dispersion, and the final volume was brought to 500 µL.  The peptide:lipid dispersions were 
sonicated at 40 °C for 30 minutes or until clear.  The final solutions were all clear.  The peptide 
concentrations were determined on a Hewlett Packard 8452A Diode Array Spectrophotometer 
using a 0.1 cm cuvette by measuring the absorbance of the Trp residues at 280 nm using an 
extinction coefficient of 5600 M-1 cm-1 per Trp.  The samples were diluted if necessary to ensure 
that the absorbance between 200 and 300 nm was below 1.5.  Each CD sample was measured 
between 200 and 250 nm, using a resolution of 0.2 nm, a band width of 1.0 nm, a response time 
of 1 second, and a scan speed of 1 nm/min.  Each spectrum was analyzed on a Jasco 710A 
spectrometer at room temperature with an average of 15 scans. 
 
2D 1H NMR 
 
 Two samples were prepared for 2D 1H NMR analysis with the peptide LfB Phe5.  The 
aqueous sample (90% H2O + 10% D2O) was prepared in a 1.5 mL Eppendorf tube by dissolving 
8.3 mg of the peptide (12mM) in 500µL dH2O and adding 80µL D2O.  The pH was adjusted to 
4.5 by adding 0.1 N HCl or 0.1 M KOH and monitored on a 420A Orion pH meter.  The volume 
was brought to 800µL with dH2O.  The solution was filtered into a new Eppendorf tube using a 
syringe and microfilter then transferred into an oven-dried, thin-walled NMR tube using a long 
Pasteur pipette.    The SDS-d25 sample (1:50 peptide:lipid ratio) was prepared in a 1.5 mL 
Eppendorf tube by first dissolving 125 mg (600 mmol) SDS-d25 (50 fold excess of peptide: 
600mM) in 500 µL dH2O and 80µL D2O and sonicating.  Then, 8.3 mg (12 mmol) peptide was 
added and sonicated until the solution cleared.  The pH was tested and found to be slightly lower 
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than 4.5, so 3µL 0.1 M KOH was added, which caused the peptide/lipid to precipitate.  To try 
and redissolve the peptide/lipid, a small amount of 0.1 N HCl was added; however, any attempt 
to dissolve the precipitate failed, so the sample was left in the Eppendorf tube to dissolve in low 
heat overnight. The final pH was ~2.2.  The following day, the SDS-d25 sample was transferred 
to an NMR tube as above and left in a heating block at 50 °C to keep the peptide/lipid dissolved. 
Note: The sample forms a gel-like precipitate immediately upon cooling below 50 °C; it could be 
re-dissolved only by brief sonication and returning it to the heating block.   
 
Oriented 31P NMR 
 
 The native LfB 6mer and LfB Lys2 1MeTrp3 were used to prepare oriented NMR 
samples.  For each peptide, 50 glass slides were laid in a radial position in 2 Petri dishes.  In a 50 
mL conical bottom flask, 4µmol of peptide (approximately 4 mg) was weighed and a 3:1 mixture 
of DOPC:DOPG (60 µmol : 20 µmol  or 1.88 mL : 630 µL ) was added.  Lipids were added from 
stock chloroform solutions of 25 mg/mL.  The mixture was sonicated to dissolve the peptide in 
the lipid/chloroform solution then dried under N2 gas to remove the liquid.  The peptide/lipid 
mixture was redissolved in 1mL chloroform forming a slightly cloudy solution; however, no 
large particulates were present.  Using a glass syringe, 25 µL of solution was applied to each 
glass slide.  The Petri dishes were air dried completely then placed in a desiccator to dry under 
high vacuum for 48 hours.  After 48 hours, the slides were hydrated with 40% deuterium-
depleted water by weight (1 µL per slide) using a glass syringe.  The slides were stacked and 
placed in a cuvette.  Empty glass slides were also placed in the cuvette to fill space.  The cuvette 
was sealed with a glass cap and epoxy glue and placed in a heating block at 45°C for about one 
week to allow the sample to become transparent.  The samples were tested by NMR 
spectroscopy even though they did not clear. 
   
Results and Discussion 
 
Fmoc Addition to 1-Methyl-Trp NH group 
 
 To synthesize the peptide LfB Lys2 1MeTrp3, it was necessary to make Fmoc protected 
1-methyl-Trp, because Fmoc-1-methyl-Trp cannot be bought.  In an attempt to improve upon the 
existing protocol, the Fmoc addition was performed three times: twice using Procedure 1 and 
once using Procedure 2 outlined above.  All crystallization jars contained aqueous material that 
was filtered and discarded. The material, which resembled small slithers of ice when frozen and 
aqueous drops at room temperature, continuously formed in the jars.  Despite this unwanted 
material, a small amount of light yellow crystals (Fmoc-1-methyl-Trp) did form.  A larger 
quantity was needed for peptide synthesis, so previously made Fmoc-1-methyl-Trp was used. 
Based on these results, it is preferable to continue to use the existing procedure7 to prepare 
Fmoc-Trp rather than the protocols used here.   
 
RP-HPLC and MS analysis 
  
RP-HPLC and MALDI/TOF mass spectrometry were employed to test the quality of the 
peptides.  In most cases, HPLC data gave more than one peak indicating either unsuccessful 
peptide synthesis and/or incomplete cleavage from the resin; however, each chromatogram 
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displayed one prominent peak.  To verify that the majority of the product was the desired 
peptide, mass spectral data was analyzed. 
  
LfB Phe3.  Figure 4 shows the HPLC of peptide LfB Phe3.  The largest peak at an elution time of 
9.5 minutes is presumably the desired product, and mass spectral data in Figure 5 confirms that 
the majority of product is the peptide LfB Phe3.  The molecular weight of the peptide is 947.11.  
In Figure 5, we see the molecular ion at 947.527 m/z.  The peak at 969.528 m/z corresponds to 
the sodium adduct ion (947.11 plus the molecular weight of sodium, 22.99).  The peaks above 


























Figure 5.  MALDI/TOF Mass Spectrum of LfB Phe3 cleaved with non-deuterated TFA (plot 
of relative intensity, r.i., versus mass-to-charge ratio, m/z) 
 
Figure 6 shows the HPLC of LfB Phe3 cleaved with deuterated TFA.  The chromatogram 
indicates that not all the product was successfully deuterated, because there are two fairly large 
peaks.  In Figure 7 we expected to see a large peak at a mass-to-charge ratio above 947.527 
indicating some deuteration of the peptide.  There are peaks at 950.564 m/z and 972.579 m/z 
meaning some of the peptide was deuterated; however, the peaks of the non-deuterated 
molecular ions (both the protonated molecular ion and the sodium adduct ion) are larger than the 



























Figure 7.  MALDI/TOF Mass Spectrum of Deuterated LfB Phe3 (plot of relative intensity, 
r.i., versus mass-to-charge ratio, m/z) 
 
The peptide LfB Phe3 was treated again with deuterated TFA to gain more deuterated 
product and tested by HPLC and MALDI/TOF MS.  The chromatogram in Figure 8 gives only 
one peak, and MS data in Figure 9 confirms that there is more deuterated product.   
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Figure 9.  MALDI/TOF Mass Spectrum of TFA-D1 treated LfB Phe3 (plot of relative 
intensity, r.i., versus mass-to-charge ratio, m/z) 
 
LfB Phe5. The peptide LfB Phe5 gave similar results to peptide LfB Phe3 above.  As in the case 
of LfB Phe3, the chromatogram in Figure 10 suggests some problems in the synthesis or cleavage 
of the peptide.  (The straight line on the chromatogram is noise in the baseline.)  The molecular 
weight of the peptide is 947.11, so the protonated molecular ion at 947.447 m/z and the sodium 
adduct ion at 969.438 m/z in Figure 11 confirm that the product was the desired peptide.   
 

















Figure 11.  MALDI/TOF Mass Spectrum of LfB Phe5 cleaved with non-deuterated TFA 
(plot of relative intensity, r.i., versus mass-to-charge ratio, m/z) 
  
Deuteration of the peptide LfB Phe5 was achieved by cleavage with TFA-D; however, 
there was still non-deuterated product.  The chromatogram in Figure 12 shows three peaks, 
indicating synthesis or cleavage problems.  The mass spectrum in Figure 13 reveals that although 
the majority of product was still non-deuterated (m/z = 947.5), a small amount of deuterated 


























Figure 13.  MALDI/TOF Mass Spectrum of Deuterated LfB Phe5 (plot of relative intensity, 
r.i., versus mass-to-charge ratio, m/z) 
 
 As with the first peptide, the peptide LfB Phe5 was treated with deuterated TFA again.  
We still see two peaks in the chromatogram (Figure 14), but the mass spectrum (Figure 15) 











































Figure 15.  MALDI/TOF Mass Spectrum of TFA-D1 treated LfB Phe5 (plot of relative 
intensity, r.i., versus mass-to-charge ratio, m/z) 
 
 It was hypothesized that one reason the HPLC chromatograms were showing two peaks 
was that the Pmc protecting group was not coming off of Arg.  To test the hypothesis, an ESI 
Mass Spectrum was analyzed for the peptide LfB Phe5.  With a Pmc group present, it is expected 
for a peak to show at an added mass of 266.4.6  The ESI spectrum in Figure 16 gives us two 
small peaks that the MALDI/TOF spectrum did not show in Figure 15; the peaks are at 1214.5 
m/z and 1236 m/z.  If we subtract 266.4 from 1214.5 and 1236, the result is approximately the 
mass-to-charge ratio of the protonated molecular ion and the sodium adduct ion: 948 and 970, 





























Figure 16.  Electrospray Ionization Mass Spectrum of LfB Phe5  
 
LfB Lys2 1MeTrp3.  The chromatogram in Figure 17 shows two major peaks indicating 
difficulties in synthesizing the peptide and/or cleaving it from the resin.  The molecular weight of 
LfB Lys2 1MeTrp3 is 972.16, so we expect to see a large peak in the mass spectrum 
corresponding to the desired peptide.  In Figure 18 we indeed see that the major peak is the 
molecular ion at 972.646 m/z.  A minor peak at 1238.737 m/z is due to some peptide containing 
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Figure 18.  MALDI/TOF Mass Spectrum of LfB Lys2 1MeTrp3  cleaved with TFA  
(plot of relative intensity, r.i., versus mass-to-charge ratio, m/z) 
  
 After cleaving the resin with TFA-D1, we again saw two peaks in the chromatogram 
shown in Figure 19.  The mass spectrum in Figure 20 shows that the majority of the product was 
deuterated.  The protonated molecular ion in the mass spectrum is the largest peak with a mass-
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to-charge ratio of 976.679 (972.646 + deuterium).  Since this peptide was successfully deuterated 


























Figure 20.  MALDI/TOF Mass Spectrum of Deuterated LfB Lys2 1MeTrp3  (plot of relative 
intensity, r.i., versus mass-to-charge ratio, m/z) 
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The complex isotope pattern revealed in the inset in Figure 20 confirms that the deuteration of 
the 1MeTrp in this peptide was successful.  [Explain isotope abundance bar graph below] 
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 For technological reasons sequence data cannot be shown.  Two sequence analyses were 
completed: one for LfB Phe3 and one for LfB Phe5.  The data for LfB Phe3 identified the 
expected sequence, Arg-Arg-Phe-Gln-Trp-Arg; however, residue 5 (Trp) showed at least three 
unidentifiable peaks.  These peaks may be the result of the Pmc protecting groups still attached 
to Arg, but because the same result occurred for peptide LfB Phe5, we propose a different 
hypothesis.  The sequence for LfB Phe5 was identified as Arg-Arg-Trp-Gln-Phe-Arg, but the 
same three unidentifiable peaks eluted with the Trp residue, only the relative intensities of the 
peaks were higher compared to the first peptide.  Because the peaks eluted with the Trp residues 
of both peptides, we propose that Trp was modified during the TFA cleavage. 
 
RP-HPLC of Test Cleavages 
 
Seeing as that there were significant troubles with the TFA cleavages, smaller test 
cleavages were performed to disclose whether changing the amount of time the reaction mixture 
is shaken yields better results or if reacting the peptide/resin with thiol scavengers would 
improve yields.  TFA test cleavages at 2 hour, 3 hour, and 4 hour reaction times were performed 
with the peptide LfB Lys2 1MeW3.  Also, 2 hour, 3 hour, and 4 hour thiol cleavages were 
performed with the same peptide.  The chromatograms in Figure 22 show that a TFA cleavage 
using thiol scavengers at 2 hours yields better results than using TIPS and 4 hours.  A large-scale 
cleavage with thiol scavengers was going to be carried out using LfB Lys2 1MeW3, but the 
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amount of peptide/resin was limited, so the cleavage was not possible with that peptide.  







































































































Figure 22.  TFA and Thiol Test Cleavages with LfB Lys2 1MeTrp3 
121 
 The large-scale thiol cleavages seen below in Figure 23 show multiple peaks, but the 
peak at a 13.5 min elution time was significantly reduced compared to the TFA cleavage using 
TIPS scavengers.  The cause of the second peak at approximately 10 min in both chromatograms 






































Figure 23.   Large-scale Thiol Cleavages with LfB Phe3 and LfB Phe5   
 
Circular Dichroism (CD) Spectroscopy 
 
 The peptide LfB Phe5 was dissolved in an aqueous solution and in SDS-d25.  CD spectra 
seen in Figure 24 show a shift in peak absorbance of the SDS-d25 sample.  When compared to 

























Figure 24.  CD Spectra of Aqueous and       Figure 25.  CD Reference 
  SDS-d25 sample 
 
 All peptides were dissolved in DOPC and DOPC:DOPG (3:1).  The CD spectra seen in 
Figure 26 show that all peptides displayed the same configuration whether in DOPC or 
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DOPC:DOPG.  Also, LfB Lys2 1MeTrp3 show a shift in peak absorbance.  All peptides are 
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The LfB hexapeptides, LfB Phe3, LfB Phe5, and LfB Lys2 1MeTrp3, were synthesized 
and cleaved from the resin successfully.  All peptides were cleaved with TFA-D in attempts to 
selectively deuterate the indole rings of Trp and 1MeTrp.  Deuteration of 1MeTrp was more 
successful than with Trp.  Mass spectral analyses revealed that such deuteration was successful 
and allowed quantitation of the amounts of deuterium incorporation in different samples. Test 
cleavages revealed that TFA cleavages using thiol scavengers for 2 hours yield better results than 
using TIPS and 4 hours.  Multiple peaks in HPLC chromatograms are probably due to the 
incomplete removal of protecting groups from amino acid side chains.  CD spectra of all 
peptides were similar in DOPC or DOPC:DOPG (3:1).  CD spectra of LfB Phe5 in water and in 
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Synthesis and Characterization of Peptides Anchored by 
Tryptophan and Arginine 
Eugenia Tsamis, University of Northern Iowa 




 RWALP23 peptides containing Tryptophan and Arginine with an alternating Leucine-
Alanine backbone were studied by HPLC, CD, and MALDI-TOF Mass Spectrometry to 
investigate the anchoring roles of Arg and Trp.  In KWALP23 peptides containing Lysine and 
Trp, as the Trps are moved further in towards the center of the bilayer, Lys becomes the 
dominant anchoring residue (1).  The goal of this project is to determine whether Arg exhibits 
snorkeling behavior similar to Lys, and is able to anchor the peptide in the membrane despite  the 
repositioning of Trp in the RWALP peptides.  Several of the candidate peptides were synthesized 
successfully.  The CD spectra show a decreasing trend in alpha-helical conformation as the Trps 
are moved closer to the bilayer center, suggesting that Arg anchors the peptide to the membrane 




 Membrane proteins control numerous functions within cells, and by understanding the 
structure and function of these proteins, much can be learned about the cell as a whole.  However, 
studying membrane proteins is challenging due to their large protein size and complexity.  In 
order to effectively study these proteins, and be able to correlate the observed function with the 
proper portion of the protein, model membrane peptides are created.  These model peptides are 
portions of a larger membrane protein, and are not only easier to study, but also easier to 
synthesize and modify.  Alterations to the smaller model membrane peptides can be made that 
enable certain characteristics of the peptide to be studied, including shape and function.   
Using model peptides in model membrane systems, the peptide structure and function can 
be studied under more controlled conditions.  Model membranes consist of one or two lipids with 
a small amount of membrane spanning protein, to simplify the membrane system and allow for 
strategic changes to be made to the system (2).  These changes that are made to the system can 
be more closely correlated with the portion of peptide they are associated with.  Model peptides 
allow for variations in the hydrophobic length and composition of residues used in the membrane 
spanning region (3), which enable specific conditions to be studied.    
The interaction of the peptide within the membrane is an important area of study.  There 
are a variety of interactions between the lipid membrane and the peptide that can affect their 
properties (4).  Hydrophobic mismatch between the membrane and the protein occurs when the 
peptide is too long (positive mismatch) or too short (negative mismatch) to span the membrane 
correctly.  This can cause many changes in the peptide, which include the formation of oligomers 
to shield groups from the polar environment, a change in the backbone structure, tilting to reduce 
length, and changing the orientation of side chains near the interface of the membrane (3).  
Lipids can also change under these conditions by stretching their acyl chains and reorganizing 
(3).   
There are several kinds of model peptides that are created and used for study, including 
the WALP peptide family, which is named from the amino acids it contains in its sequence; 
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Tryptophan (W), Alanine (A), and Leucine (L), with P standing for peptide.  These peptides are 
similar to the transmembrane portions of the larger membrane proteins, but only contain one 
membrane spanning sequence, to allow for a simpler system to investigate.  Variable lengths of  
Alanine and Leucine residues are located in the central region of the amino acid sequence, and 
remain in the membrane due to their hydrophobic properties.  Alanines are highly likely to form 
an α-helical structure, and by using an alternating Leucine/Alanine sequence, the average 
hydrophobic length of a real membrane protein can be created (2).  This creates an α-helix 
backbone for the model peptide.  Tryptophan has been found to be an important amino acid in 
the peptide, because it serves to anchor the peptide into the membrane-water interface, and 
prefers this area because of its amphipathic nature (1-5).   
Gramicidin, a bacterial membrane protein, was used to model the WALP peptides.  In 
Gramicidin, several Tryptophans serve to stabilize and anchor the channel (2).  Studies with 
Gramicidin and other model membrane peptides have helped to reveal the importance of 
aromatic residues, such as Tryptophan, or charged residues, such as Lysine and Arginine, for 
stabilizing or “anchoring” the transmembrane helices in membrane proteins.  The transmembrane 
domains of many naturally occurring membrane proteins are flanked with a ring of aromatic 
residues (4).  The aromatic residues prefer the membrane-water interface, whereas the charged 
residues prefer a position outside the membrane in the aqueous phase (5).  Based on this idea, 
studies have been done using WALP peptides that also contain Lysine, a positively charged 
amino acid.  Structural analysis of these model peptides in the membrane confirms that 
Tryptophan prefers a specific location in the polar/apolar membrane interface, while Lysine 
prefers to be located near the lipid phosphate group, which is a more polar area (4).   
Studying the effects of the movement of these strategic amino acids in the peptides has 
been integral in understanding their role as anchoring residues in the peptides, and also their 
effect on protein structure.  The Tryptophan and Lysine residues are usually found flanking the 
peptide sequence, which helps to orient the peptide in the membrane by anchoring to either end 
as the peptide spans the membrane. By progressively moving either of these residues toward the 
center of the sequence, the effect of Tryptophan or Lysine as anchors in the peptide can be 
studied.  
Mismatching effects in the bilayer were studied using Lysine (K) flanked KALP peptides 
and Tryptophan flanked WALP peptides.  It was found that as the Tryptophans were moved 
progressively closer to the center of the peptide, the structure of the peptide in the membrane was 
affected, and the peptides were no longer able to orient properly in the membrane systems, 
creating a mismatch between the membrane and the peptide (5).  This finding suggested that the 
arrangement of the peptide in the membrane was controlled primarily by the Tryptophan residues 
and their preferred location at the membrane-water interface.  The Lysine flanked peptides did 
not behave similarly, which suggested that Tryptophan served as a better anchor in the 
membrane (5).   
The flanking residues on the peptide serve to determine the mismatch conditions the 
peptide and membrane will face in several ways.  The hydrophobic length of the peptides can be 
affected by the orientation of the side chain on the flanking residue and its preferred site of 
interaction with the membrane.  The strength of the interaction between the residue and the 
membrane will also affect whether the peptide remains anchored in that position, or moves under 
mismatch conditions (3). Lipid modifications in WALP peptides are made to accommodate the 
Tryptophan in the preferred polar-apolar membrane interface, and not primarily to avoid a 
mismatch between the peptide and lipid (5).  Lysine KALP peptides do not undergo drastic lipid 
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modifications and associate with the membrane by exposing the lipid head region to hydrophobic 
residues (5).  
Studies have also been done on KWALP peptides that incorporate both Lysine and 
Tryptophan to study the effects of the movement of the Tryptophans towards the bilayer center.  
The findings suggest that KWALP peptides are able to adjust to hydrophobic mismatch 
conditions better than WALP peptides with Tryptophan alone.  Tryptophan and Lysine both play 
a role in interfacial anchoring, and Lysine appears to have a stronger role (1).  
With the addition of Lysine to the WALP peptide, the Tryptophans, which have a 
preferential binding site at the membrane interface, can be moved progressively inward in the 
peptide sequence, while the peptide remains in the proper orientation in the membrane, not 
deviating much from its position.  This finding indicates that the Lysines anchor the peptide 
more strongly than the Tryptophans, which can be adjusted slightly in their positioning in the 
membrane.  
This may be due to the “snorkeling” behavior that Lysine exhibits.  Snorkeling is the 
ability of a flexible charged residue, like Lysine, to bury the aliphatic hydrocarbon portion in the 
membrane’s hydrophobic region, with the charged amino group in the polar interface of the 
membrane (6).  This behavior decreases the entropy and increases the hydrophobic length of the 
peptides.  The snorkeling effect is a proposed way for the peptides to place charged residues such 
as Lysine and Arginine in the polar environment that they prefer (6).  
Following up on the research with KWALP peptides, my first goal was to synthesize 
RWALP peptides, which contain Arginine (R) as the charged residue rather than Lysine.  The 
role of the amino acids Tryptophan and Arginine in the model peptide in a membrane system is 
the primary focus of this research.  Here we report on the effects of Arginine versus Lysine as an 
anchoring residue in the peptide, as the Tryptophans are progressively moved in towards the 
center of the peptide.  RWALP 23 peptides are used because it has been shown that this length 
(23 amino acids) is more stable in the model membrane systems than longer or shorter peptides 
of similar composition (2, 4).   
 In order to make these model peptides, Solid State Peptide Synthesis (SPPS) was used.  
This involves a peptide chain to be assembled upon a covalently bound solid resin support, and 
allows for remaining unreacted reagents to be washed away without losing peptide in the process 
(7). Initially, the peptide sequence is constructed on the polystyrene resin beads one amino acid 
at a time from the C-terminal to the N-terminal.  Next, the peptide is cleaved from the resin solid 
support, and any protecting side groups on the amino acids are removed.  A Fmoc protecting 
group (9-Fluorenylmethoxycarbonyl) is used on the α-amino group of each amino acid, and 
prevents the amino end from reaction.  Protecting side groups are also used on Tryptophan and 
Arginine, which both have extra sites of reactivity.  A protecting PMC group (2,2,5,7,8-
pentamethylchroman-6-sulfonyl) is used on the side chain of Arginine, and a BOC group 
(butyloxycarbonyl) protects the indole nitrogen of Tryptophan.  This ensures that the addition of 
sequential amino acids occurs on the correct site.  Acid-liable protecting groups are chosen based 
on their stability under basic conditions, which allows the protecting group to remain on its site 
when the Fmoc group, which is base-liable, is removed after each successive addition to the 
peptide chain.  The remaining protecting groups are removed at the end of the synthesis using a 
trifluoroacetic acid (TFA) cleavage (7).  Structures of the protecting groups are shown in Figure 


























Figure 1: Structural diagrams of Fmoc, PMC, and Boc protecting groups.  
 
 Following the removal of the protecting groups, characterization of the peptide was 
performed by Reversed Phase High Performance Liquid Chromatography (RP-HPLC) and 
Matrix Adsorbed Laser Desorption Ionization Time of Flight (MALDI-TOF) Mass Spectrometry 
(MS) to determine the quantity and quality of the synthesized peptide.  Circular Dichroism (CD) 





Chemicals and Abbreviations: 
 
PIP: Piperidine, 99% from Aldrich 
DMF: Dimethylformamide, from Aldrich 
TFA: trifluoroacetic acid, from Pierce 
TIPS: triisoproplysilane, from Aldrich 
MtBE: Methyl t-Butyl Ether, from Burdick and Jackson 
TFE: 2,2,2-Trifluoroethanol, from J.T.Baker 
DMPC: PC(cis):1,2-Dimyristoyl-sn-Glycero-3-Phosphocholine, from Avanti Polar Lipids 
DOPC: PC(cis):1,2-Dioleoyl-sn-Glycero-3-Phosphocholine, from Avanti Polar Lipids 
1:20PC: PC(cis)1,2-Dieicosenoyl-sn-Glycero-3-Phosphocholine, from Avanti Polar Lipids 
Tris buffer: Tris(Hydroxymethyl)-Aminomethane, from OmniPur 
Fmoc-ONSu: N-(9-Fluorenylmethoxycarbonyloxy)-succinimide, 96%, from Aldrich 
TEA: Triethylamine, from Mallinckrodt 
NMP: N-Methylpyrrolidone, from Burdick and Jackson 
 
All chemicals used on the Peptide Synthesizer are purchased from Applied Biosystems.  
All amino acids and resin beads are purchased from NovaBiochem.  
 
Loading alanine on rink amide resin 
 
The synthesis was initiated by loading the first amino acid onto resin beads.  For the 
synthesis of RWALP23 peptides, the first amino acid alanine, was added to rink amide resin 
using standard Fmoc chemistry and an Applied Biosystems 433A Peptide Synthesizer, equipped 
with a UV monitoring system.  0.1 mmoles of rink amine resin beads were added to a reaction 
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vessel, and 1.0 molar equivalent (10 fold excess) of Fmoc alanine was weighed into two 
cartridges, and the Fmoc alanine was joined to the rink amide resin by double coupling with six 
hour coupling times each.  The standard Fmoc chemistry commands are given in the Appendix, 
along with a loading sheet for each Fmoc alanine loading that was performed.   
 
Loading test  
 
To verify that the addition of Fmoc alanine to the resin beads was successful, loading 
tests were performed to determine how many available sites on the resin remained, where the 
alanines have not attached. When the loading of the first amino acid to the resin was complete, 
the resin was dried under high vacuum for 30 minutes to remove excess moisture and solvents.  
Between 4 and 8 mg of the dried resin was weighed into a test tube, with a second test tube used 
for the standard.  To each test tube, 200 μL of PIP and 800μL of DMF were added to create a 
20% PIP in DMF solution.  The resin sample tube was allowed to sit for 15 minutes, with mixing 
every 5 minutes to ensure a consistent solution.  A 1:50 dilution was made using the 1 mL 
solution from each test tube and 49 mL of DMF.  These solutions were measured on a Hewlett 
Packard 8452A Diode Array Spectrophotometer to determine the absorbance of the resin at 300 
nm, using the standard solution used as a blank to calibrate the machine.  When the absorbance 
was obtained, the percent loading was calculated using Equation 1 below.   
 






= substitution of alanine on resin  
 
The values used in the calculation include the absorbance for the sample, the dilution 
factor for the solution (50 mL), the molar extinction coefficient for the Fmoc group (7800 M-
1cm-1), and the grams of sample added to the test tube.  For the rink amide resin used, the 
expected loading was 0.63 mmol/g of sample.  The actual substitution of alanine on the resin was 
divided by the expected loading to determine the percent loading, indicating how many of the 




After completion of the loading test, a capping step was performed to block the 
remaining sites on the resin beads that had not attached to an alanine.  0.57 moles of each amino 
acid were pre-weighed into cartridges and added to the peptide using standard Fmoc chemistry, 
with approximately 5 fold excess amino acid and 90 minute coupling times.  A loading sheet for 
each RWALP23 peptide that was synthesized is given in the Appendix.  
 
TFA high acid cleavage 
 
The peptide was removed from the resin beads by cleavage with TFA plus scavengers.  
After the synthesis, 60 mg of the resin-bound peptide was weighed into a round bottom flask.  A 
cleavage cocktail consisting of 2ml’s TFA, 125 μL TIPS, 125 μL deionized water, and 125 mg 
phenol was prepared in an Eppendorf centrifuge tube, and added to the round bottom flask with 
the resin-bound peptide.  This mixture was shaken for four hours at room temperature (25oC) in 
the dark, which was created by using aluminum foil to cover the round bottom flask.  Four hours 
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of shaking is required to remove the PMC groups on the Arginine in the peptide, which are hard 
to remove and require more time than usual.  After four hours, the resin slurry was transferred to 
a small side-arm flask, filtered using a glass filter, and rinsed with 2.5 mL’s TFA.  The liquid 
was transferred to a 10 mL test tube and placed under nitrogen flow to remove solvent until ¼ 
the original volume remained.  The filtrate was added drop wise into 25 mL ice cold 50/50 
MtBE/Hexane in a 50 mL centrifuge tube.  After chilling in an ice bath for 30 minutes, the 
sample was centrifuged for 10 minutes at 14,000 revolutions per minute (RPM) and 4oC using a 
Heraeus Labofuge 400 R centrifuge. After centrifugation, the supernatant liquid was poured off, 
an additional 25 mL of cold 50/50 MtBE/Hexane was added to the remaining pellet, and the 
process of chilling and centrifugation was repeated for a total of three times.  The remaining 
pellet was lyophilized by the addition of 500 μL acetonitrile and 500 μL deionized water, 
freezing with liquid nitrogen, and drying overnight under high vacuum.  
 
Quantitate peptides after synthesis 
 
To determine the amount of peptide present, after the lyophilization, 2 mL of TFE was 
added to the centrifuge tube, and 10 μL of the solution was added to two test tubes.  A 1:200 
dilution was made by adding 1990 μL of methanol to each test tube.  The absorbance of each 
sample tube was determined at 280 nm, the wavelength at which tryptophan absorbs. This 
absorbance value was used in Equation 2 below to determine the molar concentration of peptide 
in the solution.  
 







..  Molar concentration of peptide 
 
The absorbance and dilution factor (200) were used in the numerator, and the molar 
extinction coefficient for tryptophan (5600 M-1cm-1) and the number of Trp present in the peptide 
(2) are in the denominator.  The average absorbance value from the two trials was used to 
determine the average molar concentration.  Using the molecular weight, the concentration in 
mg/mL was found for the peptide.   
 
High Performance Liquid Chromatography (HPLC) samples 
 
The concentration used for the HPLC samples was 1 mg/mL.  A dilution was made based 
on  the concentration of the quantized peptide and added to an Eppendorf centrifuge tube, using 
the peptide solution and TFE.  For analysis, 10 μL of the sample was injected on the HPLC, 
which used a Hitachi L-7100 Pump and Spectroflow 757 Absorbance Detector.   The gradient 
used is given below in Table 1.  
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Table 1: Gradient used for analysis of RWALP23 peptides on the HPLC. 
 
Minute 100% methanol + 0.1% TFA (%) 100% water with 0.1% TFA  (%) 
0.0 85 15 
5.0 99 1 
8.0 99 1 
8.1 85 15 
12.0 85 15 
 
Mass spectrometry samples 
 
The mass spectrometry samples were made from a 1:10 dilution of the HPLC samples, 
using 100 μL of HPLC sample and 900 μL of methanol.   This was added to a glass vial and sent 
to the Statewide Mass Spectrometry Facility at the University of Arkansas for analysis by 
Electrospray Ionization (ESI) or Matrix Adsorbed Laser Desorption Ionization Time of Flight 
(MALDI-TOF) Mass Spectrometry.  
 
Circular Dichroism samples 
 
 For the circular dichroism samples, the desired ratio of peptide to lipid was 1:30.  Each 
CD sample contained 250 μg of peptide, which was equivalent to 0.102 μM of peptide.  Two 
samples for each lipid were prepared, using 3 different lipids: DMPC, DOPC, and 1:20PC.  The 
chemical structures of the lipids used are given in Figure 2 below.   
 
 






















For a 1:30 peptide:lipid ratio, 3.05 μmoles of each lipid was needed, which was 
equivalent to 207 μL of DMPC, 96 μL of DOPC, and 257 μL of 1:20PC.  The appropriate 
amount of peptide solution was added to six 1.5 mL screw cap vials and dried on the Savant 
SC110 Speed Vac for an hour to remove any solvent.  The lipids and their equivalent amount of 
methanol were added to the screw cap vials after the solvent had been removed.  The samples 
were stored in the dark for 30 minutes, dried on the Speed Vac for an hour and a half, and dried 
on the vacuum line for 48 hours.  After two days of drying, 500 μL of buffer was added to each 
sample.  The buffer was made using 50 mg NaCl, 30 mg of Tris buffer, and 10 mL of water, and 
adjusted to a pH of 7.4 by drop wise addition of 0.1 M HCl.  To slowly hydrate the samples, a 
small amount of water was added to a cotton swab, and placed in the top of each sample vial.  
The samples were placed in a 40oC water bath for an hour, and sonicated on a Heat Systems-
Ultrasonics W185 Sonifier Cell Disruptor for two hours to remove some of the cloudiness in the 
solution.  During sonciation, the samples were removed and shaken every 10-15 minutes to 
ensure good mixing.  After sonication, the samples were placed on a heat block at 40oC for one 
hour, then centrifuged in an Eppendorf centrifuge for 5 minutes at 12,000 RPM to pellet any 
undissolved material.  The supernatant liquid was transferred to new Eppendorf centrifuge tubes, 
and the sample tubes with the remaining pellets were saved for analysis.  The supernatant liquid 
was diluted with buffer between 1:4 and 1:64 supernatant: buffer, creating a solution with an 
absorbance lower than 1.5 at wavelengths of 280 nm and 220 nm, corresponding to the 
absorbance of the tryptophan and the backbone of the peptide, respectively. The absorbances 
were determined for each sample on the spectrophotometer.  These dilutions were used for 
Circular Dichroism analysis on the Jasco 710 Spectropolarimeter. 
Analysis of the CD sample pellets was performed to determine how much remaining 
peptide was not incorporated into the samples analyzed using CD. 0.5 mL to 1 mL of methanol 
was added to each sample vial to dilute the pellets, and the absorbance at 280 nm was recorded.   
 
Preparation of deuterated Fmoc-alanine crystals 
 
One of the synthesized peptides includes two deuterated alanines, in 50% and 100% 
amounts.  The incorporation of deuterated alanines allows for further analysis of the peptide, and 
can help in assigning peaks using 2H NMR analysis later on in the research.  In order to 
incorporate the deuterated alanine into the peptide, deuterated Fmoc alanine was synthesized, 
since it cannot be purchased.  Using a 50 mL round bottom flask, 445 mg (5 mmol) alanine was 
dissolved in 5 ml water and 700 μL (5 mmol) TEA with constant stirring.  To a test tube, 1.62 g 
(4.8 mmol) Fmoc-ONSu was dissolved in 5 mL acetonitrile with gentle heating.  The Fmoc-
ONSu solution was added to the round bottom flask when dissolved, and the mixture was stirred 
for four hours.  The pH of the solution was monitored throughout the four hours using pH strips, 
and maintained between 8.5-9.0 pH units by the addition of TEA drop wise.  After four hours, 
the mixture was filtered using a Buchner funnel, the precipitate was discarded, and the filtrate 
was concentrated on the Buchi 411 Rotary Evaporator.  When dry, the Fmoc alanine appeared as 
an orange-yellow sticky substance, and 30 mL of 1.5 N HCl was added.  The solution was 
sonicated to loosen the particles from the sides of the round bottom flask, and the milky white 
solution was refiltered and washed with methanol several times.  The filtered solid was dried on 
the vacuum line overnight, and the filtrate was discarded.   
To prepare crystals of deuterated Fmoc-Ala, 10 mL of ethyl acetate was added to a round 
bottom flask with the dried solid and heated to 60oC.  Ethyl acetate was added in 5 mL amounts 
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to continue to dissolve the material.  Any remaining insoluble material was removed by filtration.  
The filtrate was transferred to a crystallization vial, and 5 mL of hexane was added in 1 mL 
amounts.  To remove excess solvent and to encourage the formation of crystals, the solution was 
dried under nitrogen until the formation of crystals was apparent, and the vial was placed in the 
freezer overnight.   
The cold crystals were filtered with a medium glass filter, washed with cold MtBE, and 
transferred to a glass scintillation vial.  The vial was dried on the vacuum line overnight, and the 
filtrate was added to a new crystallizing vial to retrieve a second crop of crystals.  The second 
crop of crystals was treated in the same manner.  The proposed mechanism for the formation of 












Figure 3: Proposed mechanism for the formation of deuterated Fmoc-alanine.  
 
Results and Discussion 
 
 After synthesis of each peptide, analysis by HPLC was performed to determine the purity 
of the peptides.  Impurities were observed in three of the four peptides synthesized.  The first 
peptide synthesized, W3,21R2,22ALP23 shows a narrow, distinct peak shortly after 5 minutes, 
characteristic of a pure peptide (Figure 4).  In an attempt to explain the  extra peaks that occurred 
in the chromatograms representing the remaining peptides, multiple sample preparations were 
done, and the results indicate that the analysis is correct, and the problem lies with the method of 
synthesis or deprotection for these peptides.  Possible impurities could include shorter peptides 
that lack one or more amino acids due to incomplete coupling during the synthesis, or full-length 
peptides that retain one or more side-chain protecting groups due to incomplete deprotection 
during the resin-cleavage reactions.   
 In all cases, the major peak in the mass spectrum represented the molecular ion of the 
bona fide full-length desired peptide.  In some cases, a sample yielding a complex pattern of 
several HPLC peaks gives nevertheless only a single major peak, of correct mass, in its mass 
spectrum; this finding suggests that final deprotection of selected side chains may occur during 






















































































































Figure 4: HPLC spectra for RWALP synthesized peptides.   
 
 
In reviewing the UV monitoring system on the peptide synthesizer, which monitors the 
removal of the Fmoc group used during the synthesis of the peptides, it was realized that slight 
decreases in the absorbance had been occurring during some of these syntheses, which are 
uncharacteristic of normal synthesizer behavior.  This could indicate minor coupling problems 
on the synthesizer, which would explain why shorter fragments of the peptides are present in 
varying amounts, if the coupling did not correctly occur in several steps of the synthesis. Another 
possibility is the exchange of protecting groups on Tryptophan and Arginine during the removal 
of the groups, or modifications (side reactions) to the Tryptophan rings during the cleavage from 
the resin and removal of the protecting groups.   
WALP peptides are generally difficult when it comes to their synthesis, and the problem 
with the purity can also be a characteristic of particular peptides.  RWALP peptides have not 
been synthesized previously, so small changes in the chemistry of the synthesis may be needed 
beyond the scope of this project.  There may also be a problem when the Trp and Arg groups are 




closest to one another in the sequence was obtained in highly pure form (Figure 4), while the 
problems with fragmentation began to occur as the Trps were moved closer into the sequence.   
There are several possible avenues that can be explored to explain the behavior of the 
synthesized peptides.  To further understand the observed results, mass spectrometry data were 
studied to rule out possible options.   
 To confirm the mass obtained for the peptide is the expected mass, MALDI-TOF Mass 
Spectrometry was performed.  As expected, W3,21R2,22ALP23 contained a pure peak at the 
expected mass of 2459.  Fragmentation or incomplete synthesis was noticed for the remaining 
samples.  The spectra indicate that the complete peptide fragment is present in the greatest 
concentration in each sample, since the expected mass is present, but the samples are not pure as 
desired.   
   As noted above, the mass spectral data are generally more promising than the HPLC 
chromatograms for three of the peptides, suggesting that primarily full-length peptides were 
synthesized and that improvements in the deprotection protocols may yield acceptable pure 
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Figure 5: MALDI-TOF MS spectra for synthesized peptides.  
 
 
 Further analysis of the Mass Spectrometry data reveals peptide fragments with masses of 
839, 910, and 1023 for W11,13R2,22ALP.  These masses correspond to peptide fragments resulting 
from incomplete couplings during peptide synthesis.  The UV monitoring system confirmed 
problems at these same sites. The masses for these fragments correspond to specific amino acid 
sequences, which are given in Table 2.  This problem will be studied further to determine why 
these fragments are formed during synthesis, but are not included in the scope of this research.  
 
Table 2: Peptide fragment sequences for ESI MS of  W11,13R2,22ALP.  
 









Figure 6: ESI MS analysis of W11,13R2,22ALP.  
  
 
 CD analysis for each peptide was performed to estimate the peptide’s secondary structure.  
An α-helical conformation was expected for the alternating Leu-Ala backbone of the peptide.  
The spectrum for an α-helix is characterized by minima present near 222nm and 208 nm, a 
crossover at 202 nm, and a maximum at 192 nm (4).  The CD spectra obtained model the general 
α-helical conformation, when analyzed at these wavelengths.   
As found in previous studies conducted on Lys flanked peptides, the Lys peptides of a 
certain length behave shorter than expected based on their preferential site of binding in the 
membrane (1, 8). Because Lys prefers the interfacial region of the membrane, and can snorkel 
the side chain further into the membrane, Lys flanked peptides incorporate better into lipids that 
are shorter than their length (8).  Based on the length of the KALP peptides studied (1), these 
peptides should incorporate best into DOPC membranes, which contain 18 carbons in the chain 
and best match the peptide length.  However, the data show that KALP peptides incorporate best 
into DMPC membranes, which are 14 carbons in length. These shorter lipids are better suited for 
peptide incorporation because the charged residues can be placed in the interfacial area that they 
prefer, making the effective hydrophobic peptide length shorter.  This area is further outside the 
membrane than the preferred placement for Trp at the membrane interface, which explains why 
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The effective hydrophobic length for peptides containing anchoring residues was shown 
to be independent of the chemistry in the side chain (8).  Given these data, Arg, another charged 
residue, also prefers this interfacial area and should exhibit the same behavior noticed for Lys 
flanked KALP peptides.  The trend in the CD spectra obtained for the peptides indicates that Arg 
flanked RWALP peptides do behave similarly to the Lys flanked KALP peptides, and 
incorporate best in DMPC, progressively incorporating less in DOPC and lipid 1:20 as the lipids 
used become longer.  The data also indicate that as the Trp are moved closer to the center of the 
sequence, the incorporation of the peptide in the membrane decreases.   
Among the peptides, W3,21R2,22ALP demonstrated the best incorporation in the bilayer, 
with the worst incorporation noticed for W11,13R2,22ALP, with Trps near the center.  This 
decrease in incorporation based on the movement of Trp could be due to the decrease in the 
anchoring ability of the peptide.  Both Arg and Trp serve to anchor the peptide, and the peptide 
remains anchored into the membrane despite the movement of Trp, which indicates that Arg 
dominates the anchoring responsibility of the peptide in the membrane, as Trp is able to be 
moved successively closer to the center of the membrane.  However, because Trp also anchors 
the peptide, the incorporation is best when Trp is able to contribute to the anchoring along with 
Arg, which occurs best when it is placed at sites 3 and 21, closest to the Arg residues on the ends 
of the peptide.  When the Trps are moved further away from the ends of the peptide, they are no 
longer able to anchor the peptide, and the incorporation decreases, while the peptide, due to Arg, 













































































































































































































































Characterization of the deuterated Fmoc alanine crystals synthesized was performed 
using Nuclear Magnetic Resonance (NMR) Spectroscopy.   
 












































Four RWALP23 peptides have been synthesized and studied using HPLC, MALDI-TOF 
MS, and CD analysis.  The tryptophans occupy different positions in these 23-amino-acid 
peptides.  Before further analysis into the specific behavior of the peptides in oriented membrane 
samples takes place, the specific problems associated with the impurities in the peptides needs to 
be determined.  Using the results obtained thus far, it was determined that Arg does behave 
similarly to Lys as an anchoring residue in WALP peptides.  With the successive movement of 
Trp further into the membrane, the peptide remains anchored in the membrane due to Arg, which 
indicates that Arg plays a dominant role in anchoring the peptide.  This movement causes the 
incorporation of the peptide in the membrane bilayer to decrease for each successive move of the 
Trp further into the membrane, suggesting that when Trp is present close to its preferred location 
at the membrane interface, it assists Arg in anchoring the peptide, and does not play a prominent, 
necessary anchoring role in the peptide, since it is able to move into the membrane.  The 
formation of deuterated Fmoc alanine crystals was successful, and deuterated alanines were 
incorporated at 50% occupancy and 100% occupancy at two different specific sites in one of the 
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Standard Fmoc Chemistry 
 
Cycle  Chemistry 
Forced 30’ deprotection/90’ couple/ No capping a Fixed 3 hour couple 
Forced 30’ deprotection/90’ couple/Capping b Conditional Deprotection 180 
Final Deprotection c DCM Washes 
Final Deprotection and Acetylation d NMP Wash from Activator 
NMP Wash e MeOH, NMP to Aux. 
DCM Wash f Conditional Extended Coupling 
Complete Wash (NMP and DCM) g Reset to Channel 2 (PC to Detector) 
Final No Deprotection h 0.22 mm Act 2 sec. HBTU 
Fmoc-Gly Resin Test i Eject/Advance Cartridge 
Extra NMP Washes (3) A 0.55 mmol Activation: 5 sec. HBTU 
Extra DCM Washes (3) B Deprotection UV 3.5% 
2nd AA/ no deprotection/ 5 sec. HBTU/ 90/ capping  C Capping Solution @4 
1st Deuterated AA/ 2 sec. HBTU/ 3 hr D NMP Washes 
2nd AA/ no deprotection/ 2 sec. HBTU/ 90/capping E Transfer 1 loop DIEA 
Capping Only F Transfer 2 loops DIEA 
1 mm AA/ Forced deprotection/ 2 L DIEA/ 3hr/ 
Forced Capping 
G Fixed 30’ deprotection 
 H Fixed 90’ coupling 
 I 1.0 mmol Act; 9 sec HBTU 
 
Solid Phase Peptide Synthesis 
 
Amide Resin Fastmoc 0.1 mm Chemistry 
Used for Loading Alanine to Rink Resin 
 
RESIDUE  # 
 
AMINO ACID MW #mM WGT. (mg) CYCLES 
 
Rink Amide Resin   0.1 158 ccccccccc 
DDDDDDDDD 
1a Fmoc Ala 329 1.0 329 eDDBGADEHd 
b Fmoc Ala 329 1.0 329 DDADEHd 
     cc ccc 
 
Modifications to Standard Fmoc Chemistry for Loading: 
G = Forced extended deprotection 
H = 6 hr coupling (360 min; 720 cycles) 
A = 1.0 activation; 8 sec HBTU  
E= transfer 2 loops DIEA 
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Solid Phase Peptide Synthesis 
(after loading Ala to Rink resin) 
Synthesis # 596B W3,21R2,22ALP 23 
 
RESIDUE  # AMINO ACID MW #mM WGT. (mg) CYCLES 
     c, c, ccCcc, c, ecD 
23 Ala    Preloaded 
22 Arg(Pmc) 663 0.57 378 BGADEHCd 
21 Trp-Boc 527 0.57 300 BGADEHCd 
20 Leu 353 0.57 201 BGADEHCd 
19 Ala 311 0.57 177 BGADEHCd 
18 Leu 353 0.57 201 BGADEHCd 
17 Ala 311 0.57 177 BGADEHCd 
16 Leu 353 0.57 201 BGADEHCd 
15 Ala 311 0.57 177 BGADEHCd 
14 Leu 353 0.57 201 BGADEHCd 
13 Ala 311 0.57 177 BGADEHCd 
12 Leu 353 0.57 201 BGADEHCd 
11 Ala 311 0.57 177 BGADEHCd 
10 Leu 353 0.57 201 BGADEHCd 
9 Ala 311 0.57 177 BGADEHCd 
8 Leu 353 0.57 201 BGADEHCd 
7 Ala 311 0.57 177 BGADEHCd 
6 Leu 353 0.57 201 BGADEHCd 
5 Ala 311 0.57 177 BGADEHCd 
4 Leu 353 0.57 201 BGADEHCd 
3 Trp-Boc 527 0.57 300 BGADEHCd 
2 Arg(Pmc) 663 0.57 378 BGADEHCd 
1 Ac-Gly 117 0.57 67 BGADEHCd 
Final:     DDccc 
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Solid Phase Peptide Synthesis 
(after loading Ala to Rink resin) 
Synthesis # 603 B W5,19R2,22ALP 23 
 
RESIDUE  # AMINO 
ACID 
MW #mM WGT. (mg) CYCLES 
     c, c, ccCcc, c, ecD 
23 Ala    preLoaded 
22 Arg(Pmc) 663 0.57 378 BGADEHCd 
21 Ala 311 0.57 177 BGADEHCd 
20 Leu 353 0.57 201 BGADEHCd 
19 Trp-Boc 527 0.57 300 BGADEHCd 
18 Leu 353 0.57 201 BGADEHCd 
17 Ala 311 0.57 177 BGADEHCd 
16 Leu 353 0.57 201 BGADEHCd 
15 Ala 311 0.57 177 BGADEHCd 
14 Leu 353 0.57 201 BGADEHCd 
13 Ala 311 0.57 177 BGADEHCd 
12 Leu 353 0.57 201 BGADEHCd 
11 Ala 311 0.57 177 BGADEHCd 
10 Leu 353 0.57 201 BGADEHCd 
9 
50% deuterium 
Ala-d4 311 0.285 44 Ala-d4 + 
44 Ala 
BGhDEad 
 Ala 311 0.57 177 ADEHCd 
8 Leu 353 0.57 201 BGADEHCd 
7 
100% deuterium 
Ala-d4 311 0.285 88 mgs Ala-
d4 
BGhDEad 
 Ala 311 0.57 177 ADEHCd 
6 Leu 353 0.57 201 BGADEHCd 
5 Trp-Boc 527 0.57 300 BGADEHCd 
4 Leu 353 0.57 201 BGADEHCd 
3 Ala 311 0.57 177 BGADEHCd 
2 Arg(Pmc) 663 0.57 378 BGADEHCd 
1 Ac-Gly 117 0.57 67 BGADEHCd 
Final:     DDccc 
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Solid Phase Peptide Synthesis 
(after loading Ala to Rink resin) 
Synthesis # 602 B W7,17R2,22ALP 23 
 
RESIDUE  # AMINO ACID MW #mM WGT. (mg) CYCLES 
     c, c, ccCcc, c, ecD 
23 Ala    preLoaded 
22 Arg(Pmc) 663 0.57 378 BGADEHCd 
21 Ala 311 0.57 177 BGADEHCd 
20 Leu 353 0.57 201 BGADEHCd 
19 Ala 311 0.57 177 BGADEHCd 
18 Leu 353 0.57 201 BGADEHCd 
17 Trp-Boc 527 0.57 300 BGADEHCd 
16 Leu 353 0.57 201 BGADEHCd 
15 Ala 311 0.57 177 BGADEHCd 
14 Leu 353 0.57 201 BGADEHCd 
13 Ala 311 0.57 177 BGADEHCd 
12 Leu 353 0.57 201 BGADEHCd 
11 Ala 311 0.57 177 BGADEHCd 
10 Leu 353 0.57 201 BGADEHCd 
9 Ala 311 0.57 177 BGADEHCd 
8 Leu 353 0.57 201 BGADEHCd 
7 Trp-Boc 527 0.57 300 BGADEHCd 
6 Leu 353 0.57 201 BGADEHCd 
5 Ala 311 0.57 177 BGADEHCd 
4 Leu 353 0.57 201 BGADEHCd 
3 Ala 311 0.57 177 BGADEHCd 
2 Arg(Pmc) 663 0.57 378 BGADEHCd 
1 Ac-Gly 117 0.57 67 BGADEHCd 
Final:     DDccc 
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Solid Phase Peptide Synthesis 
(after loading Ala to Rink resin) 
Synthesis # 606 B W11,13R2,22ALP 23 
 
RESIDUE  # AMINO ACID MW #mM WGT. (mg) CYCLES 
     c, c, ccCcc, c, ecD 
23 Ala    preLoaded 
22 Arg(Pmc) 663 0.57 378 BGADEHCd 
21 Ala 311 0.57 177 BGADEHCd 
20 Leu 353 0.57 201 BGADEHCd 
19 Ala 311 0.57 177 BGADEHCd 
18 Leu 353 0.57 201 BGADEHCd 
17 Ala 311 0.57 177 BGADEHCd 
16 Leu 353 0.57 201 BGADEHCd 
15 Ala 311 0.57 177 BGADEHCd 
14 Leu 353 0.57 201 BGADEHCd 
13 Trp-Boc 527 0.57 300 BGADEHCd 
12 Leu 353 0.57 201 BGADEHCd 
11 Trp-Boc 527 0.57 300 BGADEHCd 
10 Leu 353 0.57 201 BGADEHCd 
9 Ala 311 0.57 177 BGADEHCd 
8 Leu 353 0.57 201 BGADEHCd 
7 Ala 311 0.57 177 BGADEHCd 
6 Leu 353 0.57 201 BGADEHCd 
5 Ala 311 0.57 177 BGADEHCd 
4 Leu 353 0.57 201 BGADEHCd 
3 Ala 311 0.57 177 BGADEHCd 
2 Arg(Pmc) 663 0.57 378 BGADEHCd 
1 Ac-Gly 117 0.57 67 BGADEHCd 
Final:     DDccc 
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Use of Microelectrochemical Assays for Detection of Circumsporozoite 
Protein of Plasmodium falciparum 
Lena Yurs, Lakeland College 




 It is the goal of this research to produce a method of detection that will aid in the 
development of a malaria vaccine.   An enzyme-linked immunoassay and an enzyme-linked 
DNA hybridization assay have both been explored for electrochemical detection of the 
circumsporozoite protein (CSP) of Plasmodium falciparum using both immunochemistry 
and DNA-hybridization that are specific to CSP. The assays use a biotin-labeled primary 
antibody or DNA probe for immobilization to a streptavidin surface, which is followed by 
the capture of the antigen or DNA target probe and an alkaline phosphatase-linked to a 
secondary antibody or DNA probe. The assays are then incubated with PAPP, which 
enzymatically generates PAP. It is the presence of PAP that is electrochemically detected 
by cyclic voltammetry (CV) in a microcavity using the recessed gold microdisk (RMD) as 
the working electrode and the top layer as the auxiliary and pseudoreference electrodes. 
These methods for the detection of malaria parasites are a much needed advancement 




 Malaria is a single celled protozoan parasite transmitted by the female Anopheles 
mosquito infecting 300-500 million people each year.1,2 There are about 1.5-2.7 million deaths 
each year from malaria, which is more than those resulting from any other communicable disease 
with the exception of tuberculosis.3 Of the four types of malaria that infect humans, P. 
falciparum causes the worst illness and is the main form of malaria in sub-Saharan Africa.3 The 
global distribution of malaria risk showed that from 1946 to 1994 much of the disease was 
becoming confined to tropical regions,4 but due to parasites becoming resistant to drugs and 
mosquitoes resistant to insecticides,1 malaria is believed to have a high potential to recur in the 
United States and is an increasing threat worldwide.5 At this time, there is no licensed vaccine 
for the disease.6  
 Current antimalarial drugs have adverse side effects and are not as effective, since drug 
resistance is high in the parasites.7 For these reasons, researchers are working on developing a 
vaccine that will interrupt the transmission of malaria with the hope of eventually being able to 
immunize against all stages of the infection with a single vaccination.8 In order to help make 
such a vaccine a reality, better detection methods for malaria parasites are greatly needed. The 
methods of quantification and detection being used involve fluorescence and Giemsa staining, 
which are tedious, time-consuming, and require human expertise to accomplish.9-13 With such 
methods, detection limits are still too high. PCR amplification detects 3-4 parasites per 
microliter.14 To be of interest for vaccine development, the detection limit needs to be closer to 1 
parasite per microliter.13  
 Our research has explored electrochemical methods for use in malaria detection.  They 
have not been used previously for this application.  Electrochemistry has made it possible to 
improve the speed, accuracy, sensitivity, and limits of detection.  
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 The two assays to be reported are an enzyme-linked immunoassay and an enzyme-linked 
DNA hybridization assay (See figures 1 and 2). Both consist of four main steps to the assembly 
of the assays. The first is immobilizing the biotinylated primary antibody or DNA probe to the 
streptavidin surface followed by the capture of the CSP specific antigen or DNA target. The 
assembly is completed with the addition of the secondary antigen and the hybridization of the 
secondary probe, both of which are labeled with alkaline phosphatase for the enzymatic 
generation of PAPR once the assays are exposed to PAPP. It is the enzymatically generated 




 Chemicals and Materials. All chemicals were reagent grade and used as received unless 
otherwise indicated. Tris(hydroxymethyl)aminomethane (Tris), Tris-HCl (1 M Tris, pH 8.0), 
sodium citrate, ethylenediaminetetraacetic acid (EDTA), 2-chloracetamide, bovine serum 
albumin fraction V powder (BSA), alkaline phosphatase, sodium azide, polyoxethylenesorbitan 
monolaurate (Tween 20), goat serum, (GS), and p-aminophenol hydrochloride were attained 
from Sigma-Aldrich (St. Louis, MO). Sodium dodecyl sulfate (SDS) and sodium phosphate were 
ordered from J. T. Baker (Philipsburg, NJ). Potassium chloride was purchased from Aldrich 
(Milwaukee, WI). Potassium phosphate and sodium chloride were obtained from Fisher 
Scientific (Fair Lawns, NJ). Reacti-bind streptavidin coated polystyrene strip plates were 
acquired from Pierce (Rockford, IL) and streptavidin coated PCR tubes were purchased from 
Roche Diagnostics (West Chester, PA). PAPP was synthesized, purified, and characterized as 
previously described.15 Aqueous solutions were prepared using high-purity deionized (DI) water 
from a Millipore Milli-Q filtration system (model RG, Bedford, MA). 
 The biotin-labeled primary antibody 1B2.2 mouse IgG (0.25mg in 0.5mL PBS-Tween 
20), the enzyme-conjugated alkaline phosphatase secondary antibody 1B2.2 mouse IgG (0.25mg 
in 0.5mL PBS-Tween 20), and the antigen CSP recombinant protein, R32.tet32 were provided by 
Dr. Robert A. Wirtz of the Center for Disease Control and Prevention (Atlanta, GA). The 
oligonucleotides used were ordered from Genemed Synthesis, Inc. (San Francisco, CA). The 
target DNA (5’-ATT-GCA-AAC-CCA-ATT-GCA-AAC-CCA-ATT-GCA-AAC-CCA-AAT-
GCA-AAC-CCA-AAT-GCA-AAC-CCA-ATT-GCA-AAC-CCA-ATT-GCA-AAC-CCA-ATT-
GCA-AAC-CCA-3’, 29, 257g/mol) is a 96-base oligomer that is specific for the P. falciparum 
repeat region that codes for CSP. The biotinylated primary probe used to modify the walls of the 
streptavidin coated PCR tubes is a 48-base oligonucleotide (5’-TGG-GTT-TGC-ATT-TGG-
GTT-TGC-ATT-TGG-GTT-TGC-ATT-TGG-GTT-TGC-ATT-TGG-GTT-TGC-ATT-3’, 15,257 
g/mol) that is complementary to the target DNA probe with the biotin attached to the 3’ end. The 
secondary probe (5’-CAT-TTG-GGT-TTG-CAT-TTG-GGT-TTG-3’, 7, 426 g/mol) is a 24-base 
oligonucleotide complementary to the target and labeled with alkaline phosphatase at the 5’ end. 
Also, a 48-base alkaline phosphatase labeled anti-primary probe, complementary to the primary 
probe, (5’-CCA-AAT-GCA-AAC-CCA-ATT-GCA-AAC-CCA-AAT-GCA-AAC-CCA-AAT-
GCA-AAC-3’) was used with the alkaline phosphatase attached to the 3’ end. 
 Argon gas was obtained from PG Walker (Springdale, AR). Glovebags were purchased 
from Instruments for Research and Industry (Cheltenham, PA). 
  
 Buffer Solutions. The buffer solutions that are used in this study follow. (a) 0.1 M Tris: 
0.10 M Tris, 5 mM magnesium chloride, and 0.02% (w/v) sodium azide, pH 9.0. (d) PBS-Tween 
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20: 0.01M sodium phosphate, 0.02 M potassium phosphate, 0.14 M sodium chloride, 0.1 M 
potassium choride, and 0.05% (v/v) Tween 20, pH 7.4. (e) PBS-BSA-GS: 10% (w/v) Bovine 
Serum Albumin, and 10% (w/v) goat serum (unless otherwise indicated), pH 7.4, diluted with 
PBS-Tween 20 buffer. (f) Wash buffer: 50mM Tris, 0.15mM NaCl, and 0.1% (v/v) Tween 20, 
pH 7.4. (g) Hybridization buffer: 1% polyethylene glycol (PEG), 60mM sodium citrate, and 
0.6mM NaCl, pH 7.0. (h) Rinse Solution: 50mM Tris, 0.15mM NaCl, 0.1% (v/v) Tween 20, and 
2mM EDTA, pH 7.4. The pH of each buffer was adjusted with 6 M HCl or 6 M NaOH. 
  
 Microcavity Devices. The design and procedure for the original fabrication of the 
microcavity chips that are used for electrochemical detection following the assembly of the 
assays have been previously reported.16,17 The cavities used in this study consist of 5 layers of 
material (See Figure 3). Layers 1, 3, and 5 are the gold microdisk, microring, and rim electrodes, 
respectively. Layers 2 and 4 are polyimide, which insulates the metal layers from each other. The 
1.25 x 2.50 cm chip has 4, 50 µm-diameter cavities near one edge. The opposite end has contact 
pads to which an edge connector may be attached. 
 
 Enzyme-Linked Immunoassay in Streptavidin Coated Microwells. A working 
solution of the biotinylated primary antibody of 2 µg mL-1 (unless otherwise stated) was 
prepared by diluting the correct volume of 0.5 mg mL-1 stock solution with PBS-Tween 20 
buffer. The microwells were filled with 100 µL of the primary antibody solution, covered, and 
shaken on a vortex genie (VWR International) for 30 min. The immobilization of the primary 
antibody to the streptavidin coated microwells was done on the lab bench at room temperature. 
Following incubation, the wells were emptied using a pipet, rinsed six times with 300µL of PBS-
Tween 20, blocked with 200 µL of PBS-BSA-GS for 30 min while shaking on a vortex genie, 
and then emptied.  
 For the second part of the assay, a working solution of 10 ng mL-1 CSP recombinant 
protein (unless otherwise stated) was prepared by diluting the correct volume of 0.74 mg mL-1 
stock with PBS-BSA-GS. For the capture of the antigen, 100µL of the working CSP recombinant 
protein solution was placed into each primary antibody immobilized microwell and incubated 20 
min at room temperature while shaking on a vortex genie. After the incubation, the wells were 
emptied with a pipet rinsed with 300µL of PBS-Tween 20 six times (emptying with a pipet for 
the first three and inverting the wells to empty for the second set of three), blocked with 200µL 
PBS-BSA-GS for 15 min while shaking on a vortex genie, and emptied.  
 The final step of the assembly is the capture of the alkaline phosphatase labeled 
secondary antibody. A working solution of 2 µg mL-1 (unless other wise indicated) of the 
secondary antibody was made by diluting the correct volume of 0.5 mg mL-1 stock solution with 
PBS-Tween 20. The microwells, which now have the immobilized antibody and antigen, were 
filled with 100 µL of the secondary antibody working solution and incubated for 60 min at room 
temperature while shaking on a vortex genie. The wells were then emptied with a pipet, rinsed 
with 300 µL of PBS-Tween 20 following the same steps as previous rinses, blocked with 200 µL 
of PBS-BSA-GS for 15 min while shaking on a vortex genie, and emptied.  
 The assay assembly complete, the wells were rinsed three times with 0.1 M Tris pH 9.0. 
Inside an Ar purged glovebag, 100 µL of the Ar purged (15-30 min) enzyme substrate, PAPP, 
was placed into the wells and incubated covered in aluminum foil inside the Ar filled glovebag 
for 30 min at room temperature. This incubation allows for the enzymatic generation of PAPR, 
which is the electroactive specie that is electrochemically detected.  Minimizing the number of 
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wells used in any given experiment, as well as immediately performing cyclic voltammetry after 
placement of the drop on the microcavity prevented evaporation during detection.  
 
 DNA Hybridization Assay in Streptavidin Coated PCR Tubes. For the 
immobilization of the primary DNA probe to the streptavidin coated PCR tubes, a working 
solution of 5 µM biotinylated primary antibody was prepared by diluting the correct amount of 
330 µg mL-1stock with PBS-Tween 20. The PCR tubes were filled with 100 µL of the primary 
antibody solution, capped, and incubated for 30 min at room temperature. Following 
immobilization, the tubes were emptied with a pipet and rinsed three times with 300 µL of wash 
buffer, emptying with a pipet.  
 A working solution of 0.5 µM target DNA probe was made by diluting the appropriate 
amount of 330 µg mL-1 stock with hybridization buffer. For the capture of the target probe, 100 
µL of the working target solution was placed into each tube, which now contain immobilized 
primary probe. The target was incubated in the modified PCR tubes for 30 min at 37 C. After 
incubation, the tubes were emptied with a  pipet, rinsed three times with 300 µL of rinse 
solution, and emptied using a pipet.  
 The hybridization of the alkaline phosphatase labeled secondary DNA probe was done 
using a working solution of 0.88 µM of the secondary antibody prepared by diluting the 300 µg 
mL-1 stock solution with hybridization buffer. The PCR tubes containing the immobilized 
primary probe and captured target were filled with 100µL of working solution and incubated for 
30 min at 37 C. Following hybridization, the tubes were emptied with a pipet, rinsed three times 
with 300 µL of rinse solution, and emptied with a  pipet.  
 The assay assembly complete, the wells were rinsed three times with 0.1 M Tris pH 9.0. 
Inside an Ar purged glovebag, 100 µL of the Ar purged (15-30 min) enzyme substrate, PAPP, 
was placed into the wells and incubated covered in aluminum foil inside the Ar filled glovebag 
for 30 min at room temperature. This incubation allows for the enzymatic generation of PAPR, 
illustrated in Figure 4, which is the electroactive specie that is electrochemically detected. 
Minimizing the number of tubes used in any given experiment, as well as immediately 
performing cyclic voltammetry after placement of the drop on the microcavity prevented 
evaporation during detection.  
 
 Electrochemical Detection. A CH Instruments electrochemical workstation potentiostat 
with a picoampere booster and Faraday cage (CH Instruments, Inc., Austin, TX) was used to 
perform cyclic voltammetry (CV). The characterization of the microcavities and detection were 
done using an internal two electrode set up with the RMD as the working electrode and the top 
gold layer as the auxiliary/pseudoreference electrode. Characterization was completed using 
either 4mM K3Fe(CN)6 in 0.1 M KCl or 4mM PAPR in 0.1 M Tris pH 9.0. Detection of the 
enzymatically generated PAPR from the assays consisted of placing a 1µL aliquot of the solution 
from the assay onto a microcavity and performing CV. The shape of the CV response  was 
sigmoidal, as expected, due to a current that is limited by radial diffusion to the microelectrodes. 
The potential range was narrow enough to avoid unwanted electrochemistry of the electrode 
itself and of the solvent.  
 
Data Analysis. The faradaic current of each CV response was measured by determining 
the half-wave potential (E1/2) and measuring the current at 120 mV on either side of that value. 
This method of calculating the current accounted for the reference shift as well as the 
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background current. Following analysis, the data gathered from each study were normalized. 
This is a calculation of the percent of the maximum signal possible (that of 4 mM PAP solution) 
that was actually generated by the assays. CV responses that have been normalized are 
represented by a dimensionless current to allow for comparison between figures. 
 
Results and Discussion 
 
 Immunoassay in Microtiter Plate for CSP Recombinant Protein. Studies were 
performed to determine the optimal antibody solution concentrations that result in assay surfaces 
at which nonspecific adsorption is minimized and where the antigen detection limit is optimized. 
The initial study involved a grid of primary antibody and secondary antibody-enzyme conjugate 
concentrations 2 µg mL-1, 4 µg mL-1, 10 µg mL-1, 20 µg mL-1, and 40 µg mL-1. The antigen was 
either absent or present at a concentration of 0.01 µg mL-1. Figure 5 compares the signals 
obtained from these experiments. At 10 µg mL-1 and 20 µg mL-1 of secondary antibody-enzyme 
conjugate, it is evident that the signals are due to nonspecific adsorption (NSA) of the alkaline 
phosphatase labeled secondary antibody.  It is not clear at this time why there is no NSA at the 
40 µg mL-1 concentration. It was determined from this study as well (figure 5) that the primary 
antibody is saturating the surface at a concentration of 20 µg mL-1.  
The results from the initial antibody concentration study led to a second antibody 
concentration study that focused on the concentration gap (4 µg mL-1 to 10 µg mL-1) of the first 
study, where it was evident that the secondary antibody begins to nonspecifically adsorb. A grid 
of primary and secondary antibody concentrations 2 µg mL-1, 4 µg mL-1, 6 µg mL-1, 8 µg mL-1, 
and 10 µg mL-1 was assembled. Again, the antigen concentration was held constant at 0.01 µg 
mL-1 and it was prepared in blocking buffer without goat serum (see below for reasons why goat 
serum was excluded). This concentration study showed that from these secondary antibody 
concentrations, 8 µg mL-1 is the optimal secondary antibody concentration.  
A study was performed to determine the effect of goat serum in the blocking buffer in 
which the antigen is diluted has on the CSP recombinant protein.  The PBS-BSA-GS blocking 
buffer was originally intended for use with C. parvum and its purpose in the assay specific for 
the CSP recombinant protein of P. falciparum, reported here, was uncertain. This experiment 
used primary and secondary antibody concentrations of 4 µg mL-1 (known to yield no NSA) and 
an antigen concentration of 0.01 µg mL-1 to determine if the goat serum was hindering the 
capture of the antigen, which would cause the assay to give a smaller signal. As Figure 6 
illustrates, a larger signal was detected from the assay when the goat serum was omitted from the 
blocking buffer used to dilute the antigen. With the studies to follow, the antigen was diluted in 
PBS-BSA and the blocking steps were still performed with PBS-BSA-GS, as the goat serum is a 
blocking agent, which helps to prevent NSA.  
 Another objective regarding this assay was the accomplishment of an antigen 
concentration study using the optimal antibody concentrations. The purpose of the antigen 
concentration study was to determine the detection limit of the assay. The concentrations of CSP 
recombinant protein tested were 0.01 µg mL-1, 0.001µg mL-1, 0.0001 µg mL-1, 0.00001 µg mL-1, 
and 1x10-6 µg mL-1. The primary and secondary antibody concentrations were held constant at 
20 µg mL-1 and 8 µg mL-1, respectively. This results lead to two conclusions. One is that the 
secondary antibody-enzyme conjugate  concentration must be less than 8 µg mL-1 because, as 
Figure 7 illustrates, there was still NSA with 8 µg mL-1 of secondary antibody.  The second, as 
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Figure 7 also shows, is the assay cannot detect the CSP recombinant protein below 0.01 µg mL-1, 
as is consistent with previous studies. However, with future work being to assemble the assay 
inside the microcavity, it will likely be possible to achieve a lower detection limit. 
 DNA Hybridization Assay in PCR Tubes for a DNA Sequence for a Portion of the 
CSP Repeat Region.  At the start of this project, a protocol for this DNA hybridization assay 
was developed. It is the procedure that was the starting point for this most recent work described 
herein. Some preliminary studies were done using this original procedure. Figure 8 depicts the 
results of one such experiment, in which there were two tubes with only 0.88 µM alkaline 
phosphatase labeled secondary DNA probe in them, two tubes with only a 0.88 µM solution of 
alkaline phosphatase, and one well that was modified with full assembly (from 5 µM primary 
DNA probe, 0.5 µM target, and 0.88 µM secondary DNA probe). It is quite clear that each 
assembly yielded a signal, when, ideally, only the full assembly should have yielded such. These 
results, along with data from a previous concentration study (all probe concentrations varied), 
confirmed that the protocol as it was described was not adequate.  Efforts were made to find a 
new procedure.   
 A thorough literature search on what reagents (rinsing and blocking buffers) have been 
successfully used for heterogeneous DNA-hybridization assays was made. From this search, a 
new procedure was designed, which is the DNA hybridization assay protocol described in this 
report. A study was conducted to compare this new procedure to a procedure previously reported 
by Aguilar and Fritsch18 for a DNA sequence for heat shock protein 70 for Cryptosporidium 
parvum for a macro setup. That procedure was shown to eliminate NSA in the DNA assay.  
Incubation times from that procedure were adapted to account for the micro set up described 
here. For each of the DNA studies reported here the DNA probe concentrations were held 
constant at 5 µM primary probe, 0.5 µM target, and 0.88 µM secondary probe conjugated to 
alkaline phosphatase.  
 The data from the first study done to test the two procedures and compare them to each 
other still showed NSA. However, the assay in tubes that followed the Aguilar procedure with no 
target produced signals with magnitudes similar to those with full assembly. Not only does this 
suggest significant NSA, but it shows that the signal is completely independent of the primary 
probe as well as the target. A second procedure designed from the literature (described in the 
experimental section) also resulted in some NSA, but the signals from the assemblies lacking 
target were 5% larger than those with a full set up.  
 Following this latter study, another was carried out to further reduce NSA by adding a 
blocking step in the procedure right after the rinsing and following the capture of the target. The 
blocking buffer used was a 2% PEG diluted in wash buffer. PEG is a common blocking agent for 
DNA. The study consisted of the following assemblies (all of which were formed using both 
procedures): full, no target, primary probe and anti-primary probe (0.88 µM), and anti-primary 
probe alone. The purpose of the anti-primary probe, a DNA sequence complementary to the 
primary probe and labeled with alkaline phosphatase, is to verify the presence of the primary 
probe. As, Figure 9 illustrates, the data gathered using the Aguilar procedure shows the same 
results as described earlier. However, it is clear from Figure 10 that the data from the second 
procedure, when normalized and compared to the signals from the same assemblies prepared 
using the original procedure, show a significant reduction in NSA. The new procedure that is 
reported is an improvement, but has not yet completely eliminated the NSA associated with this 
assay.  
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 Future work should involve experiments that increase concentrations of PEG as a 
blocking buffer in the assay. After NSA has been eliminated, concentration studies could then be 




 Our laboratory has reported the first electrochemically-based assays for the CSP of P. 
falciparum. The goals of the research described herein were to explore the two different assays to 
determine which approach would accomplish faster assay time and lower detection limits for use 
in the development of a malaria vaccine.  
 The immunoassay did not exhibit nonspecific adsorption for a set range of antibody 
concentrations, and those conditions were used to detect the antigen, CSP recombinant protein, at 
a concentration of 0.01 µg mL-1, even after the removal of the goat serum which was hindering 
its activity. This detection limit is not as low as the goal of 1x10-6 µg mL-1 CSP recombinant 
protein, but with future work to use redox cycling and assemble the assay immediately adjacent 
to a detecting electrode inside the microcavity, it is likely the desired detection limit will be 
achieved.  
 The DNA hybridization assay was not optimized, but significant improvements were 
made on the original procedure that did not sufficiently control the nonspecific adsorption of the 
alkaline phosphatase labeled secondary probe. It was determined that the procedure reported here 
is a better foundation for optimizing the DNA hybridization assay because the nonspecific 
adsorption was significantly reduced when compared to previous identical assemblies. If future 
work were to be done with this assay, increasing the concentration of the blocking agent, PEG, 
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